Document

0001012477-19-000008.txt : 20190809 0001012477-19-000008.hdr.sgml : 20190809 20190809130717 ACCESSION NUMBER: 0001012477-19-000008 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 95 CONFORMED PERIOD OF REPORT: 20190630 FILED AS OF DATE: 20190809 DATE AS OF CHANGE: 20190809 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AVADEL PHARMACEUTICALS PLC CENTRAL INDEX KEY: 0001012477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-37977 FILM NUMBER: 191012267 BUSINESS ADDRESS: STREET 1: BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK STREET 2: BALLYCOOLIN CITY: DUBLIN STATE: L2 ZIP: 15 BUSINESS PHONE: 636-449-1830 MAIL ADDRESS: STREET 1: 16640 CHESTERFIELD GROVE ROAD STREET 2: SUITE 200 CITY: CHESTERFIELD STATE: MO ZIP: 63005 FORMER COMPANY: FORMER CONFORMED NAME: FLAMEL TECHNOLOGIES SA DATE OF NAME CHANGE: 19960422 10-Q 1 avdl2019q2.htm 10-Q Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

———————

FORM 10-Q

———————

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: June 30, 2019

———————

AVADEL PHARMACEUTICALS PLC

(Exact name of registrant as specified in its charter)

———————



Ireland	000-28508	98-1341933
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

Block 10-1, Blanchardstown Corporate Park

Ballycoolin

Dublin 15, Ireland

(Address of Principal Executive Office and Zip Code)

+353-1-485-1200

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

———————

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.



Large accelerated filer	¨	Accelerated filer	þ
Non-accelerated	¨	Smaller reporting company	¨
(Do not check if a smaller reporting company)		Emerging growth company	¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No þ

At August 6, 2019, 37,450,300 ordinary shares, nominal value $0.01 each, of the Company were outstanding.

TABLE OF CONTENTS



		Page #
Cautionary Note Regarding Forward Looking Statements		3

PART I - FINANCIAL INFORMATION
Item 1.	Financial Statements	4
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	30
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	47
Item 4.	Controls and Procedures	47

PART II - OTHER INFORMATION
Item 1.	Legal Proceedings	47
Item 1A.	Risk Factors	47
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	47
Item 3.	Defaults Upon Senior Securities	48
Item 4.	Mine Safety Disclosures	48
Item 5.	Other Information	48
Item 6.	Exhibits	48

- 2 -

Cautionary Note Regarding Forward-Looking Statements

This quarterly report on Form 10-Q includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These include statements as to our future expectations, beliefs, plans, strategies, objectives, events, conditions, financial performance, prospects, or other events. In some cases, forward-looking statements can be identified by the use of words such as “will,” “may,” “believe,” “expect,” “anticipate,” “estimate,” “project” and similar expressions, and the negatives thereof.

Our forward-looking statements are based on estimates and assumptions that are made within the bounds of our knowledge of our business and operations and that we consider reasonable. However, our business and operations are subject to significant risks and as a result there can be no assurance that actual results of our research, development and commercialization activities and the results of our business and operations will not differ materially from the results contemplated in such forward-looking statements. Factors that could cause actual results to differ from expectations in our forward-looking statements include:

(a) risks relating to our recent net losses and restructuring plan, including risks relating to the following:


•	due to a decrease in our available liquid assets, our business strategy has been refocused and is now substantially dependent upon a single product, FT218;


•	our recent restructuring plan may not be as effective as we anticipate and may have unintended negative impacts;


•	further restructuring actions, if needed, may require third-party consents (including consents under the indenture governing our convertible debt) and such consents may not be granted;


•	the Chapter 11 bankruptcy filing by our subsidiary Avadel Specialty Pharmaceuticals LLC may have unexpected adverse results; and

•

Patient enrollment for our FT 218 clinical trial is not expected to be complete until the second half of 2020. As a result, we do not expect to submit an application for FDA approval of FT218 until sometime during 2021. Our financial resources are currently anticipated to be sufficient to finance our operations into 2021. Accordingly, it may be necessary for us to seek additional financial resources to continue our operations, and such financial resources may not be available to us on reasonable terms, or at all.

(b) risks relating to the following:


•	our three products Bloxiverz®, Vazculep® and Akovaz®, which are not patent protected, and have a small number of customers, currently produce substantially all of our revenues, and could face further competition resulting in a further loss of market share and/or forcing us to further reduce our prices for those products;


•	our current “unapproved marketed drug” (UMD) product candidate, AV001, could fail to achieve FDA approval; or we could fail to develop future potential UMD product candidates, or competitors could develop such products and market such products with FDA approval before us;


•	we could experience failure or further delay in completing the Phase III clinical trial for FT218, and if the FDA ultimately approves such product, the approval may not include any period of market exclusivity;


•	we may not have sufficient cash or the ability to raise sufficient cash to service our $143.75 million Exchangeable Senior Notes due 2023, including cash necessary to repay such Notes at maturity, to settle exchanges of such Notes in cash or to repurchase such Notes as required following a “fundamental change” event described in the indenture governing such Notes;


•	we depend on one or a limited number of third parties to manufacture certain of our products and to provide certain raw materials used in our products;


•	our competitors may develop and market technologies or products that are more effective or safer than ours, or obtain regulatory approval and market such technologies or products before we do;


•	we face challenges in protecting intellectual property underlying our products and drug delivery technologies; and


•	we depend on key personnel to execute our business plan.

(c) the other risks and uncertainties described in the “Risk Factors” section of Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2018 which we filed with the Securities and Exchange Commission on March 15, 2019.

Forward-looking statements speak only as of the date they are made and are not guarantees of future performance. Accordingly, you should not place undue reliance on forward-looking statements. We do not undertake any obligation to publicly update or revise the forward-looking statements contained in this Quarterly Report.

- 3 -

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

AVADEL PHARMACEUTICALS PLC

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF LOSS

(In thousands, except per share data)

(Unaudited)



	Three Months Ended June 30,						Six Months Ended June 30,
	2019			2018			2019			2018

Revenues:
Product sales	$	17,554		$	29,116		$	33,991		$	62,277
License revenue	—			114			—			246
Total revenues	17,554			29,230			33,991			62,523
Operating expenses:
Cost of products	3,622			3,512			6,888			10,104
Research and development expenses	10,292			11,890			17,621			21,841
Selling, general and administrative expenses	6,758			27,843			17,204			52,330
Intangible asset amortization	204			1,609			405			3,376
Changes in fair value of related party contingent consideration	(377		)	(12,889		)	1,757			(9,921		)
Restructuring costs	1,506			50			2,734			203
Total operating expenses	22,005			32,015			46,609			77,933
Operating loss	(4,451		)	(2,785		)	(12,618		)	(15,410		)
Investment and other income, net	950			583			1,767			637
Interest expense	(3,106		)	(2,980		)	(6,168		)	(4,577		)
Loss on deconsolidation of subsidiary	(167		)	—			(2,840		)	—
Other (expense) income - changes in fair value of related party payable	(50		)	1,402			(357		)	1,007
Loss before income taxes	(6,824		)	(3,780		)	(20,216		)	(18,343		)
Income tax provision (benefit)	1,781			(342		)	1,407			(2,669		)
Net loss	$	(8,605	)	$	(3,438	)	$	(21,623	)	$	(15,674	)

Net loss per share - basic	$	(0.23	)	$	(0.09	)	$	(0.58	)	$	(0.42	)
Net loss per share - diluted	(0.23		)	(0.09		)	(0.58		)	(0.42		)

Weighted average number of shares outstanding - basic	37,356			36,772			37,355			37,666
Weighted average number of shares outstanding - diluted	37,356			36,772			37,355			37,666

See accompanying notes to unaudited condensed consolidated financial statements.

- 4 -

AVADEL PHARMACEUTICALS PLC

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(In thousands)

(Unaudited)



	Three Months Ended June 30,						Six Months Ended June 30,
	2019			2018			2019			2018

Net loss	$	(8,605	)	$	(3,438	)	$	(21,623	)	$	(15,674	)
Other comprehensive (loss) income, net of tax:
Foreign currency translation gain (loss)	62			(482		)	(99		)	(233		)
Net other comprehensive income (loss), net of ($23), ($11), ($41) and ($70) tax, respectively	293			78			667			(160		)
Total other comprehensive income (loss), net of tax	355			(404		)	568			(393		)
Total comprehensive loss	$	(8,250	)	$	(3,842	)	$	(21,055	)	$	(16,067	)

See accompanying notes to unaudited condensed consolidated financial statements.

- 5 -

AVADEL PHARMACEUTICALS PLC

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except per share data)



	June 30, 2019			December 31, 2018
	(unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	17,111		$	9,325
Marketable securities	62,151			90,590
Accounts receivable	10,172			11,330
Inventories	2,601			4,770
Prepaid expenses and other current assets	5,165			8,836
Total current assets	97,200			124,851
Property and equipment, net	934			1,911
Operating lease right-of-use assets	5,454			—
Goodwill	18,491			18,491
Intangible assets, net	1,224			1,629
Research and development tax credit receivable	7,833			7,272
Other non-current assets	34,573			36,146
Total assets	$	165,709		$	190,300

LIABILITIES AND SHAREHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Current portion of long-term debt	$	105		$	106
Current portion of long-term related party payable	8,264			9,439
Current portion of operating lease liability	999			—
Accounts payable	4,798			3,503
Accrued expenses	15,737			21,695
Other current liabilities	3,677			3,640
Total current liabilities	33,580			38,383
Long-term debt, less current portion	118,631			115,734
Long-term related party payable, less current portion	15,983			19,401
Long-term operating lease liability	3,617			—
Other non-current liabilities	11,675			14,002
Total liabilities	183,486			187,520

Shareholders’ (deficit) equity:
Preferred shares, nominal value of $0.01 per share; 50,000 shares authorized; none issued or outstanding at June 30, 2019 and December 31, 2018, respectively	—			—
Ordinary shares, nominal value of $0.01 per share; 500,000 shares authorized; 42,763 issued and 37,356 outstanding at June 30, 2019 and 42,720 issued and 37,313 outstanding at December 31, 2018	427			427
Treasury shares, at cost, 5,407 shares held at June 30, 2019 and December 31, 2018, respectively	(49,998		)	(49,998		)
Additional paid-in capital	434,254			433,756
Accumulated deficit	(379,612		)	(357,989		)
Accumulated other comprehensive loss	(22,848		)	(23,416		)
Total shareholders’ (deficit) equity	(17,777		)	2,780
Total liabilities and shareholders’ (deficit) equity	$	165,709		$	190,300

See accompanying notes to unaudited condensed consolidated financial statements.

- 6 -

AVADEL PHARMACEUTICALS PLC

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ (DEFICIT) EQUITY

(In thousands)

(Unaudited)

Six Months Ended June 30, 2019



	Ordinary shares			Additional		Accumulated			Accumulated other comprehensive			Treasury Shares				Total shareholders’
	Shares	Amount		paid-in capital		deficit			(loss) income			Shares	Amount			(deficit) equity
Balance, December 31, 2018	42,720	$	427	$	433,756	$	(357,989	)	$	(23,416	)	5,407	$	(49,998	)	$	2,780
Net loss	—	—		—		(13,018		)	—			—	—			(13,018		)
Other comprehensive income	—	—		—		—			213			—	—			213
Vesting of restricted shares	1	—		—		—			—			—	—			—
Employee share purchase plan share issuance	42	—		92		—			—			—	—			92
Stock-based compensation expense	—	—		351		—			—			—	—			351
Balance, March 31, 2019	42,763	$	427	$	434,199	$	(371,007	)	$	(23,203	)	5,407	$	(49,998	)	$	(9,582	)
Net loss	—	—		—		(8,605		)	—			—	—			(8,605		)
Other comprehensive income	—	—		—		—			355			—	—			355
Stock-based compensation expense	—	—		55		—			—			—	—			55
Balance, June 30, 2019	42,763	$	427	$	434,254	$	(379,612	)	$	(22,848	)	5,407	$	(49,998	)	$	(17,777	)

- 7 -

AVADEL PHARMACEUTICALS PLC

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ (DEFICIT) EQUITY

(In thousands)

(Unaudited)

Six Months Ended June 30, 2018



	Ordinary shares			Additional		Accumulated			Accumulated other comprehensive			Treasury Shares				Total shareholders’
	Shares	Amount		paid-in capital		deficit			(loss) income			Shares	Amount			equity
Balance, December 31, 2017	41,463	$	414	$	393,478	$	(262,685	)	$	(23,266	)	2,117	$	(22,361	)	$	85,580
Net loss	—	—		—		(12,236		)	—			—	—			(12,236		)
Other comprehensive income	—	—		—		—			(404		)	—	—			(404		)
Exercise of warrants	603	6		2,905		—			—			—	—			2,911
Expiration of warrants	—	—		2,167		—			—			—	—			2,167
Stock-based compensation expense	—	—		2,134		—			—			—	—			2,134
Equity component of 2023 Notes	—	—		26,699		—			—			—	—			26,699
Share repurchases	—	—		—		—			—			2,307	(20,212		)	(20,212		)
Balance, March 31, 2018	42,066	$	420	$	427,383	$	(274,921	)	$	(23,670	)	4,424	$	(42,573	)	$	86,639
Net loss	—	—		—		(3,438		)	—			—	—			(3,438		)
Other comprehensive income	—	—		—		—			11			—	—			11
Exercise of stock options	82	1		534		—			—			—	—			535
Stock-based compensation expense	—	—		2,224		—			—			—	—			2,224
Share repurchases	—	—		—		—			—			983	(7,425		)	(7,425		)
Balance, June 30, 2018	42,148	$	421	$	430,141	$	(278,359	)	$	(23,659	)	5,407	$	(49,998	)	$	78,546

- 8 -

AVADEL PHARMACEUTICALS PLC

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)



	Six Months Ended June 30,
	2019			2018

Cash flows from operating activities:
Net loss	$	(21,623	)	$	(15,674	)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	1,064			3,810
Loss on disposal of property and equipment	478			—
Amortization of premiums on marketable securities	17			1,693
Remeasurement of related party acquisition-related contingent consideration	1,757			(9,921		)
Remeasurement of related party financing-related contingent consideration	357			(1,007		)
Amortization of debt discount and debt issuance costs	2,918			2,019
Change in deferred tax and income tax deferred charge	1,900			(3,247		)
Stock-based compensation expense	406			4,358
Loss on deconsolidation of subsidiary	1,750			—
Other adjustments	(1,012		)	91
Net changes in assets and liabilities
Accounts receivable	579			(157		)
Inventories	2,124			(242		)
Prepaid expenses and other current assets	(1,829		)	1,587
Research and development tax credit receivable	(593		)	(1,003		)
Accounts payable & other current liabilities	3,127			5,206
Accrued expenses	(3,737		)	(9,831		)
Earn-out payments for related party contingent consideration in excess of acquisition-date fair value	(5,790		)	(11,113		)
Royalty payments for related party payable in excess of original fair value	(917		)	(1,618		)
Other assets and liabilities	(3,629		)	(2,893		)
Net cash used in operating activities	(22,653		)	(37,942		)

Cash flows from investing activities:
Purchases of property and equipment	(29		)	(99		)
Proceeds from the disposal of property and equipment	154			—
Purchase of intangible asset	—			(20,000		)
Proceeds from sales of marketable securities	52,202			253,525
Purchases of marketable securities	(21,991		)	(312,638		)
Net cash provided by (used in) investing activities	30,336			(79,212		)

Cash flows from financing activities:
Earn-out payments for related party contingent consideration	—			(645		)
Proceeds from debt issuance	—			143,750
Payments for debt issuance costs	—			(5,760		)
Share repurchases	—			(27,637		)
Proceeds from issuance of ordinary shares and warrants	92			3,446
Other financing activities, net	(37		)	6
Net cash provided by financing activities	55			113,160

Effect of foreign currency exchange rate changes on cash and cash equivalents	48			(93		)

Net change in cash and cash equivalents	7,786			(4,087		)
Cash and cash equivalents at January 1,	9,325			16,564
Cash and cash equivalents at June 30,	$	17,111		$	12,477

Supplemental disclosures of cash flow information:
Interest paid	$	3,234		$	394
Income taxes paid	$	140		$	409

See accompanying notes to unaudited condensed consolidated financial statements.

- 9 -

AVADEL PHARMACEUTICALS PLC

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share data)

NOTE 1: Summary of Significant Accounting Policies

Nature of Operations. Avadel Pharmaceuticals plc (Nasdaq: AVDL) (“Avadel,” the “Company,” “we,” “our,” or “us”) is a branded specialty pharmaceutical company. Our primary focus is on the development and potential U.S. Food and Drug Administration (“FDA”) approval for FT218 which is in a Phase 3 clinical trial for the treatment of narcolepsy patients suffering from excessive daytime sleepiness (EDS) and cataplexy. In addition, we market three sterile injectable drugs used in the hospital setting which were developed under our “unapproved marketed drug” (UMD) program. The Company is headquartered in Dublin, Ireland with operations in St. Louis, Missouri and Lyon, France. For more information, please visit www.avadel.com.

Avadel is developing FT218, an investigational once-nightly formulation of sodium oxybate based on its propriety Micropump® drug delivery technology, for the treatment of EDS and cataplexy in patients suffering from narcolepsy. FT218 is currently being evaluated in a Phase 3 clinical trial called REST-ON. In addition, the Company submitted a new drug application (“NDA”) in March 2019 on a fourth sterile injectable drug used in the hospital setting (“UMD #4”), which, if approved, could contribute revenues to Avadel starting in 2020. In May 2019, the FDA accepted this NDA, AV001, with a Prescription Drug User Fee Act (PDUFA) target action date of December 15, 2019.

Our current marketed products include:


•	Akovaz® (ephedrine sulfate injection, USP), an alpha- and beta-adrenergic agonist and a norepinephrine-releasing agent that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.


•	Bloxiverz® (neostigmine methylsulfate injection), a cholinesterase inhibitor, is indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents (NMBAs) after surgery.


•	Vazculep® (phenylephrine hydrochloride injection), an alpha-1 adrenergic receptor agonist indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.

Each of our Akovaz, Bloxiverz and Vazculep products is used primarily in the hospital setting and was developed under our UMD program.

The Company was incorporated on December 1, 2015 as an Irish private limited company, and re-registered as an Irish public limited company, or plc, on November 21, 2016. Our principal place of business is located at Block 10-1, Blanchardstown Corporate Park, Ballycoolin, Dublin 15, Ireland. Avadel’s phone number is 011-353-1-485-1200. Our website is www.avadel.com, where we make available free of charge our reports (and any amendments thereto) on Forms 10-K, 10-Q and 8-K as soon as reasonably practicable after they are electronically filed with or furnished to the U.S. Securities and Exchange Commission (“SEC”). These filings are also available to the public at www.sec.gov.

The Company is the successor to Flamel Technologies S.A., a French société anonyme (“Flamel”), as the result of the France-to-Ireland redomestication merger of Flamel with and into the Company completed on December 31, 2016 (the “Merger”). In the Merger, we changed our company name to Avadel Pharmaceuticals plc and our jurisdiction of organization to Ireland; we assumed all the assets and liabilities of Flamel; and we issued one Avadel ordinary share (either directly or in the form of an American Depositary Share (ADS)) in exchange for each formerly outstanding share of Flamel, all of which were canceled. Thus, an Avadel ordinary share held (either directly or represented by an ADS) immediately after the Merger continued to represent the same proportional interest in our equity owned by the holder of a share of Flamel immediately prior to the Merger. References in this Annual Report on Form 10-K to “Avadel,” the “Company,” “we,” “our,” “us,” and similar terms shall be deemed to be references to Flamel prior to the completion of the Merger, unless the context otherwise requires. Additional details about the Merger are set forth in Item 1 under the caption “The Reincorporation Merger” of the Company’s Annual Report on Form 10-K filed with the SEC on March 15, 2019.

- 10 -

Management Corporation, (iv) FSC Holding Company and (v) Avadel Operations Company, Inc. Avadel Finance Ireland Designated Activity Company is the holding entity of Avadel Finance Cayman Limited. Flamel Ireland Limited (operating under the trade name Avadel Ireland) is an Irish corporation which, since December 16, 2014, has been the owner of substantially all of Avadel’s intellectual property. Avadel France Holding SAS, a French société par actions simplifiée, is the holding entity of Avadel Research SAS through which Avadel conducts substantially all of its R&D activities.

Basis of Presentation. The unaudited condensed consolidated balance sheet as of June 30, 2019, which is derived from the prior year 2018 audited consolidated financial statements, and the interim unaudited condensed consolidated financial statements presented herein, have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP), the requirements of Form 10-Q and Article 10 of Regulation S-X and, consequently, do not include all information or footnotes required by U.S. GAAP for complete financial statements or all the disclosures normally made in an annual report on Form 10-K. Accordingly, the unaudited condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements and footnotes included in the Company’s 2018 Annual Report on Form 10-K filed with the SEC on March 15, 2019.

The unaudited condensed consolidated financial statements include the accounts of the Company and subsidiaries, and reflect all adjustments (consisting only of normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the dates and periods presented. All material intercompany accounts and transactions have been eliminated. Results for interim periods are not necessarily indicative of the results to be expected during the remainder of the current year or for any future period.

On February 6, 2019, the Company’s indirect wholly-owned subsidiary, Avadel Specialty Pharmaceuticals, LLC (“Specialty Pharma”), filed a voluntary petition for reorganization under Chapter 11 of the United States (“U.S.”) Code (the “Bankruptcy Code”). in the U.S. District Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”), Case No. 19-10248. Specialty Pharma is operating and managing its business as “debtors-in-possession” under the jurisdiction of the Bankruptcy Court and in accordance with the applicable provisions of the Bankruptcy Code and order of the Bankruptcy Court. As a result of Specialty Pharma’s voluntary bankruptcy filing on February 6, 2019, we no longer controlled the operations of Specialty Pharma; therefore, we deconsolidated Specialty Pharma effective with the bankruptcy filing and the Company recorded its investment in Specialty Pharma under the cost method. See Note 3: Subsidiary Bankruptcy and Deconsolidation. Our results of operations for the period January 1, 2019 through February 6, 2019 include the results of Specialty Pharma prior to its February 6, 2019 voluntary petition for reorganization under Chapter 11 of the U.S. Bankruptcy Code.

Our results of operations for the period January 1, 2018 through February 16, 2018 include the results of FSC Therapeutics and FSC Laboratories, Inc., (collectively “FSC”), prior to its February 16, 2018 disposition date. See Note 14: Divestiture of the Pediatric Assets, for additional information. All intercompany accounts and transactions have been eliminated.

Revenue. Revenue includes sales of pharmaceutical products, licensing fees, and, if any, milestone payments for research and development (“R&D”) achievements.

Accounting Standards Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers” applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. Under ASC 606, an entity recognizes revenue when the performance obligations to the customer have been satisfied through the transfer of control of the goods or services. To determine the appropriate revenue recognition for arrangements that the Company believes are within the scope of ASC 606, we perform the following five steps: (i) Identify the contract(s) with a customer; (ii) Identify the performance obligations in the contract; (iii) Determine the transaction price; (iv) Allocate the transaction price to the performance obligations in the contract; and (v) Recognize revenue when (or as) the entity satisfies a performance obligation. The Company applies the five-step model to contracts only when the Company and its customer’s rights and obligations under the contract can be determined, the contract has commercial substance, and it is probable that the Company will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. For contracts that are determined to be within the scope of ASC 606, the Company identifies the promised goods or services in the contract to determine if they are separate performance obligations or if they should be bundled with other goods and services into a single performance obligation. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.

Product Sales and Services

- 11 -

chargebacks, payment discounts, rebates, and other sales allowances and are estimated based on analysis of historical data for the product or comparable products, future expectations for such products and other judgments and analysis.

License Revenue

The Company from time to time may enter into out-licensing agreements which are within the scope of ASC 606 under which it licenses to third parties certain rights to its products or intellectual property. The terms of these arrangements typically include payment to the Company of one or more of the following: non-refundable, upfront license fees; development, regulatory, and commercial milestone payments; and sales-based royalty payments. Each of these payments results in license revenue.

For a complete discussion of the accounting for net product revenue and license revenues, see Note 4: Revenue Recognition.

NOTE 2: Newly Issued Accounting Standards

Recent Accounting Guidance Not Yet Adopted

In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework— Changes to the Disclosure Requirement for Fair Value Measurement” which amends certain disclosure requirements over Level 1, Level 2 and Level 3 fair value measurements. The amendments in ASU 2018-13 are effective for fiscal years beginning after December 15, 2019, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2018-13.

In January 2017, the FASB issued ASU 2017-04, “Intangibles - Goodwill and Other: Simplifying the Test for Goodwill Impairment.” This update eliminates step 2 from the goodwill impairment test, and requires the goodwill impairment test to be performed by comparing the fair value of a reporting unit with its carrying amount. An impairment charge should be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. This guidance is effective for the Company in the first quarter of 2020. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The Company will assess the timing of adoption and impact of this guidance to future impairment considerations.

NOTE 3: Subsidiary Bankruptcy and Deconsolidation

Bankruptcy Filing and Deconsolidation

As a result of Specialty Pharma’s bankruptcy filing on February 6, 2019, Avadel has ceded authority for managing the business to the Bankruptcy Court, and Avadel management cannot carry on Specialty Pharma’s activities in the ordinary course of business without Bankruptcy Court approval. Avadel manages the day-to-day operations of Specialty Pharma, but does not have discretion to make significant capital or operating budgetary changes or decisions and purchase or sell significant assets, as Specialty Pharma’s material decisions are subject to review by the Bankruptcy Court. For these reasons, we have concluded that Avadel has lost control of Specialty Pharma, and no longer has significant influence over Specialty Pharma during the pendency of the bankruptcy. Therefore, we deconsolidated Specialty Pharma effective with the filing of the Chapter 11 bankruptcy in February 2019.

In order to deconsolidate Specialty Pharma, the carrying values of the assets and certain liabilities of Specialty Pharma were removed from our unaudited condensed consolidated balance sheet as of February 5, 2019, and we recorded our investment in Specialty Pharma at its estimated fair value of $0. As the estimated fair value of our investment in Specialty Pharma was lower than its net book value immediately prior to the deconsolidation, we recorded a non-cash charge of approximately $167 and 2,840 for the three and six months ended June 30, 2019, respectively, associated with the deconsolidation of Specialty Pharma. Subsequent to the deconsolidation of Specialty Pharma, we are accounting for our investment in Specialty Pharma using the cost method of accounting because Avadel does not exercise significant influence over the operations of Specialty Pharma due to the Chapter 11 filing.

On April 26, 2019, Specialty Pharma sold its intangible assets and remaining inventory to an unaffiliated third party in exchange for aggregate cash proceeds of approximately $250, pursuant to an order approving such sale which was issued by the Bankruptcy Court on April 15, 2019. As a result of such sale, Specialty Pharma has completed its divestment of the assets of the Noctiva business.

On July 2, 2019, Specialty Pharma was made aware of a $50,695 claim made by the Internal Revenue Service (IRS) as part of the bankruptcy claims process against Specialty Pharma. Specialty Pharma files its U.S. federal tax return as a member of the Company’s consolidated U.S. tax group. As such, the IRS claim was filed against Specialty Pharma in the bankruptcy proceedings

- 12 -

due to IRS tax law requirements for joint and several liability of all members in a consolidated U.S. tax group. Both Specialty Pharma and the Company disagree with the merits of the IRS claim, and intend to defend their positions vigorously.

DIP Financing – Related Party Relationship

In connection with the bankruptcy filing, Specialty Pharma entered into a Debtor in Possession Credit and Security Agreement with Avadel US Holdings (“DIP Credit Agreement”) dated as of February 8, 2019, in an aggregate amount of up to $2,700, of which the funds are to be used by Specialty Pharma solely to fund operations through February 6, 2020. As of June 30, 2019, the Company had funded $407 under the DIP Credit Agreement. As the Company has assessed that it is unlikely that Specialty Pharma will pay back the loan to Avadel, the $407 has been recorded as part of the loss on deconsolidation of subsidiary within the unaudited condensed consolidated statements of loss. At June 30, 2019 the fair value of the remaining commitment under the DIP Credit Agreement is not material.

NOTE 4: Revenue Recognition

The Company generates revenue primarily from the sale of pharmaceutical products to customers. From time to time the Company also generates revenue from licensing arrangements whereby the Company provides access to certain of its intellectual property.

Product Sales and Services

Effective January 1, 2018, the Company implemented ASC 606, “Revenue From Contracts With Customers”. The Company sells products primarily through wholesalers and considers these wholesalers to be its customers. Under ASC 606, revenue from product sales is recognized when the customer obtains control of the Company’s product and the Company’s performance obligations are met, which occurs typically upon receipt of delivery to the customer. As is customary in the pharmaceutical industry, the Company’s gross product sales are subject to a variety of price adjustments in arriving at reported net product sales. These adjustments include estimates for product returns, chargebacks, payment discounts, rebates, and other sales allowances and are estimated when the product is delivered based on analysis of historical data for the product or comparable products, as well as future expectations for such products.

Reserves to reduce Gross Revenues to Net Revenues

Revenues from product sales are recorded at the net selling price, which includes estimated reserves to reduce gross product sales to net product sales resulting from product returns, chargebacks, payment discounts, rebates, and other sales allowances that are offered within contracts between the Company and its customers and end users. These reserves are based on the amounts earned or to be claimed on the related sales and are classified as reductions of accounts receivable if the amount is payable to the customer, except in the case of the estimated reserve for future expired product returns, which are classified as a liability. The reserves are classified as a liability if the amount is payable to a party other than a customer. Where appropriate, these estimated reserves take into consideration relevant factors such as the Company’s historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company’s best estimates to reduce gross selling price to net selling price to which it expects to be entitled based on the terms of its contracts. The actual selling price ultimately received may differ from the Company’s estimates. If actual results in the future vary from the Company’s estimates, the Company adjusts these estimates, which would affect net product revenue and earnings in the period such variances become known.

Product Returns

Consistent with industry practice, the Company maintains a returns policy, that generally offers customers a right of return for product that has been purchased from the Company. The Company estimates the amount of product returns and records this estimate as a reduction of revenue in the period the related product revenue is recognized. The Company currently estimates product return liabilities based on analysis of historical data for the product or comparable products, as well as future expectations for such products and other judgments and analysis.

Chargebacks, Discounts and Rebates

Chargebacks, discounts and rebates represent the estimated obligations resulting from contractual commitments to sell products to its customers or end users at prices lower than the list prices charged to our wholesale customers. Customers charge the Company for the difference between the gross selling price they pay for the product and the ultimate contractual price agreed to between the Company and these end users. These reserves are established in the same period that the related revenue is recognized, resulting

- 13 -

in a reduction of product revenue and accounts receivable. Chargebacks, discounts and rebates are estimated at the time of sale to the customer.

Revenue from licensing arrangements

The terms of the Company’s licensing agreements may contain multiple performance obligations, including certain R&D activities. The terms of these arrangements typically include payment to the Company of one or more of the following: non-refundable, up-front license fees; development, regulatory and commercial milestone payments. Each of these payments results in license revenues.

License of Intellectual Property

If the license to the Company’s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, up-front fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are bundled with other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, up-front fees. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.

Disaggregation of revenue

The Company’s primary source of revenue is from the sale of pharmaceutical products, which are equally affected by the same economic factors as it relates to the nature, amount, timing, and uncertainty of revenue and cash flows. For further detail about the Company’s revenues by product, see Note 18: Company Operations by Product.

Contract Balances

The Company does not recognize revenue in advance of invoicing its customers and therefore has no related contract assets.

A receivable is recognized in the period the Company sells its products and when the Company’s right to consideration is unconditional.

There were no material deferred contract costs at June 30, 2019.

Transaction Price Allocated to the Remaining Performance Obligation

For product sales, the Company generally satisfies its performance obligations within the same period the product is delivered. Product sales recognized in 2019 from performance obligations satisfied (or partially satisfied) in previous periods were immaterial.

For certain licenses of intellectual property, specifically those with performance obligations satisfied over time, the Company allocates a portion of the transaction price to that performance obligation and recognizes revenue using an appropriate measure of progress towards development of the product.

The Company has elected certain of the practical expedients from the disclosure requirement for remaining performance obligations for specific situations in which an entity need not estimate variable consideration to recognize revenue. Accordingly, the Company applies the practical expedient in ASC 606 to its stand-alone contracts and does not disclose information about variable consideration from remaining performance obligations for which the Company recognizes revenue.

NOTE 5: Fair Value Measurement

The Company is required to measure certain assets and liabilities at fair value, either upon initial recognition or for subsequent accounting or reporting. For example, we use fair value extensively when accounting for and reporting certain financial instruments, when measuring certain contingent consideration liabilities and in the initial recognition of net assets acquired in a business combination. Fair value is estimated by applying the hierarchy described below, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement.

- 14 -

ASC 820, “Fair Value Measurements and Disclosures,” defines fair value as a market-based measurement that should be determined based on the assumptions that marketplace participants would use in pricing an asset or liability. When estimating fair value, depending on the nature and complexity of the asset or liability, we may generally use one or each of the following techniques:


•	Income approach, which is based on the present value of a future stream of net cash flows.


•	Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities.

As a basis for considering the assumptions used in these techniques, the standard establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value as follows:


•	Level 1 - Quoted prices for identical assets or liabilities in active markets.


•	Level 2 - Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are directly or indirectly observable, or inputs that are derived principally from, or corroborated by, observable market data by correlation or other means.


•	Level 3 - Unobservable inputs that reflect estimates and assumptions.

The following table summarizes the financial instruments measured at fair value on a recurring basis classified in the fair value hierarchy (Level 1, 2 or 3) based on the inputs used for valuation in the accompanying unaudited condensed consolidated balance sheets:



	As of June 30, 2019						As of December 31, 2018
Fair Value Measurements:	Level 1		Level 2		Level 3		Level 1		Level 2		Level 3

Marketable securities (see Note 6)
Equity securities	$	4,038	$	—	$	—	$	9,145	$	—	$	—
Money market funds	47,033		—		—		52,996		—		—
Corporate bonds	—		3,664		—		—		6,339		—
Government securities - U.S.	—		5,234		—		—		12,701		—
Other fixed-income securities	—		2,182		—		—		9,409		—
Total assets	$	51,071	$	11,080	$	—	$	62,141	$	28,449	$	—

Related party payable (see Note 10)	$	—	$	—	$	24,247	$	—	$	—	$	28,840
Total liabilities	$	—	$	—	$	24,247	$	—	$	—	$	28,840

A review of fair value hierarchy classifications is conducted on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. During the periods ended June 30, 2019 and December 31, 2018, respectively, there were no transfers in and out of Level 1, 2, or 3. During the three month periods ended June 30, 2019 and 2018, respectively, we did not recognize any other-than-temporary impairment loss.

Some of the Company’s financial instruments, such as cash and cash equivalents, accounts receivable and accounts payable, are reflected in the balance sheet at carrying value, which approximates fair value due to their short-term nature.

Debt

We estimate the fair value of our $143,750 aggregate principal amount of 4.50% exchangeable senior notes due 2023 (the “2023 Notes”), a Level 2 input, based on interest rates that would be currently available to the Company for issuance of similar types of debt instruments with similar terms and remaining maturities or recent trading prices obtained from brokers. The estimated fair value of the 2023 Notes at June 30, 2019 is $60,914 compared to a book value of $118,625.

Additionally, the Company’s other debt is reflected in the balance sheet at carrying value. The fair value of these loans is impracticable to estimate as these represent non-interest bearing grants from the French government and are repayable only if the research project is technically or commercially successful.

See Note 11: Long-Term Debt for additional information regarding our debt obligations.

- 15 -

NOTE 6: Marketable Securities

The Company has investments in available-for-sale marketable securities which are recorded at fair market value. The change in the fair value of available-for-sale equity investments is recognized in our unaudited condensed consolidated statements of loss and the change in the fair value of all other available-for-sale investments is recorded as other comprehensive income (loss) in shareholders’ (deficit) equity, net of income tax effects.

The following tables show the Company’s available-for-sale securities’ adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category as of June 30, 2019 and December 31, 2018, respectively:



	June 30, 2019
Marketable Securities:	Adjusted Cost		Unrealized Gains		Unrealized Losses			Fair Value

Equity securities	$	4,166	$	—	$	(128	)	$	4,038
Money market funds	46,314		719		—			47,033
Corporate bonds	3,611		54		(1		)	3,664
Government securities - U.S.	5,122		114		(2		)	5,234
Other fixed-income securities	2,154		29		(1		)	2,182
Total	$	61,367	$	916	$	(132	)	$	62,151



	December 31, 2018
Marketable Securities:	Adjusted Cost		Unrealized Gains		Unrealized Losses			Fair Value

Equity securities	$	10,101	$	—	$	(956	)	$	9,145
Money market funds	52,733		316		(53		)	52,996
Corporate bonds	6,411		7		(79		)	6,339
Government securities - U.S.	12,714		66		(79		)	12,701
Other fixed-income securities	9,400		22		(13		)	9,409
Total	$	91,359	$	411	$	(1,180	)	$	90,590

We determine realized gains or losses on the sale of marketable securities on a specific identification method. We reflect these gains and losses as a component of investment income in the accompanying unaudited condensed consolidated statements of loss.

We recognized gross realized gains of $174 and $22 for the three months ended June 30, 2019, and 2018, respectively. These realized gains were offset by realized losses of $0 and $194 for the three months ended June 30, 2019, and 2018, respectively. We recognized gross realized gains of $268 and $235 for the six months ended June 30, 2019, and 2018, respectively. These realized gains were offset by realized losses of $147 and $328 for the six months ended June 30, 2019 and 2018, respectively. We reflect these gains and losses as a component of investment income in the accompanying condensed consolidated statements of income (loss).

The following table summarizes the estimated fair value of our investments in marketable debt securities, accounted for as available-for-sale securities and classified by the contractual maturity date of the securities as of June 30, 2019:



	Maturities
Marketable Debt Securities:	Less than 1 Year		1-5 Years		5-10 Years		Greater than 10 Years		Total

Corporate bonds	$	735	$	2,929	$	—	$	—	$	3,664
Government securities - U.S.	—		4,798		—		436		5,234
Other fixed-income securities	426		1,756		—		—		2,182
Total	$	1,161	$	9,483	$	—	$	436	$	11,080

The Company has classified our investment in available-for-sale marketable securities as current assets in the unaudited condensed consolidated balance sheets as the securities need to be available for use, if required, to fund current operations. There are no restrictions on the sale of any securities in our investment portfolio.

- 16 -

NOTE 7: Inventories

The principal categories of inventories, net reserves of $1,143 and $4,757 at June 30, 2019 and December 31, 2018, respectively, are comprised of the following:



Inventory:	June 30, 2019		December 31, 2018

Finished goods	$	2,127	$	4,270
Raw materials	474		500
Total	$	2,601	$	4,770

Total net reserves decreased by $3,614 during the six months ended June 30, 2019 driven largely by the deconsolidation of Specialty Pharma.

NOTE 8: Goodwill and Intangible Assets

The Company’s amortizable and unamortizable intangible assets at June 30, 2019 and December 31, 2018 are as follows:



	June 30, 2019							December 31, 2018
Goodwill and Intangible Assets:	Gross Value		Accumulated Amortization			Net Carrying Amount		Gross Value		Accumulated Amortization			Impairment			Net Carrying Amount

Amortizable intangible assets:
Acquired developed technology - Noctiva	$	—	$	—		$	—	$	73,111	$	(7,024	)	$	(66,087	)	$	—
Acquired developed technology - Vazculep	12,061		(10,837		)	1,224		12,061		(10,432		)	—			1,629
Total amortizable intangible assets	$	12,061	$	(10,837	)	$	1,224	$	85,172	$	(17,456	)	$	(66,087	)	$	1,629

Unamortizable intangible assets:
Goodwill	$	18,491	$	—		$	18,491	$	18,491	$	—		$	—		$	18,491
Total unamortizable intangible assets	$	18,491	$	—		$	18,491	$	18,491	$	—		$	—		$	18,491

The Company recorded amortization expense related to amortizable intangible assets of $204 and $1,609 for the three months ended June 30, 2019 and 2018, respectively and $405 and $3,376 for the six months ended June 30, 2019 and 2018, respectively.

During the fourth quarter 2018, certain conditions came to light, largely the lack of a meaningful increase in Noctiva prescriptions despite the substantial investment of resources, which indicated that the carrying value of the asset, may not be fully recoverable. As such, the Company performed an impairment test based on a comparison of the pretax discounted cash flows expected to be generated by the asset, which is a Level 3 fair value estimate, to the recorded value of the asset and concluded that the associated cash flows did not support any of the carrying value of the intangible asset and the Company recorded a full impairment charge of $66,087 at December 31, 2018 related to the acquired developed technology associated with Noctiva. The February 6, 2019 Chapter 11 bankruptcy filing of Specialty Pharma, the subsidiary which markets, sells and distributes Noctiva, confirmed management’s conclusion on the impairment.

- 17 -

Amortizable intangible assets are amortized over their estimated useful lives, which generally range from three to fifteen years. Estimated amortization of intangible assets for the next five years is as follows:



Estimated Annual Amortization Expense:	Amount

2019	$	815
2020	814
2021	—
2022	—
2023	—

NOTE 9: Leases

In February 2016, the FASB issued ASU 2016-02, “Leases” which supersedes ASC 840 “Leases” and creates a new topic, ASC 842 “Leases.” This update requires lessees to recognize on their balance sheet a lease liability and a lease asset for all leases, including operating leases, with a term greater than 12 months. On January 1, 2019, the Company adopted the ASU using the modified retrospective transition approach and elected the transition option to recognize the adjustment in the period of adoption rather than in the earliest period presented. As January 1, 2019, adoption of the new guidance resulted in the initial recognition of operating lease right-of-use assets of $5,046 and operating lease liabilities of $5,131. At June 30, 2019, the balances of the operating lease right-of-use asset and total operating lease liability are $5,454 and $4,616, respectively, of which $999 of the operating lease liability is current.

The Company leases certain facilities for office and manufacturing purposes, comprising approximately 99% of the total lease population. All leased facilities are classified as operating leases with remaining lease terms between one and seven years. The Company determines if a contract is a lease at the inception of the arrangement. The Company reviews all options to extend, terminate, or purchase its right-of-use assets at the inception of the lease and will include these options in the lease term when they are reasonably certain of being exercised. For all of the Company’s leases, lease and non-lease components are accounted for as a single lease component, as all non-lease components are immaterial to break out separately.

The components of lease costs, which is included in selling, general and administrative expenses in the unaudited condensed consolidated statements of loss for the three and six months ended June 30 were as follows:



Lease cost:	Three months ended June 30, 2019		Six months ended June 30, 2019

Operating lease costs ⁽¹⁾	$	394	$	739
Sublease income ⁽²⁾	61		105
Total lease cost	$	333	$	634

⁽¹⁾Variable lease costs were immaterial for the three and six months ended June 30, 2019.

⁽²⁾ Represents sublease income received for the vacated office facility in Charlotte, North Carolina, which was acquired with the FSC acquisition in February 2016. The lease and sublease agreements terminate in December 2020. The Company also vacated a portion of the office facility in St. Louis, Missouri during May 2019 and started receiving sublease income starting in May 2019. The lease agreement ends in April 2025 and the sublease agreement ends in May 2020 with a one year renewal option.

During the three and six months ended June 30, 2019, the Company reduced its operating lease liabilities by $394 and $704 for cash paid. In addition, during the six months ended June 30, 2019, new operating leases commenced resulting in the recognition of operating lease right-of-use assets and liabilities of $1,000 and $0, respectively, as the entire lease payment was paid on March 31, 2019. There were no new leases during the three months ended June 30, 2019. As of June 30, 2019, the Company is aware of one additional embedded lease that has not yet commenced and will not commence until the time of FDA approval of the product (if approved). Once FDA approval is given and the start date is determined, annual production suite fees of approximately $3,000 to $4,000 would commence and at that time, and an operating lease right-of-use asset and corresponding operating lease liability will be recorded.

As of June 30, 2019, our operating leases have a weighted-average remaining lease term of 5.0 years and a weighted-average discount rate of 5.3%. Nearly all of Avadel’s lease contracts do not provide a readily determinable implicit rate. For these contracts, Avadel’s estimated incremental borrowing rate is based on information available at the inception of the lease.

- 18 -

Maturities of the Company’s operating lease liabilities were as follows:



Maturities:	Operating Leases

Remaining six months of 2019	$	603
2020	1,213
2021	1,003
2022	763
2023	692
Thereafter	958
Total lease payments	5,232
Less: interest	616
Present value of lease liabilities	$	4,616

Under the prior lease guidance, minimum rental commitments for non-cancelable leases as of December 31, 2018 were:



Lease Commitment:	Operating Leases

2019	$	1,191
2020	1,208
2021	1,008
2022	767
2023	695
Thereafter	967
Total minimum lease payments	$	5,836

NOTE 10: Long-Term Related Party Payable

Long-term related party payable and related activity are reported at fair value and consist of the following at June 30, 2019 and December 31, 2018:



				Activity during the Six Months Ended June 30, 2019
							Changes in Fair Value of Related Party Payable
Long-Term Related Party Payable:	Balance, December 31, 2018			Payments to Related Parties			Operating Expense		Other Expense		Balance, June 30, 2019

Acquisition-related contingent consideration:
Earn-out payments - Éclat Pharmaceuticals (a)	$	25,615		$	(5,790	)	$	1,757	$	—	$	21,582
Financing-related:
Royalty agreement - Deerfield (b)	2,184			(621		)	—		236		1,799
Royalty agreement - Broadfin (c)	1,041			(296		)	—		121		866
Total related party payable	28,840			$	(6,707	)	$	1,757	$	357	24,247
Less: current portion	(9,439		)								(8,264		)
Total long-term related party payable	$	19,401									$	15,983

- 19 -

Long-term related party payable and related activity are reported at fair value and consist of the following at June 30, 2019 and March 31, 2019:



				Activity during the Three Months Ended June 30, 2019
							Changes in Fair Value of Related Party Payable
Long-Term Related Party Payable:	Balance, March 31, 2019			Payments to Related Parties			Operating Expense			Other Expense		Balance, June 30, 2019

Acquisition-related contingent consideration:
Earn-out payments - Éclat Pharmaceuticals (a)	$	24,569		$	(2,610	)	$	(377	)	$	—	$	21,582
Financing-related:
Royalty agreement - Deerfield (b)	2,048			(277		)	—			28		1,799
Royalty agreement - Broadfin (c)	976			(132		)	—			22		866
Total related party payable	27,593			$	(3,019	)	$	(377	)	$	50	24,247
Less: current portion	(9,391		)									(8,264		)
Total long-term related party payable	$	18,202										$	15,983

(a) In March 2012, the Company acquired all of the membership interests of Éclat from Breaking Stick Holdings, L.L.C. (“Breaking Stick”, formerly Éclat Holdings), an affiliate of Deerfield. Breaking Stick is majority owned by Deerfield, with a minority interest owned by the Company’s former CEO, and certain other current and former employees. As part of the consideration, the Company committed to provide quarterly earn-out payments equal to 20% of any gross profit generated by certain Éclat products. These payments will continue in perpetuity, to the extent gross profit of the related products also continue in perpetuity.

(b)

As part of a February 2013 debt financing transaction conducted with Deerfield, the Company received cash of $2,600 in exchange for entering into a royalty agreement whereby the Company shall pay quarterly a 1.75% royalty on the net sales of certain Éclat products until December 31, 2024. In connection with such debt financing transaction, the Company granted Deerfield a security interest in the product registration rights of the Eclat products.


(c)	As part of a December 2013 debt financing transaction conducted with Broadfin Healthcare Master Fund, a related party and current shareholder, the Company received cash of $2,200 in exchange for entering into a royalty agreement whereby the Company shall pay quarterly a 0.834% royalty on the net sales of certain Éclat products until December 31, 2024.

At June 30, 2019, the fair value of each related party payable listed in (a), (b) and (c) above was estimated using a discounted cash flow model based on estimated and projected annual net revenues or gross profit, as appropriate, of each of the specified Éclat products using an appropriate risk-adjusted discount rate of 15%. These fair value measurements are based on significant inputs not observable in the market and thus represent a level 3 measurement as defined in ASC 820. Subsequent changes in the fair value of the acquisition-related related party payables, resulting primarily from management’s revision of key assumptions, will be recorded in the unaudited condensed consolidated statements of loss in the line items entitled “Changes in fair value of related party contingent consideration” for items noted in (b) above and in “Other expense - changes in fair value of related party payable” for items (b) and (c) above. See Note 1: Summary of Significant Accounting Policies under the caption Acquisition-related Contingent Consideration and Financing-related Royalty Agreements in Part II, Item 8 of the Company’s 2018 Annual Report on Form 10-K for more information on key assumptions used to determine the fair value of these liabilities.

The Company has chosen to make a fair value election pursuant to ASC 825, “Financial Instruments” for its royalty agreements detailed in items (b) and (c) above. These financing-related liabilities are recorded at fair market value on the unaudited condensed consolidated balance sheets and the periodic change in fair market value is recorded as a component of “Other expense – change in fair value of related party payable” on the unaudited condensed consolidated statements of loss.

- 20 -

The following table summarizes changes to the related party payables, a recurring Level 3 measurement, for the six-month periods ended June 30, 2019 and 2018, respectively:



Related Party Payable Rollforward:	Balance

Balance, December 31, 2017	$	98,925
Payments of related party payable	(13,376		)
Fair value adjustments ⁽¹⁾	(10,928		)
Expiration of warrants	(2,167		)
Disposition of the pediatric assets	(20,337		)
Balance, June 30, 2018	$	52,117

Balance, December 31, 2018	$	28,840
Payments of related party payable	(6,707		)
Fair value adjustments ⁽¹⁾	2,114
Balance, June 30, 2019	$	24,247

⁽¹⁾Fair value adjustments are reported as changes in fair value of related party contingent consideration and other expense - changes in fair value of related party payable in the unaudited condensed consolidated statements of loss.

NOTE 11: Long-Term Debt

Long-term debt is summarized as follows:



	June 30, 2019			December 31, 2018
Principal amount of 4.50% exchangeable senior notes due 2023	$	143,750		$	143,750
Less: debt discount and issuance costs, net	(25,125		)	(28,059		)
Net carrying amount of liability component	118,625			115,691
Other debt	111			149
Subtotal	118,736			115,840
Less: current maturities	(105		)	(106		)
Long-term debt	$	118,631		$	115,734

Equity component:
Equity component of exchangeable notes, net of issuance costs	$	(26,699	)	$	(26,699	)

NOTE 12: Income Taxes

The components of loss before income taxes are as follows:



	Three Months Ended June 30,						Six Months Ended June 30,
Loss Before Income Taxes:	2019			2018			2019			2018

Ireland	$	(12,089	)	$	(10,962	)	$	(22,323	)	$	(15,889	)
United States	9,800			7,019			6,357			(2,816		)
France	(4,535		)	163			(4,250		)	362
Total loss before income taxes	$	(6,824	)	$	(3,780	)	$	(20,216	)	$	(18,343	)

- 21 -

The items accounting for the difference between the income tax provision computed at the statutory rate and the Company’s effective tax rate are as follows:



	Three Months Ended June 30,						Six Months Ended June 30,
Income Tax Rate Reconciliation:	2019			2018			2019			2018

Statutory tax rate	12.5		%	12.5		%	12.5		%	12.5		%
International tax rates differential	10.6		%	(1.5		)%	6.9		%	6.8		%
Change in valuation allowance	(52.9		)%	(39.4		)%	(25.4		)%	(11.9		)%
Change in fair value of nondeductible contingent consideration	1.6		%	67.6		%	(1.5		)%	10.9		%
Nondeductible stock-based compensation	—		%	(4.7		)%	(0.2		)%	(1.8		)%
Unrecognized tax benefits	(2.5		)%	(7.6		)%	(1.4		)%	(2.8		)%
State and local income taxes, net of federal	(0.4		)%	1.0		%	(0.1		)%	0.3		%
Nondeductible interest expense	(3.7		)%	—		%	(2.0		)%	—		%
Other	8.7		%	(18.9		)%	4.4		%	0.5		%
Effective income tax rate	(26.1		)%	9.0		%	(6.8		)%	14.5		%

Income tax benefit - at statutory tax rate	$	(853	)	$	(473	)	$	(2,526	)	$	(2,293	)
International tax rates differential	(723		)	57			(1,391		)	(1,241		)
Change in valuation allowance	3,609			1,491			5,129			2,181
Change in fair value of nondeductible contingent consideration	(110		)	(2,556		)	303			(2,005		)
Nondeductible stock-based compensation	(2		)	176			49			336
Unrecognized tax benefits	168			288			292			508
State and local income taxes, net of federal	25			(38		)	27			(57		)
Nondeductible interest expense	253			—			410			—
Other	(586		)	713			(886		)	(98		)
Income tax provision (benefit) - at effective income tax rate	$	1,781		$	(342	)	$	1,407		$	(2,669	)

The income tax provision was $1,781 for the three months ended June 30, 2019 and a benefit of $342 for the three months ended June 30, 2018. The increase in the income tax provision for the three months ended June 30, 2019 is primarily the result of a decrease in the amount of nontaxable gain from the revaluation of contingent consideration and an increase in the amount of valuation allowances recorded on foreign income tax losses.

The income tax provision was $1,407 for the six months ended June 30, 2019 and a benefit of $2,669 for the six months ended June 30, 2018. The increase in the income tax provision for the six months ended June 30, 2019 is primarily the result of a decrease the amount of nontaxable gain from the revaluation of contingent consideration and an increase in the amount of valuation allowances recorded on foreign income tax losses.

The IRS commenced an examination of the Company's U.S. income tax returns for 2016 and 2017 during the second quarter 2019.

- 22 -

NOTE 13: Other Assets and Liabilities

Various other assets and liabilities are summarized as follows:



Prepaid Expenses and Other Current Assets:	June 30, 2019		December 31, 2018

Valued-added tax recoverable	$	671	$	1,378
Prepaid and other expenses	2,594		2,145
Guarantee from Armistice (see Note 14)	551		534
Income tax receivable	997		921
Research and development tax credit receivable	270		283
Short-term deposit	—		3,350
Other	82		225
Total	$	5,165	$	8,836



Other Non-Current Assets:	June 30, 2019		December 31, 2018

Deferred tax assets, net	$	21,072	$	23,029
Long-term deposits	1,477		1,477
Guarantee from Armistice (see Note 14)	5,413		5,697
Right of use assets at contract manufacturing organizations	6,561		5,894
Other	50		49
Total	$	34,573	$	36,146



Accrued Expenses	June 30, 2019		December 31, 2018

Accrued compensation	$	1,946	$	3,971
Accrued social charges	789		1,009
Accrued restructuring (see Note 15)	1,441		879
Customer allowances	6,279		6,541
Accrued contract research organization charges	1,815		1,000
Accrued contract manufacturing organization costs	1,591		2,028
Accrued contract sales organization and marketing costs	—		3,469
Other	1,876		2,798
Total	$	15,737	$	21,695



Other Non-Current Liabilities:	June 30, 2019		December 31, 2018

Provision for retirement indemnity	$	—	$	1,024
Customer allowances	867		1,352
Unrecognized tax benefits	5,315		5,315
Guarantee to Deerfield (see Note 14)	5,432		5,717
Other	61		594
Total	$	11,675	$	14,002

14: Divestiture of the Pediatric Assets

- 23 -

5, 2016, between Holdings, Flamel Technologies SA (the predecessor of the Company) and Deerfield and certain of its affiliates, which payment obligations consist of the following (collectively, the “Assumed Obligations”): (i) a quarterly payment of $263 beginning in July 2018 and ending in October 2020, amounting to an aggregate payment obligation of $2,625; (ii) a payment in January 2021 of $15,263; and (iii) a quarterly royalty payment of 15% on net sales of the FSC products through February 5, 2026 (“FSC Product Royalties”), in an aggregate amount of up to approximately $10,300. Cerecor also assumed certain contracts and other obligations related to the acquired assets, and in that connection Holdings agreed to pay Cerecor certain make-whole payments associated with obligations Cerecor is assuming related to a certain supply contract related to Karbinal™ ER.

In conjunction with the divestiture, the Company also entered into the following arrangements:

License and Development Agreement

Also, in connection with the closing under the Purchase Agreement, Flamel Ireland Limited, an Irish limited company operating under the trade name of Avadel Ireland (“Avadel Ireland”) and a wholly-owned subsidiary of the Company, and Cerecor entered into a license and development agreement (the “License and Development Agreement”) pursuant to which, among other things:


•	Avadel Ireland will provide Cerecor with four product formulations utilizing Avadel Ireland’s LiquiTime™ technology, and will complete pilot bioequivalence studies for such product formulations within 18 months;


•	Cerecor will reimburse Avadel Ireland for development costs of the four LiquiTime™ products in excess of $1,000 in the aggregate;


•	Upon transfer of the four product formulations, Cerecor will assume all remaining development costs and responsibilities for the product development, clinical studies, NDA applications and associated filing fees; and


•	Upon regulatory approval and commercial launch of any LiquiTime™ products, Cerecor will pay Avadel Ireland quarterly royalties based on a percentage of net sales of any such products in the mid-single digit range.

Deerfield Guarantee

In connection with the closing under the Purchase Agreement, the Company and Holdings provided their guarantee (the “Deerfield Guarantee”) in favor of Deerfield. Under the Deerfield Guarantee, the Company and Holdings guaranteed to Deerfield the payment by Cerecor of the Assumed Obligations under the Membership Interest Purchase Agreement between the Company and Deerfield dated February 5, 2016. The Assumed Obligations include (i) a quarterly payment of $263 beginning in July 2018 and ending in October 2020, amounting to an aggregate payment obligation of $2,625; (ii) a payment in January 2021 of $15,263; and (iii) a quarterly royalty payment of 15% on net sales of the FSC products through February 6, 2026 (“FSC Product Royalties”), in an aggregate amount of up to approximately $10,300. In addition, under the Deerfield Guarantee, the Company and Holdings guaranteed that Deerfield would receive certain minimum annual FSC Product Royalties through February 6, 2026 (the “Minimum Royalties”). Given the Company’s explicit guarantee to Deerfield, the Company recorded the guarantee in accordance with ASC 460. A valuation was performed, which was based largely on an analysis of the potential timing of each possible cash outflow described above and the likelihood of Cerecor’s default on such payments assuming an S&P credit rating of CCC+. The result of this valuation identified a guarantee liability of $6,643. This liability is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield. At June 30, 2019, the carrying value of this liability was $5,985.

Armistice Guarantee

In connection with the closing under the Purchase Agreement, Armistice Capital Master Fund, Ltd., the then majority shareholder of Cerecor, guaranteed to Holdings the payment by Cerecor of the Assumed Obligations, including the Minimum Royalties. A valuation of the guarantee asset was performed in accordance with ASC 460 and a guarantee asset of $6,620 was recorded. This asset is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield noted above. At June 30, 2019, the carrying value of this asset was $5,964.

The fair values of the Avadel guarantee to Deerfield and the guarantee received by Avadel from Armistice largely offset and when combined are not material.

- 24 -

results of operations for the period January 1, 2018 through February 16, 2018 include the results of FSC, prior to its February 16, 2018 disposition date.

The net impact of this transaction was not material to the unaudited condensed consolidated statements of loss.

NOTE 15: Restructuring Costs

2019 French Restructuring

During the second quarter of 2019, the Company initiated a plan to substantially reduce all of its workforce at its Vénissieux, France site (“2019 French Restructuring”). This reduction is an effort to align the Group’s cost structure with our ongoing and future planned projects. The reduction in workforce is projected to be substantially complete by the end of calendar year 2019, and to result in employee severance, benefits and other costs of up to approximately $3,500, which are likely to be recognized through December 31, 2019. Restructuring charges associated with this plan of $1,939 were recognized during the three and six months ended June 30, 2019. Included in the 2019 French Restructuring charges of $1,939 were charges for employee severance, benefits and other costs of $2,414, a charge of $525 related to fixed asset impairment, as well as a benefit of $1,000 related to the reversal of the French retirement indemnity obligation.

The following table sets forth activities for the Company’s cost reduction plan obligations for the three and six months ended June 30, 2019:



2019 French Restructuring Obligation:	2019

Balance of restructuring accrual at January 1,	$	—
Charges for employee severance, benefits and other costs	2,414
Payments	(1,332		)
Foreign currency impact	20
Balance of restructuring accrual at June 30,	$	1,102

The 2019 French Restructuring liabilities of $1,078 and $24 are included in the unaudited condensed consolidated balance sheet in accrued expenses and accounts payable at June 30, 2019, respectively.

2019 Corporate Restructuring

During the first quarter of 2019, the Company announced a plan to reduce its Corporate workforce by more than 50% (“2019 Corporate Restructuring”). The reduction in workforce is primarily a result of the exit of Noctiva during the first quarter of 2019 (see Note 3: Subsidiary Bankruptcy and Deconsolidation), as well as an effort to better align the Company’s remaining cost structure at our U.S. and Ireland locations with our ongoing and future planned projects. The reduction in workforce is projected to be substantially complete by the end of calendar year 2019, and to result in employee severance, benefits and other costs of up to approximately $3,000, which are likely to be recognized through December 31, 2019. The restructuring benefit associated with this plan of $435 and restructuring charges of $963 were recognized during the three and six months ended June 30, 2019, respectively. Included in the 2019 Corporate Restructuring benefit of $435 for the three months ended June 30, 2019 were charges for employee severance, benefit and other costs of $541, as well as a benefit of $976 related to share based compensation forfeitures related to the employees affected by the global reduction in workforce. Included in the 2019 Corporate Restructuring charges of $963 for the six months ended June 30, 2019, were charges for employee severance, benefit and other costs of $2,359, as well as a benefit of $1,396 related to share based compensation forfeitures related to the employees affected by the global reduction in workforce.

The following table sets forth activities for the Company’s cost reduction plan obligations for the six months ended June 30, 2019:



2019 Corporate Restructuring Obligation:	2019

Balance of restructuring accrual at January 1,	$	—
Charges for employee severance, benefits and other costs	2,359
Payments	(2,016		)
Balance of restructuring accrual at June 30,	$	343

- 25 -

2019 Corporate Restructuring liabilities of $343 are included in the unaudited condensed consolidated balance sheet in accrued expenses at June 30, 2019.

2017 French Restructuring

During the first quarter of 2017, the Company announced a plan to reduce its workforce at the Venissieux, France site by approximately 50% (“2017 French Restructuring”). This reduction was an effort to align the Company’s cost structure with our ongoing and future planned projects. In July 2017, the Company completed negotiations with the works council for our French operations and received approval from the French Labor Commission (DIRECCTE) to implement the plan. The reduction was substantially complete at June 30, 2019. The 2017 French restructuring costs for the three months ended June 30, 2019 and 2018 were immaterial. The 2017 French Restructuring income of $168 and restructuring charges of $203 were recognized during the six months ended June 30, 2019 and 2018, respectively. The following table sets forth activities for the Company’s cost reduction plan obligations for the six months ended June 30, 2019 and 2018:



2017 French Restructuring Obligation:	2019			2018

Balance of restructuring accrual at January 1,	$	879		$	1,000
Charges for employee severance, benefits and other	(168		)	203
Payments	(647		)	(515		)
Foreign currency impact	(8		)	(55		)
Balance of restructuring accrual at June 30,	$	56		$	633

The 2017 French Restructuring accrual is included in the unaudited condensed consolidated balance sheet in accrued expenses and other non-current liabilities at June 30, 2019 and 2018.

NOTE 16: Net Loss Per Share

Basic net loss per share is calculated by dividing net loss by the weighted average number of shares outstanding during each period. Diluted net (loss) income per share is calculated by dividing net (loss) income by the diluted number of shares outstanding during each period. Except where the result would be anti-dilutive to net loss, diluted net loss per share would be calculated assuming the impact of the conversion of the 2023 Notes, the exercise of outstanding equity compensation awards, ordinary shares expected to be issued under our employee stock purchase plan (“ESPP”) and the exercise of contingent consideration warrants, all which have been exercised or have expired during the first quarter of 2018.

We have a choice to settle the conversion obligation under the 2023 Notes in cash, shares or any combination of the two. We utilize the if-converted method to reflect the impact of the conversion of the 2023 Notes, unless the result is anti-dilutive. This method assumes the conversion of the 2023 Notes into shares of our ordinary shares and reflects the elimination of the interest expense related to the 2023 Notes.

The dilutive effect of the warrants, stock options, RSU’s and ordinary shares expected to be issued under or ESPP has been calculated using the treasury stock method.

- 26 -

A reconciliation of basic and diluted net loss per share, together with the related shares outstanding in thousands is as follows:



	Three Months Ended June 30,						Six Months Ended June 30,
Net Loss Per Share:	2019			2018			2019			2018

Net loss	$	(8,605	)	$	(3,438	)	$	(21,623	)	$	(15,674	)

Weighted average shares:
Basic shares	37,356			36,772			37,355			37,666
Effect of dilutive securities—employee and director equity awards outstanding and 2023 Notes	—			—			—			—
Diluted shares	37,356			36,772			37,355			37,666

Net loss per share - basic	$	(0.23	)	$	(0.09	)	$	(0.58	)	$	(0.42	)
Net loss per share - diluted	$	(0.23	)	$	(0.09	)	$	(0.58	)	$	(0.42	)

Potential common shares of 20,359 and 18,831 were excluded from the calculation of weighted average shares for the three months ended June 30, 2019 and 2018, respectively, because their effect was considered to be anti-dilutive. Potential common shares of 20,502 and 15,300 were excluded from the calculation of weighted average shares for the six months ended June 30, 2019 and 2018, respectively. For the three and six months ended June 30, 2019 and 2018, the effects of dilutive securities were entirely excluded from the calculation of net loss per share as a net loss was reported in this period.

NOTE 17: Comprehensive Loss

The following table shows the components of accumulated other comprehensive loss for the three and six months ended June 30, 2019 and 2018, respectively, net of tax effects:



	Three Months Ended June 30,						Six Months Ended June 30,
Accumulated Other Comprehensive Loss:	2019			2018			2019			2018

Foreign currency translation adjustment:
Beginning balance	$	(23,782	)	$	(22,953	)	$	(23,621	)	$	(23,202	)
Net other comprehensive (loss) income	62			(482		)	(99		)	(233		)
Balance at June 30,	$	(23,720	)	$	(23,435	)	$	(23,720	)	$	(23,435	)

Unrealized gain (loss) on marketable securities, net
Beginning balance	$	579		$	(302	)	$	205		$	(64	)
Net other comprehensive income (loss), net of ($23), ($11), ($41) and ($70) tax, respectively	293			78			667			(160		)
Balance at June 30,	$	872		$	(224	)	$	872		$	(224	)
Accumulated other comprehensive loss at June 30,	$	(22,848	)	$	(23,659	)	$	(22,848	)	$	(23,659	)

The effect on the Company’s unaudited condensed consolidated financial statements of amounts reclassified out of accumulated other comprehensive loss was immaterial for all periods presented.

NOTE 18: Revenue by Product

The Company has determined that it operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer based technology. The Company’s Chief Operating Decision Maker is the CEO. The CEO reviews profit and loss information on a consolidated basis to assess performance and make overall operating decisions as well as resource allocations. All products are included in one segment because the Company’s products have similar economic and other characteristics, including the nature of the products and production processes, type of customers, distribution methods and regulatory environment.

- 27 -

The following table presents a summary of total revenues by these products:



	Three Months Ended June 30,					Six Months Ended June 30,
Revenues by Product:	2019			2018		2019		2018

Bloxiverz	$	2,358		$	5,544	$	4,926	$	13,035
Vazculep	9,410			11,377		18,883		24,338
Akovaz	5,946			11,875		9,738		22,092
Other	(160		)	320		444		2,812
Total product sales	17,554			29,116		33,991		62,277
License revenue	—			114		—		246
Total revenues	$	17,554		$	29,230	$	33,991	$	62,523

NOTE 19: Commitments and Contingencies

Litigation

The Company is subject to potential liabilities generally incidental to our business arising out of present and future lawsuits and claims related to product liability, personal injury, contract, commercial, intellectual property, tax, employment, compliance and other matters that arise in the ordinary course of business. The Company accrues for potential liabilities when it is probable that future costs (including legal fees and expenses) will be incurred and such costs can be reasonably estimated. At June 30, 2019 and December 31, 2018, there were no contingent liabilities with respect to any litigation, arbitration or administrative or other proceeding that are reasonably likely to have a material adverse effect on the Company’s unaudited condensed consolidated financial position, results of operations, cash flows or liquidity.

Litigation Related to Noctiva

Note 3: Subsidiary Bankruptcy and Deconsolidation briefly describes the Chapter 11 bankruptcy case which our subsidiary Specialty Pharma commenced on February 6, 2019, and which on April 26, 2019 resulted in the bankruptcy court-approved sale of all of Specialty Pharma’s intangible assets and inventory to an unaffiliated third party. As a result of such sale, Specialty Pharma has completed its divestment of the assets of the Noctiva business. During the pendency of the bankruptcy case, all pending litigation against Specialty Pharma is automatically stayed and any new litigation against Specialty Pharma is precluded unless the bankruptcy court orders otherwise. Below are descriptions of a litigation to which Specialty Pharma is a party and a contract dispute involving Specialty Pharma, both of which matters are subject to the automatic stay during the bankruptcy case.

Ferring Litigation. Some of the patents covering the Noctiva^TM product (the “Noctiva Patents”) are the subject of litigation initiated by Ferring Pharmaceuticals Inc. and two of its foreign affiliates, who manufacture a competing product known as Nocdurna. Nocdurna was approved by the FDA in June 2018 and commercially launched in the U.S. in November 2018. In this litigation, Ferring seeks to invalidate and disputes the inventorship of the Noctiva Patents, seeks damages for various alleged breaches of contractual and common law duties, and seeks damages for alleged infringement by Noctiva^TM of Ferring’s “Nocdurna” trademark. Specialty Pharma and certain other parties including Serenity Pharmaceuticals, LLC (“Serenity”) (the licensor of the Noctiva Patents) have defended this litigation, and have made counterclaims against Ferring, including for infringement of the Noctiva Patents and a declaratory judgment of noninfringement with respect to Ferring’s “Nocdurna” trademark. The court dismissed Ferring’s inventorship claim and its claims for alleged breaches of contractual and common law duties, although these dismissals may be appealed by Ferring. On February 15, 2019, Specialty Pharma and its co-defendants moved to stay the litigation pending completion of the bankruptcy proceeding of Specialty Pharma. On May 15, 2019, that motion was denied due to an impending settlement of the litigation with respect to just Ferring and Specialty Pharma.

Contract Dispute. On January 21, 2019, Serenity gave notice to Specialty Pharma of an alleged breach of the parties’ Noctiva license agreement. Serenity alleges that Specialty Pharma breached its contractual obligation to devote commercially reasonable efforts to the commercialization of Noctiva and seeks unspecified damages. On January 27, 2019, Specialty Pharma notified Serenity of a claim for $1.7 million in damages as a result of Serenity’s breach of its contractual obligation to pay the costs of the Ferring Litigation. Serenity’s notice to Specialty Pharma invoked the dispute resolution provisions of the Noctiva license agreement, which culminate in arbitration, but neither party has yet initiated an arbitration proceeding or filed suit.

- 28 -

Material Commitments

Due to the Chapter 11 bankruptcy case of Specialty Pharma, the Company’s various commitments to purchase finished product from suppliers has changed from what was included in Part II, Item 8 of the Company’s 2018 Annual Report on Form 10-K. As of June 30, 2019, commitments for these arrangements, at maximum quantities and at contractual prices over the remaining life of the contract, and excluding any waived commitments, are as follows for the years ended December 31:



Purchase Commitments:	Balance

2019	$	7,194
2020	1,320
2021	1,320
2022	1,320
2023	220
Thereafter	—
Total	$	11,374

Other than commitments disclosed in Note 15: Contingent Liabilities and Commitments to the Company’s audited consolidated financial statements included in Part II, Item 8 of the Company’s 2018 Annual Report on Form 10-K, there were no other material commitments outside of the normal course of business. Material commitments in the normal course of business include long-term debt obligations which are disclosed in Note 10: Long-Term Debt, respectively, to the Company’s consolidated financial statements included in Part II, Item 8 of the Company’s 2018 Annual Report on Form 10-K and long-term contingent consideration payable as disclosed in Note 10: Long-Term Related Party Payable, to the Company’s unaudited condensed consolidated financial statements included in Part I, Item 1 of this report.

NOTE 20: Subsequent Events

Subsequent to June 30, 2019, the Company became aware of market conditions that could have a material impact on the estimated and projected annual net revenues and gross profit of certain hospital products that were used to estimate the total related party payable. The Company believes the effect of this change in estimate could reduce the total related party payable by approximately $3,000.

- 29 -

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Management’s Discussion and Analysis

(In thousands, except per share data)

(Unaudited)

You should read the discussion and analysis of our financial condition and results of operations set forth in this Item 2 together with our unaudited condensed consolidated financial statements and the related notes appearing elsewhere in this quarterly report on Form 10-Q. Some of the information contained in this discussion and analysis or set forth elsewhere in this quarterly report on Form 10-Q, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks and uncertainties, and reference is made to the “Cautionary Note Regarding Forward-Looking Statements” set forth immediately following the Table of Contents of this Quarterly Report on Form 10-Q for further information on the forward looking statements herein. In addition, you should read the “Risk Factors” section in Part I, Item 1A of our Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (“SEC”) on March 15, 2019 and Part II, Item 1A in this quarterly report on Form 10-Q for a discussion of additional important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis and elsewhere in this quarterly report.

Overview

General Overview

Avadel Pharmaceuticals plc (Nasdaq: AVDL) (“Avadel,” the “Company,” “we,” “our,” or “us”) is a branded specialty pharmaceutical company. Our primary focus is on the development and potential U.S. Food and Drug Administration (“FDA”) approval for FT218 which is in a Phase 3 clinical trial for the treatment of narcolepsy patients suffering from excessive daytime sleepiness (EDS) and cataplexy. In addition, we market three sterile injectable drugs used in the hospital setting which were developed under our “unapproved marketed drug” (UMD) program. The Company is headquartered in Dublin, Ireland with operations in St. Louis, Missouri and Lyon, France. For more information, please visit www.avadel.com.

Our current marketed products include:


•	Akovaz® (ephedrine sulfate injection, USP), an alpha- and beta-adrenergic agonist and a norepinephrine-releasing agent that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.


•	Bloxiverz® (neostigmine methylsulfate injection), a cholinesterase inhibitor, is indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents (NMBAs) after surgery.


•	Vazculep® (phenylephrine hydrochloride injection), an alpha-1 adrenergic receptor agonist indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.

Each of our Akovaz, Bloxiverz and Vazculep products is used primarily in the hospital setting and was developed under our UMD program.

Business Strategies

Our primary business strategy is to focus on the development and potential FDA approval for FT218 which is in a Phase 3 clinical trial for the treatment of narcolepsy patients suffering from EDS and cataplexy. In addition, we will continue market and distribute our current approved hospital products portfolio, including seeking FDA approval for and the commercialization of our fourth UMD product. Additionally, we will continue to evaluate opportunities to expand our product portfolio. These strategies are described below in greater detail.

FT218 (Micropump® sodium oxybate): FT218 (Micropump® sodium oxybate): Avadel is developing a product that uses our Micropump® drug-delivery technology for the treatment of EDS and cataplexy in patients suffering from narcolepsy. Avadel

- 30 -

currently refers to this product as FT218. FT218 is a Micropump®-based formulation of sodium oxybate. Sodium oxybate is the sodium salt of gamma hydroxybutyrate, an endogenous compound and metabolite of the neurotransmitter gamma-aminobutyric acid. Sodium oxybate has been described as a therapeutic agent with high medical value. Sodium oxybate is approved in Europe and the United States as a twice nightly formulation indicated for the treatment of EDS and cataplexy in patients with narcolepsy.

In preparation for a clinical trial of FT218, Avadel reached an agreement with the FDA for the design and planned analysis of our pivotal Phase 3 study, Rest-On through a Special Protocol Assessment (“SPA”). A SPA is an acknowledgment by the FDA that the design and planned analysis of a pivotal clinical trial adequately addresses the objectives necessary to support a regulatory submission. Pursuant to the SPA, in December 2016, Avadel initiated patient enrollment and dosing for the Rest-On clinical trial to assess the safety and efficacy of a once-nightly formulation of FT218 for the treatment of EDS and cataplexy in patients suffering from narcolepsy. The study is a randomized, double-blind, placebo-controlled study of 264 patients being conducted in 45 to 55 clinical sites in the U.S., Canada, Western Europe and Australia. Avadel believes that, if successful, this study could demonstrate improved efficacy, safety and patient satisfaction over the current primary product serving this market, which is a twice nightly sodium oxybate formulation, which the marketer generated revenues of approximately $1.4 billion in 2018.

To date, due in part to narcolepsy being a rare disease with a small patient population with no significant geographic concentration, we have not completed patient enrollment for the FT218 clinical trial. Based on our best projections and the current clinical trial design we expect to complete enrollment in the second half of 2020. Recently, the Company hired an experienced clinical development expert as its chief medical officer who added experienced clinical operations and medical affairs staff. The clinical development and medical affairs team continues to execute the study to ensure completion of enrollment in the second half of 2020 while delivering high quality data.

In January 2018, the FDA granted FT218 Orphan Drug Designation, which makes the drug eligible for certain development and commercial incentives, including a potential U.S. market exclusivity for up to seven years as the only once-nightly formulation. However, please see the information set forth under the caption “- Risks Related to Regulatory and Legal Matters - If FT218 is approved by the FDA, we may not obtain orphan drug marketing exclusivity” in the “Risk Factors” included in Part I, Item 1A of the Company’s Annual Report on Form 10-K filed with the SEC on March 15, 2019.

Development of Micropump®-Based Products

Avadel’s Micropump® drug delivery technology presents product development opportunities, representing either “life cycle” opportunities, whereby additional intellectual property can be added to a pharmaceutical product to extend the commercial viability of a currently marketed product, or innovative formulation opportunities for new chemical entities (“NCEs”). FT218 is formulated using this technology. If approved by the FDA, this product may be commercialized either by Avadel and/or by partners via licensing/distribution agreements.

Unapproved Marketed Drug (“UMD”) Products

In 2006, the FDA issued its Marketed Unapproved Drugs - Compliance Policy Guide with the intention to incentivize pharmaceutical companies to pursue approvals for pharmaceutical products, many of which pre-date the establishment of the FDA. Although these products are not protected by patents or similar intellectual property, the FDA’s Compliance Policy Guide dictates that should FDA approve a new drug application for any such products via a 505(b)(2) process, the FDA will remove competing unapproved manufacturers until a generic application is approved. Avadel believes that over a thousand unapproved drugs are marketed in the United States today and, while many of these products are outdated therapies, we strategically evaluate those UMD products that are more commonly used as candidates for possible future FDA approval and marketing under our UMD program.

To date, Avadel has received FDA approvals for three UMD products which we currently market under the brand names Bloxiverz® (neostigmine methylsulfate injection), Vazculep® (phenylephrine hydrochloride injection) and Akovaz® (ephedrine sulfate injection).

Additional UMD Products. Avadel is developing and intends to seek FDA approval of a NDA for UMD #4, a sterile injectable product used in the hospital setting. The Company submitted an NDA in March 2019 on UMD #4, which, if approved, could contribute revenues to Avadel starting in 2020. In May 2019, the FDA has accepted the NDA for the Company’s fourth hospital product, AV001. It was granted Priority Review status by the FDA resulting in a six-month review period with an initial assigned PDUFA target date of September 15, 2019. On July 31, 2019, the Company received notification that the FDA has extended the PDUFA date to December 15, 2019. This extension relates to recent submissions the Company made in response to FDA requests for additional analytical information. The FDA determined that these submissions constitute a major amendment and will require additional time to review. This three-month extension will not likely impact the launch timeline, which is still anticipated for early 2020. In addition, Avadel continues to monitor and evaluate other UMDs with large existing markets and limited competition

- 31 -

for feasibility of possible future NDAs. Avadel believes its strategy to create opportunities to commercialize UMD products in markets with a limited number of competitors may have a limited number of opportunities given the lack of patent protection from competition. Avadel believes this shorter-term strategy may provide us with near term revenue growth and provide cash flows that can be used to fund R&D and inorganic initiatives for other products.

Corporate Information

The Company currently has five direct wholly-owned subsidiaries: (a) Avadel US Holdings, Inc., (b) Flamel Ireland Limited, which conducts business under the name Avadel Ireland, (c) Avadel Investment Company Limited, (d) Avadel Finance Ireland Designated Activity Company and (e) Avadel France Holding SAS. Avadel US Holdings, Inc., a Delaware corporation, is the holding entity of (i) Avadel Specialty Pharmaceuticals, LLC (currently the subject of a voluntary Chapter 11 bankruptcy proceeding as noted in Note 3: Subsidiary Bankruptcy and Deconsolidation), (ii) Avadel Legacy Pharmaceuticals, LLC, (iii) Avadel Management Corporation, (iv) FSC Holding Company and (v) Avadel Operations Company, Inc. Avadel Finance Ireland Designated Activity Company is the holding entity of Avadel Finance Cayman Limited. Flamel Ireland Limited (operating under the trade name Avadel Ireland) is an Irish corporation which, since December 16, 2014, has been the owner of substantially all of Avadel’s intellectual property. Avadel France Holding SAS, a French société par actions simplifiée, is the holding entity of Avadel Research SAS through which Avadel conducts substantially all of its R&D activities.

References in these unaudited condensed consolidated financial statements and the notes thereto to “Avadel,” the “Company,” “we,” “our,” “us,” and similar terms shall be deemed to be references to Flamel prior to the completion of the Merger, unless the context otherwise requires.

Key Business Trends and Highlights

In operating our business and monitoring our performance, we consider a number of performance measures, as well as trends affecting our industry as a whole, which include the following:

•

Healthcare and Regulatory Reform: Various health care reform laws in the U.S. may impact our ability to successfully commercialize our products and technologies. The success of our commercialization efforts may depend on the extent to which the government health administration authorities, the health insurance funds in the E.U. Member States, private health insurers and other third-party payers in the U.S. will reimburse consumers for the cost of healthcare products and services.

•

Competition and Technological Change: Competition in the pharmaceutical and biotechnology industry continues to be intense and is expected to increase. We compete with academic laboratories, research institutions, universities, joint ventures, and other pharmaceutical and biotechnology companies, including other companies developing niche branded or generic specialty pharmaceutical products or drug delivery platforms. Furthermore, major technological changes can happen quickly in the pharmaceutical and biotechnology industries. Such rapid technological change, or the development by our competitors of technologically improved or differentiated products, could render our drug delivery platforms obsolete or noncompetitive.

- 32 -


•	Pricing Environment for Pharmaceuticals: The pricing environment continues to be in the political spotlight in the U.S. As a result, the need to obtain and maintain appropriate pricing for our products may become more challenging due to, among other things, the attention being paid to healthcare cost containment and other austerity measures in the U.S. and worldwide.


•	Generics Playing a Larger Role in Healthcare: Generic pharmaceutical products will continue to play a large role in the U.S. healthcare system. Specifically, we have seen, or likely will see, additional generic competition to our current and future products and we continue to expect generic competition in the future.


•	Access to and Cost of Capital: The process of raising capital and associated cost of such capital for a company of our financial profile can be difficult and potentially expensive. If the need were to arise to raise additional capital, access to that capital may be difficult and/or expensive and, as a result, could create liquidity challenges for the Company.


•	Net Loss from Operations in 2019: In part because we expect sales of our hospital products to significantly decline from 2018’s levels and we will incur substantial expenses to further the clinical development of FT218, we likely will incur a net loss in 2019 the amount of which is not known to us at this time.

Financial Highlights

Highlights of our consolidated results for the three and six months ended June 30, 2019 are as follows:

•

Revenue was $17,554 and $33,991 for the three and six months ended June 30, 2019, respectively, compared to $29,230 and $62,523 in the same periods last year, respectively. This year over year decrease was primarily the result of increased competition driving lower prices as noted above in our discussion of Key Business Trends and Highlights. We experienced price and unit volume declines across all our hospital products due to additional competition.

•

Operating loss was $4,451 and $12,618 for the three and six months ended June 30, 2019, respectively, compared to operating loss of $2,785 and $15,410 and for the same periods last year, respectively. The increase in operating loss for the three months ended June 30, 2019 was largely driven by lower gross margin of $11,786 and a lower gain on the change in fair value of related party contingent consideration of $12,512, partially offset by lower selling, general and administrative (SG&A) expenses of $21,085 driven by the exit of the Noctiva business in 2019 of approximately $18,100. The primary reasons for the decrease in operating loss for the six months ended June 30, 2019 were due to lower SG&A expense of $35,126, lower research and development expense of $4,220, partially offset by lower gross margin of $25,316 and expense related to the changes in fair value of related party contingent consideration of $11,678.

•

Net loss was $8,605 and $21,623 for the three and six months ended June 30, 2019, respectively, compared to net loss of $3,438 and $15,674 in the same periods last year, respectively. Included in the net loss during the six months ended June 30, 2019 was a loss on the deconsolidation of Avadel Specialty Pharmaceuticals, LLC (“Specialty Pharma”) of $2,840. As a result of Avadel Specialty Pharmaceuticals, LLC bankruptcy filing on February 6, 2019, the Company concluded that it no longer controls the operations of this subsidiary and accordingly deconsolidated this subsidiary.


•	Diluted net loss per share was $0.23 and $0.58 for the three and six months ended June 30, 2019, respectively, compared to diluted net loss per share of $0.09 and $0.42 in the same period last year, respectively.


•	Cash and marketable securities decreased $20,653 to $79,262 at June 30, 2019, from $99,915 at December 31, 2018. This decrease was largely driven from $22,653 use of cash in operations.

Critical Accounting Estimates

The Company’s unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. To prepare these financial statements, management makes estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, as well as the disclosures of contingent assets and liabilities. Actual results could be significantly different from these estimates.

Our significant accounting policies are described in Note 1 of the audited consolidated financial statements included in our Annual Report Form 10-K for the year ended December 31, 2018 (the “2018 Form 10-K”). The SEC suggests companies provide additional disclosure on those accounting policies considered most critical. The SEC considers an accounting policy to be critical if it is important to our financial condition and results of operations and requires significant judgments and estimates on the part of management in its application. Our estimates are often based on complex judgments, probabilities and assumptions that management believes to be reasonable, but that are inherently uncertain and unpredictable. It is also possible that other professionals, applying reasonable judgment to the same facts and circumstances, could develop and support a range of alternative estimated

- 33 -

amounts. For a complete discussion of our critical accounting policies, see the “Critical Accounting Policies” section of the MD&A in our 2018 Form 10-K. Effective January 1, 2019, the Company implemented ASC 842, Leases. The impact of adopting this new accounting standard required the Company to recognize $5,046 and $5,131 of assets and liabilities, respectively, related to the Company’s operating leases. See Note 9: Leases in the notes to the unaudited condensed consolidated financial statements for further information.

Results of Operations

The following is a summary of our financial results (in thousands, except per share amounts) for the three months ended June 30, 2019 and 2018, respectively:



							Three Months Ended
	Three Months Ended June 30,						Increase / (Decrease)
	Three Months Ended June 30,						2019 vs. 2018
Comparative Statements of Loss	2019			2018			$			%

Product sales	$	17,554		$	29,116		$	(11,562	)	(39.7	)%
License revenue	—			114			(114		)	(100.0	)%
Total revenues	17,554			29,230			(11,676		)	(39.9	)%
Operating expenses:
Cost of products	3,622			3,512			110			3.1	%
Research and development expenses	10,292			11,890			(1,598		)	(13.4	)%
Selling, general and administrative expenses	6,758			27,843			(21,085		)	(75.7	)%
Intangible asset amortization	204			1,609			(1,405		)	(87.3	)%
Changes in fair value of related party contingent consideration	(377		)	(12,889		)	12,512			97.1	%
Restructuring costs	1,506			50			1,456			2,912.0	%
Total operating expenses	22,005			32,015			(10,010		)	(31.3	)%
Operating loss	(4,451		)	(2,785		)	(1,666		)	(59.8	)%
Investment and other income, net	950			583			367			63.0	%
Interest expense	(3,106		)	(2,980		)	(126		)	(4.2	)%
Loss on deconsolidation of subsidiary	(167		)	—			(167		)	n/a
Other (expense) income - changes in fair value of related party payable	(50		)	1,402			(1,452		)	(103.6	)%
Loss before income taxes	(6,824		)	(3,780		)	(3,044		)	(80.5	)%
Income tax provision (benefit)	1,781			(342		)	2,123			620.8	%
Net loss	$	(8,605	)	$	(3,438	)	$	(5,167	)	(150.3	)%
Net loss per share - diluted	$	(0.23	)	$	(0.09	)	$	(0.14	)	(155.6	)%

- 34 -

The following is a summary of our financial results (in thousands, except per share amounts) for the six months ended June 30, 2019 and 2018, respectively:



							Six Months Ended
	Six Months Ended June 30,						Increase / (Decrease)
	Six Months Ended June 30,						2019 vs. 2018
Comparative Statements of Loss	2019			2018			$			%

Product sales	$	33,991		$	62,277		$	(28,286	)	(45.4	)%
License revenue	—			246			(246		)	(100.0	)%
Total revenues	33,991			62,523			(28,532		)	(45.6	)%
Operating expenses:
Cost of products	6,888			10,104			(3,216		)	(31.8	)%
Research and development expenses	17,621			21,841			(4,220		)	(19.3	)%
Selling, general and administrative expenses	17,204			52,330			(35,126		)	(67.1	)%
Intangible asset amortization	405			3,376			(2,971		)	(88.0	)%
Changes in fair value of related party contingent consideration	1,757			(9,921		)	11,678			117.7	%
Restructuring costs	2,734			203			2,531			1,246.8	%
Total operating expenses	46,609			77,933			(31,324		)	(40.2	)%
Operating loss	(12,618		)	(15,410		)	2,792			18.1	%
Investment and other income, net	1,767			637			1,130			177.4	%
Interest expense	(6,168		)	(4,577		)	(1,591		)	(34.8	)%
Loss on deconsolidation of subsidiary	(2,840		)	—			(2,840		)	n/a
Other (expense) income - changes in fair value of related party payable	(357		)	1,007			(1,364		)	(135.5	)%
Loss before income taxes	(20,216		)	(18,343		)	(1,873		)	(10.2	)%
Income tax provision (benefit)	1,407			(2,669		)	4,076			152.7	%
Net loss	$	(21,623	)	$	(15,674	)	$	(5,949	)	(38.0	)%
Net loss per share - diluted	$	(0.58	)	$	(0.42	)	$	(0.16	)	(38.1	)%

The revenues for each of the Company’s significant products for the three months ended June 30, 2019 and 2018 were as follows:



						Three Months Ended
	Three Months Ended June 30,					Increase / (Decrease)
	Three Months Ended June 30,					2019 vs. 2018
Revenues:	2019			2018		$			%

Bloxiverz	$	2,358		$	5,544	$	(3,186	)	(57.5	)%
Vazculep	9,410			11,377		(1,967		)	(17.3	)%
Akovaz	5,946			11,875		(5,929		)	(49.9	)%
Other	(160		)	320		(480		)	(150.0	)%
Product sales	17,554			29,116		(11,562		)	(39.7	)%
License revenue	—			114		(114		)	(100.0	)%
Total revenues	$	17,554		$	29,230	$	(11,676	)	(39.9	)%

Total revenues were $17,554 for the three months ended June 30, 2019, compared to $29,230 for the same prior year period. Bloxiverz’s revenue declined $3,186 in the current quarter when compared to the same prior year period primarily due to lower net selling price and lower unit volumes sold driven largely by new competition which entered the market driving price and unit volumes lower. Vazculep’s revenue decreased $1,967 during the quarter when compared to the prior year period due primarily to lower net selling prices in the current period when compared to the same prior year period. Akovaz’s revenue declined $5,929 driven largely by lower net selling price due to new competition which entered the market driving lower prices.

- 35 -

The revenues for each of the Company’s significant products for the six months ended June 30, 2019 and 2018 were as follows:



					Six Months Ended
	Six Months Ended June 30,				Increase / (Decrease)
	Six Months Ended June 30,				2019 vs. 2018
Revenues:	2019		2018		$			%

Bloxiverz	$	4,926	$	13,035	$	(8,109	)	(62.2	)%
Vazculep	18,883		24,338		(5,455		)	(22.4	)%
Akovaz	9,738		22,092		(12,354		)	(55.9	)%
Other	444		2,812		(2,368		)	(84.2	)%
Product sales	33,991		62,277		(28,286		)	(45.4	)%
License revenue	—		246		(246		)	(100.0	)%
Total revenues	$	33,991	$	62,523	$	(28,532	)	(45.6	)%

Total revenues were $33,991 for the six months ended June 30, 2019, compared to $62,523 for the same prior year period. Bloxiverz’s revenue declined $8,109 when compared to the same period last year, primarily due to lower unit volumes and net selling prices driven largely by new competitors that entered the market. Vazculep’s revenue declined $5,455 compared to the same period last year, due primarily to lower unit volumes and net selling prices driven largely by new competitors that entered the market. Akovaz’s revenue declined $12,354 driven by lower unit volumes and net selling prices driven largely by new competitors that entered the market. The decrease in other revenues during the six months ended June 30, 2019 is driven by the deconsolidation of Specialty Pharma on February 6, 2019 as well as a reduction in revenue related to the February 2018 divestiture of the pediatric products.



							Three Months Ended
	Three Months Ended June 30,						Increase / (Decrease)
	Three Months Ended June 30,						2019 vs. 2018
Cost of Products:	2019			2018			$		%

Cost of products	$	3,622		$	3,512		$	110	3.1	%
Percentage of total revenues	20.6		%	12.0		%

Cost of products increased $110 or 3.1% during the three months ended June 30, 2019 compared to the same prior year period. As a percentage of total revenue, cost of products sold was higher than the prior year period due to lower net selling prices of the Company’s hospital products.



							Six Months Ended
	Six Months Ended June 30,						Increase / (Decrease)
	Six Months Ended June 30,						2019 vs. 2018
Cost of Products:	2019			2018			$			%

Cost of products	$	6,888		$	10,104		$	(3,216	)	(31.8	)%
Percentage of total revenues	20.3		%	16.2		%

Cost of products decreased $3,216 or 31.8% during the six months ended June 30, 2019 compared to the same prior year period driven by lower sold units. As a percentage of total revenue, cost of products sold was higher than the prior year period primarily due to lower net selling prices of the Company’s hospital products.

- 36 -



							Three Months Ended
	Three Months Ended June 30,						Increase / (Decrease)
	Three Months Ended June 30,						2019 vs. 2018
Research and Development Expenses:	2019			2018			$			%

Research and development expenses	$	10,292		$	11,890		$	(1,598	)	(13.4	)%
Percentage of total revenues	58.6		%	40.7		%

Research and development expenses decreased $1,598 or 13.4% during the three months ended June 30, 2019 as compared to the same period in 2018. This decline was a result of $0.7 million of lower spending associated with the exit of Noctiva and $0.8 million of cost reductions at the Company’s Lyon, France R&D center. The Company continues to invest a substantial portion of R&D in its FT218 development program.



							Six Months Ended
	Six Months Ended June 30,						Increase / (Decrease)
	Six Months Ended June 30,						2019 vs. 2018
Research and Development Expenses:	2019			2018			$			%

Research and development expenses	$	17,621		$	21,841		$	(4,220	)	(19.3	)%
Percentage of total revenues	51.8		%	34.9		%

Research and development expenses decreased $4,220 or 19.3% during the six months ended June 30, 2019 as compared to the same period in 2018. This decline was a result of $2.0 million of lower spending associated with the exit of Noctiva and $2.2 million of cost reductions at the Company’s Lyon, France R&D center. The Company continues to invest a substantial portion of R&D in its FT218 development program.



							Three Months Ended
	Three Months Ended June 30,						Increase / (Decrease)
	Three Months Ended June 30,						2019 vs. 2018
Selling, General and Administrative Expenses:	2019			2018			$			%

Selling, general and administrative expenses	$	6,758		$	27,843		$	(21,085	)	(75.7	)%
Percentage of total revenues	38.5		%	95.3		%

Selling, general and administrative expenses decreased $21,085 or 75.7% during the three months ended June 30, 2019 as compared to the same prior year period. This decrease was primarily due to a decrease of $18,100 of sales and marketing costs related to the exit of Noctiva during the current quarter when compared to the same period of the prior year. Also contributing to the decrease is lower other payroll and share-based compensation of $2,100 due to reduced headcount as a result of the 2019 Corporate and French restructuring plans.



							Six Months Ended
	Six Months Ended June 30,						Increase / (Decrease)
	Six Months Ended June 30,						2019 vs. 2018
Selling, General and Administrative Expenses:	2019			2018			$			%

Selling, general and administrative expenses	$	17,204		$	52,330		$	(35,126	)	(67.1	)%
Percentage of total revenues	50.6		%	83.7		%

Selling, general and administrative expenses decreased $35,126 or 67.1% during the six months ended June 30, 2019 as compared to the same prior year period. This decrease was primarily due to a decrease of $24,200 of sales and marketing costs related to the exit of Noctiva during the first quarter 2019 as well as $2,700 of decreased costs due to the 2018 divestiture of the pediatric products. Also contributing to the decrease is lower other payroll and share-based compensation of $4,700 due to reduced headcount as a result of the 2019 Corporate and French restructuring plans.

- 37 -



							Three Months Ended
	Three Months Ended June 30,						Increase / (Decrease)
	Three Months Ended June 30,						2019 vs. 2018
Intangibles Asset Amortization:	2019			2018			$			%

Intangible asset amortization	$	204		$	1,609		$	(1,405	)	(87.3	)%
Percentage of total revenues	1.2		%	5.5		%

Intangible asset amortization expense decreased $1,405 or 87.3% during the three months ended June 30, 2019 driven by the impairment of the intangible asset related to Noctiva at December 31, 2018.



							Six Months Ended
	Six Months Ended June 30,						Increase / (Decrease)
	Six Months Ended June 30,						2019 vs. 2018
Intangibles Asset Amortization:	2019			2018			$			%

Intangible asset amortization	$	405		$	3,376		$	(2,971	)	(88.0	)%
Percentage of total revenues	1.2		%	5.4		%

Intangible asset amortization expense decreased $2,971 or 88.0% during the six months ended June 30, 2019 driven by the impairment of the intangible asset related to Noctiva at December 31, 2018.



							Three Months Ended
	Three Months Ended June 30,						Increase / (Decrease)
	Three Months Ended June 30,						2019 vs. 2018
Changes in Fair Value of Related Party Contingent Consideration:	2019			2018			$		%

Changes in fair value of related party contingent consideration	$	(377	)	$	(12,889	)	$	12,512	97.1	%
Percentage of total revenues	(2.1		)%	(44.1		)%

We compute the fair value of the related party contingent consideration using several significant assumptions and when these assumptions change, due to underlying market conditions, the fair value of these liabilities change as well. Each of the underlying assumptions used to determine the fair values of these contingent liabilities can, and often do, change based on adjustments in current market conditions, competition and other factors. These changes can have a material impact on our unaudited condensed consolidated statements of loss and balance sheet.

As a result of changes in the underlying assumptions used to determine the estimated fair values of our acquisition-related contingent consideration earn-out payments - Éclat, we recorded gains of $377 and $12,889 and lowered the fair value of the acquisition-related contingent consideration earn-out payments - Éclat for the three months ended June 30, 2019 and 2018, respectively. As noted in our critical accounting estimates included in the 2018 Form 10-K, there are numerous assumptions and estimates we use when determining the fair value of the acquisition-related earn-out payments - Éclat. These assumptions include estimates of pricing, market size, the market share the related products are forecast to achieve, the cost of goods related to such products and an appropriate discount rate to use when present valuing the related cash flows.

For the three months ended June 30, 2019, as a result of changes to these estimates when compared to the same estimates at March 31, 2019, we recorded an decrease in the fair value of our contingent consideration liabilities due to changes in certain underlying market conditions of the acquisition-related contingent consideration earn-out payments - Éclat.

For the three months ended June 30, 2018, as a result of changes to these estimates when compared to the same estimates at March 31, 2018, we recorded a decrease in the fair value of our contingent consideration liabilities, largely due to changes in certain underlying market conditions of the acquisition-related contingent consideration earn-out payments - Éclat.

- 38 -



							Six Months Ended
	Six Months Ended June 30,						Increase / (Decrease)
	Six Months Ended June 30,						2019 vs. 2018
Changes in Fair Value of Related Party Contingent Consideration:	2019			2018			$		%

Changes in fair value of related party contingent consideration	$	1,757		$	(9,921	)	$	11,678	117.7	%
Percentage of total revenues	5.2		%	(15.9		)%

As a result of changes in the underlying assumptions used to determine the estimated fair values of our acquisition-related contingent consideration earn-out payments - Éclat, we recorded an expense of $1,757 and a gain of $9,921 and increased/lowered the fair value of the acquisition-related contingent consideration earn-out payments - Éclat for the six months ended June 30, 2019 and 2018, respectively. As noted in our critical accounting estimates included in the 2018 Form 10-K, there are numerous assumptions and estimates we use when determining the fair value of the acquisition-related earn-out payments - Éclat. These assumptions include estimates of pricing, market size, the market share the related products are forecast to achieve, the cost of goods related to such products and an appropriate discount rate to use when present valuing the related cash flows.

For the six months ended June 30, 2019, as a result of changes to these estimates when compared to the same estimates at December 31, 2018, we recorded an increase in the fair value of our contingent consideration liabilities due to changes in certain underlying market conditions of the acquisition-related contingent consideration earn-out payments - Éclat.

For the six months ended June 30, 2018, as a result of changes to these estimates when compared to the same estimates at December 31, 2017, we recorded a decrease in the fair value of our contingent consideration liabilities, largely due to changes in certain underlying market conditions of the acquisition-related contingent consideration earn-out payments - Éclat.



							Three Months Ended
	Three Months Ended June 30,						Increase / (Decrease)
	Three Months Ended June 30,						2019 vs. 2018
Restructuring Costs	2019			2018			$		%

Restructuring costs	$	1,506		$	50		$	1,456	2,912.0	%
Percentage of total revenues	8.6		%	0.2		%

During the first quarter of 2019, the Company announced a plan to reduce its Corporate workforce at our U.S. and Ireland sites by more than 50%. This reduction is an effort to align the Company’s cost structure with its ongoing and future planned projects and revenue stream. Additionally, during the second quarter of 2019, the Company announced a plan to reduce its French workforce. This reduction is an effort to align the Company’s cost structure with our ongoing and future planned projects. See Note 15: Restructuring Costs for further details. As a result of these actions, the Company recorded restructuring charges of $1,506 that are primarily related to the 2019 French and Corporate restructuring plans. These charges included severance and legal costs, impairment of certain assets and the reversal of certain retirement indemnity obligations.

- 39 -



							Six Months Ended
	Six Months Ended June 30,						Increase / (Decrease)
	Six Months Ended June 30,						2019 vs. 2018
Restructuring Costs	2019			2018			$		%

Restructuring costs	$	2,734		$	203		$	2,531	1,246.8	%
Percentage of total revenues	8.0		%	0.3		%

Restructuring charges of $2,734 were recognized during the six months ended June 30, 2019. These charges were primarily related to the French and Corporate restructuring actions and included severance and legal costs, impairment of certain assets and the reversal of certain retirement indemnity obligations. See Note 15: Restructuring Costs for further details.



							Three Months Ended
	Three Months Ended June 30,						Increase / (Decrease)
	Three Months Ended June 30,						2019 vs. 2018
Investment and Other Income, net	2019			2018			$		%

Investment and other income, net	$	950		$	583		$	367	63.0	%
Percentage of total revenues	5.4		%	2.0		%

Investment and other income, net increased for the three months ended June 30, 2019 when compared to the same period in the prior year driven by higher realized gains on our marketable securities during the current period when compared to the prior period.



							Six Months Ended
	Six Months Ended June 30,						Increase / (Decrease)
	Six Months Ended June 30,						2019 vs. 2018
Investment and Other Income, net	2019			2018			$		%

Investment and other income, net	$	1,767		$	637		$	1,130	177.4	%
Percentage of total revenues	5.2		%	1.0		%

Investment and other income, net increased for the six months ended June 30, 2019 when compared to the same period in the prior year driven by higher unrealized gains on our marketable equity securities during the current period when compared to the prior period.



							Three Months Ended
	Three Months Ended June 30,						Increase / (Decrease)
	Three Months Ended June 30,						2019 vs. 2018
Interest Expense	2019			2018			$		%

Interest expense	$	3,106		$	2,980		$	126	4.2	%
Percentage of total revenues	17.7		%	10.2		%

Interest expense for the three months end June 30, 2019 was largely comparable to the same period in the prior year. Interest expense represents the imputed interest on the 2023 Notes.

- 40 -



							Six Months Ended
	Six Months Ended June 30,						Increase / (Decrease)
	Six Months Ended June 30,						2019 vs. 2018
Interest Expense	2019			2018			$		%

Interest expense	$	6,168		$	4,577		$	1,591	34.8	%
Percentage of total revenues	18.1		%	7.3		%

Interest expense increased $1,591 for the six months end June 30, 2019 when compared to the same period in the prior year as a result of a six months of interest recorded in 2019 versus 4.5 months of this amount in 2018 due to the 2023 Notes issued in February 2018.



							Three Months Ended
	Three Months Ended June 30,						Increase / (Decrease)
	Three Months Ended June 30,						2019 vs. 2018
Loss on Deconsolidation of Subsidiary	2019			2018			$			%

Loss on deconsolidation of subsidiary	$	(167	)	$	—		$	(167	)	n/a
Percentage of total revenues	(1.0		)%	—		%

As a result of Specialty Pharma’s bankruptcy filing on February 6, 2019, the Company concluded that it no longer controls its operations and accordingly deconsolidated this subsidiary. The Company recorded a loss on the deconsolidation as a result of removing the net assets and certain liabilities of this subsidiary from our unaudited condensed consolidated financial statements. The loss of $167 during the three months ended June 30, 2019 represents expenses that the Company paid on behalf of Specialty Pharma. See Note 3: Subsidiary Bankruptcy and Deconsolidation for more discussion.



							Six Months Ended
	Six Months Ended June 30,						Increase / (Decrease)
	Six Months Ended June 30,						2019 vs. 2018
Loss on Deconsolidation of Subsidiary	2019			2018			$			%

Loss on deconsolidation of subsidiary	$	(2,840	)	$	—		$	(2,840	)	n/a
Percentage of total revenues	(8.4		)%	—		%

As a result of Avadel Specialty Pharmaceuticals, LLC bankruptcy filing on February 6, 2019, the Company concluded that it no longer controls its operations and accordingly deconsolidated this subsidiary. The Company recorded a loss on the deconsolidation as a result of removing the net assets and certain liabilities of this subsidiary from our unaudited condensed consolidated financial statements. See Note 3: Subsidiary Bankruptcy and Deconsolidation for more discussion.



							Three Months Ended
	Three Months Ended June 30,						Increase / (Decrease)
	Three Months Ended June 30,						2019 vs. 2018
Other (Expense) Income - Changes in Fair Value of Related Party Payable	2019			2018			$			%

Other (expense) income - changes in fair value of related party payable	$	(50	)	$	1,402		$	(1,452	)	(103.6	)%
Percentage of total revenues	(0.3		)%	4.8		%

We recorded expense of $50 and income of $1,402 to increase and reduce the fair value of these liabilities during the three months ended June 30, 2019 and 2018, respectively, due to the same reasons associated with the Éclat product sales forecasts as described in the section “Changes in Fair Value of Related Party Contingent Consideration” for these periods. As noted in our critical accounting estimates section included in the 2018 Form 10-K, there are a number of assumptions and estimates we use when determining the fair value of the related party payable payments. These estimates include pricing, market size, the market share

- 41 -

the related products are forecast to achieve and an appropriate discount rate to use when present valuing the related cash flows. These estimates often do change based on changes in current market conditions, competition and other factors.



							Six Months Ended
	Six Months Ended June 30,						Increase / (Decrease)
	Six Months Ended June 30,						2019 vs. 2018
Other (Expense) Income - Changes in Fair Value of Related Party Payable	2019			2018			$			%

Other (expense) income - changes in fair value of related party payable	$	(357	)	$	1,007		$	(1,364	)	(135.5	)%
Percentage of total revenues	(1.1		)%	1.6		%

We recorded expense of $357 and income of $1,007 to increase and reduce the fair value of these liabilities during the six months ended June 30, 2019 and 2018, respectively, due to the same reasons associated with the Éclat product sales forecasts as described in the section “Changes in Fair Value of Related Party Contingent Consideration” for these periods. As noted in our critical accounting estimates section included in the 2018 Form 10-K, there are a number of assumptions and estimates we use when determining the fair value of the related party payable payments. These estimates include pricing, market size, the market share the related products are forecast to achieve and an appropriate discount rate to use when present valuing the related cash flows. These estimates often do change based on changes in current market conditions, competition and other factors.

- 42 -



							Three Months Ended
	Three Months Ended June 30,						Increase / (Decrease)
	Three Months Ended June 30,						2019 vs. 2018
Income Tax Provision (Benefit):	2019			2018			$		%

Income tax provision (benefit)	$	1,781		$	(342	)	$	2,123	620.8	%
Percentage of loss before income taxes	26.1		%	(9.0		)%

The items accounting for the difference between the income tax provision (benefit) computed at the statutory rate and the Company’s effective tax rate for the three months ended June 30, 2019 and 2018, are as follows:



	Three Months Ended June 30,
	2019			2018

Statutory tax rate	12.5		%	12.5		%
International tax rates differential	10.6		%	(1.5		)%
Change in valuation allowance	(52.9		)%	(39.4		)%
Change in fair value of nondeductible contingent consideration	1.6		%	67.6		%
Nondeductible stock-based compensation	—		%	(4.7		)%
Unrecognized tax benefits	(2.5		)%	(7.6		)%
State and local income taxes, net of federal	(0.4		)%	1.0		%
Nondeductible interest expense	(3.7		)%	—		%
Other	8.7		%	(18.9		)%
Effective income tax rate	(26.1		)%	9.0		%

Income tax benefit - at statutory tax rate	$	(853	)	$	(473	)
International tax rates differential	(723		)	57
Change in valuation allowance	3,609			1,491
Change in fair value of nondeductible contingent consideration	(110		)	(2,556		)
Nondeductible stock-based compensation	(2		)	176
Unrecognized tax benefits	168			288
State and local income taxes, net of federal	25			(38		)
Nondeductible interest expense	253			—
Other	(586		)	713
Income tax provision (benefit) - at effective income tax rate	$	1,781		$	(342	)



							Six Months Ended
	Six Months Ended June 30,						Increase / (Decrease)
	Six Months Ended June 30,						2019 vs. 2018
Income Tax Provision (Benefit):	2019			2018			$		%

Income tax provision (benefit)	$	1,407		$	(2,669	)	$	4,076	152.7	%
Percentage of loss before income taxes	7.0		%	(14.6		)%

- 43 -

The items accounting for the difference between the income tax provision (benefit) computed at the statutory rate and the Company’s effective tax rate for the six months ended June 30, 2019 and 2018, are as follows:



	Six Months Ended June 30,
	2019			2018

Statutory tax rate	12.5		%	12.5		%
International tax rates differential	6.9		%	6.8		%
Change in valuation allowance	(25.4		)%	(11.9		)%
Change in fair value of nondeductible contingent consideration	(1.5		)%	10.9		%
Nondeductible stock-based compensation	(0.2		)%	(1.8		)%
Unrecognized tax benefits	(1.4		)%	(2.8		)%
State and local income taxes, net of federal	(0.1		)%	0.3		%
Nondeductible interest expense	(2.0		)%	—		%
Other	4.4		%	0.5		%
Effective income tax rate	(6.8		)%	14.5		%

Income tax benefit - at statutory tax rate	$	(2,526	)	$	(2,293	)
International tax rates differential	(1,391		)	(1,241		)
Change in valuation allowance	5,129			2,181
Change in fair value of nondeductible contingent consideration	303			(2,005		)
Nondeductible stock-based compensation	49			336
Unrecognized tax benefits	292			508
State and local income taxes, net of federal	27			(57		)
Nondeductible interest expense	410			—
Other	(886		)	(98		)
Income tax provision (benefit) - at effective income tax rate	$	1,407		$	(2,669	)

The IRS commenced an examination of the Company's U.S. income tax returns for 2016 and 2017 during the second quarter 2019.

Liquidity and Capital Resources

The Company’s cash flows from operating, investing and financing activities, as reflected in the unaudited condensed consolidated statements of cash flows, are summarized in the following table:



							Six Months Ended
	Six Months Ended June 30,						Increase / (Decrease)
	Six Months Ended June 30,						2019 vs. 2018
Net cash provided by (used in):	2019			2018			$			%

Operating activities	$	(22,653	)	$	(37,942	)	$	15,289		40.3	%
Investing activities	30,336			(79,212		)	109,548			138.3	%
Financing activities	55			113,160			(113,105		)	(100.0	)%

Operating Activities

Net cash used in operating activities of $22,653 for the six months ended June 30, 2019 decreased $15,289 compared to the same prior year period. This decrease in cash used in operating cash flow is due to higher cash earnings (net loss adjusted for non-cash

- 44 -

credits and charges) of $5,890 when compared to the same period last year. The decrease in cash used in operating cash flow was also due to lower cash used for accrued expenses of $6,094 when compared to the same period last year and lower cash payments for related party contingent consideration of $6,024 during the current period when compared to the prior period.

Investing Activities

Cash provided by investing activities was $30,336 for the six months ended June 30, 2019, was related to net cash proceeds received from the excess of sales over purchases of marketable securities. Cash used in investing activities of $79,212 during the same prior year period was related to the use of cash to purchase marketable securities in excess of sales of marketable securities. The Company also made a payment of $20,000 during the second quarter of 2018 related to the Company’s purchase of developed technology as part of the ELAA with Serenity Pharmaceuticals, LLC.

Financing Activities

Cash provided by financing activities for the six months ended June 30, 2019 was $55, which decreased $113,105 from the same prior year period. During the six months ended June 30, 2018, $143,750 of cash was provided by financing activities through the issuance of the 2018 Notes. A portion of the proceeds from the offering of the 2018 Notes was used for share repurchases totaling $27,637 and to pay direct expenses of $5,760 associated with the issuance of the 2018 Notes.

Liquidity and Risk Management

The adequacy of our cash resources depends on the outcome of certain business conditions including the cost of our FT218 clinical development plan, our cost structure, our hospital products revenue stream and other factors set forth in “Risk Factors” within Part I, Item 1A of the 2018 Form 10-K and within Part II, Item 1A of this quarterly report on Form 10-Q. To complete the FT218 clinical development plan and to ensure an adequate and robust NDA for filing with the FDA we will need to commit substantial resources, which could result in future losses or otherwise limit our opportunities or affect our ability to operate our business. Our assumptions concerning the outcome of certain business conditions may prove to be wrong or other factors may adversely affect our business, and as a result we could exhaust or significantly decrease our available cash and marketable securities balances which could, among other things, force us to raise additional funds and/or force us to reduce our expenses, either of which could have a material adverse effect on our business. If available to us raising additional capital may be accomplished through one or more public or private debt or equity financings, collaborations or partnering arrangements. Any equity financing would be dilutive to our shareholders.

Borrowings

In February 2018, we issued the 2023 Notes. We received net proceeds of approximately $137,560 from the sale of the 2023 Notes, after deducting fees and expenses of $6,190.

Share Repurchase Programs

The Company fully completed its authorized share buyback program during the year ended December 31, 2018.

Other Matters

Litigation

Litigation Related to Noctiva

- 45 -

the bankruptcy court orders otherwise. Below are descriptions of a litigation to which Specialty Pharma is a party and a contract dispute involving Specialty Pharma, both of which matters are subject to the automatic stay during the bankruptcy case.

Tax Matters. On July 2, 2019, Specialty Pharma was made aware of a $50,695 claim made by the Internal Revenue Service (IRS) as part of the bankruptcy claims process against Specialty Pharma. Specialty Pharma files its U.S. federal tax return as a member of the Company’s consolidated U.S. tax group. As such, the IRS claim was filed against Specialty Pharma in the bankruptcy proceedings due to IRS tax law requirements for joint and several liability of all members in a consolidated U.S. tax group. Both Specialty Pharma and the Company disagree with the merits of the IRS claim, and intend to defend their positions vigorously.

Material Commitments



Purchase Commitments:	Balance

2019	$	7,194
2020	1,320
2021	1,320
2022	1,320
2023	220
Thereafter	—
Total	$	11,374

- 46 -

Contractual Obligations

Disclosures regarding contractual obligations are included in Part II, Item 7 of the Company’s 2018 Annual Report on Form 10-K and updated in Note 10: Long-Term Related Party Payable to the Company’s unaudited condensed consolidated financial statements included in Part I, Item 1 of this Report.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Interest Rate Risk

The Company is subject to interest rate risk as a result of its portfolio of marketable securities. The primary objectives of our investment policy are as follows: safety and preservation of principal and diversification of risk; liquidity of investments sufficient to meet cash flow requirements; and competitive yield. Although our investments are subject to market risk, our investment policy specifies credit quality standards for our investments and limits the amount of credit exposure from any single issue, issuer or certain types of investment. Our investment policy allows us to maintain a portfolio of cash equivalents and marketable securities in a variety of instruments, including U.S. federal government and federal agency securities, European Government bonds, corporate bonds or commercial paper issued by U.S. or European corporations, money market instruments, certain qualifying money market mutual funds, certain repurchase agreements, tax-exempt obligations of states, agencies, and municipalities in the U.S and Europe, and equities.

ITEM 4. CONTROLS AND PROCEDURES.

Management of the Company, with the participation of its Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures as of June 30, 2019, the end of the period covered by this quarterly report on Form 10-Q. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (“Exchange Act”), means controls and other procedures of a company that are designed to provide reasonable assurance that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures are also designed to provide reasonable assurance that such information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure. Based on their evaluation, as of the end of the period covered by this Form 10-Q, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) were effective as of June 30, 2019.

Changes in Internal Control over Financial Reporting

During the quarter ended June 30, 2019, as part of our restructuring initiatives described in this Quarterly Report under Item 1 “Financial Statements - Note 15 (Restructuring Costs)” and Item 2 “Management Discussion and Analysis of Results of Operations and Financial Condition - Results of Operation,” we moved all of our Irish and a portion of our French accounting operations to St. Louis, Missouri. Further, as part of these restructuring initiatives, the Company completed the outsourcing of a majority of its Information Technology resources to a third party. These moves were made in order to consolidate our accounting systems, gain efficiencies of scale, reduce costs and make internal control over financial reporting more consistent across our various entities. These moves were not made in response to any identified deficiency or weakness in the Company’s internal control over financial reporting. Other than these changes, there has been no change in our internal control over financial reporting during the quarter ended June 30, 2019 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION


ITEM 1.	LEGAL PROCEEDINGS.

The information contained in Note 19: Commitments and Contingencies to the Company’s unaudited condensed consolidated financial statements included in Part I, Item 1 of this Report is incorporated by reference herein.

ITEM 1A. RISK FACTORS.

There have been no material changes in our risk factors from those previously disclosed in the Company’s 2018 Annual Report.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

The Company fully completed its authorized share buyback program during the year ended December 31, 2018.

- 47 -

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4. MINE SAFETY DISCLOSURES.

Not applicable.

ITEM 5. OTHER INFORMATION.

None.

ITEM 6. EXHIBITS.



Exhibit No.		Description

10.1		Amended Employment Agreement, dated June 3, 2019, between Avadel Management Corporation and Gregory J. Divis (incorporated by reference to Exhibit 10.1 to the registrant’s current report on Form 8-K, filed on June 5, 2019)
10.2		Employment Agreement, dated June 5, 2019, between Avadel Management Corporation and Jordan Dubow (incorporated by reference to Exhibit 10.2 to the registrant’s current report on Form 8-K, filed on June 5, 2019)
31.1*		Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) promulgated under the Exchange Act
31.2*		Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) promulgated under the Exchange Act
32.1**		Certification of the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**		Certification of the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*		XBRL Instance Document
101.SCH*		XBRL Taxonomy Extension Schema Document
101.CAL*		XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*		XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*		XBRL Taxonomy Extension Label Linkbase Document
101.PRE*		XBRL Taxonomy Extension Presentation Linkbase Document

______________________

* Filed herewith.

** Furnished herewith.

- 48 -

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



	AVADEL PHARMACEUTICALS PLC
	(Registrant)

Date: August 9, 2019	By:	/s/ Michael F. Kanan
		Michael F. Kanan
		Senior Vice President and Chief Financial Officer
		(Duly Authorized Officer and Principal Financial and Accounting Officer)

- 49 -

EX-31.1 2 exhibit311q22019.htm EXHIBIT 31.1 Exhibit

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Gregory J. Divis, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Avadel Pharmaceuticals plc;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



Date: August 9, 2019	/s/ Gregory J. Divis
	Gregory J. Divis
	Chief Executive Officer

EX-31.2 3 exhibit312q22019.htm EXHIBIT 31.2 Exhibit

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Michael F. Kanan, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Avadel Pharmaceuticals plc:

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



Date: August 9, 2019	/s/ Michael F. Kanan
	Michael F. Kanan
	Senior Vice President and Chief Financial Officer

EX-32.1 4 exhibit321q22019.htm EXHIBIT 32.1 Exhibit

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Avadel Pharmaceuticals plc (the “Company”) for the period ended June 30, 2019 (the “Report”), the undersigned hereby certifies in his capacity as Chief Executive Officer of the Company pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date: August 9, 2019	/s/ Gregory J. Divis
	Gregory J. Divis
	Chief Executive Officer

EX-32.2 5 exhibit322q22019.htm EXHIBIT 32.2 Exhibit

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Avadel Pharmaceuticals plc (the “Company”) for the period ended June 30, 2019 (the “Report”), the undersigned hereby certifies in his capacity as Chief Financial Officer of the Company pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Date: August 9, 2019	/s/ Michael F. Kanan
	Michael F. Kanan
	Senior Vice President and Chief Financial Officer

EX-101.INS 6 avdl-20190630.xml XBRL INSTANCE DOCUMENT 0001012477 2019-01-01 2019-06-30 0001012477 2019-08-06 0001012477 2019-04-01 2019-06-30 0001012477 2018-04-01 2018-06-30 0001012477 2018-01-01 2018-06-30 0001012477 us-gaap:ProductMember 2018-04-01 2018-06-30 0001012477 us-gaap:LicenseMember 2019-04-01 2019-06-30 0001012477 us-gaap:ProductMember 2018-01-01 2018-06-30 0001012477 us-gaap:LicenseMember 2019-01-01 2019-06-30 0001012477 us-gaap:ProductMember 2019-04-01 2019-06-30 0001012477 us-gaap:LicenseMember 2018-01-01 2018-06-30 0001012477 us-gaap:ProductMember 2019-01-01 2019-06-30 0001012477 us-gaap:LicenseMember 2018-04-01 2018-06-30 0001012477 2019-06-30 0001012477 2018-12-31 0001012477 2017-12-31 0001012477 us-gaap:CommonStockMember 2018-03-31 0001012477 2018-01-01 2018-03-31 0001012477 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0001012477 us-gaap:TreasuryStockMember 2018-01-01 2018-03-31 0001012477 us-gaap:CommonStockMember 2018-04-01 2018-06-30 0001012477 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0001012477 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-04-01 2018-06-30 0001012477 us-gaap:TreasuryStockMember 2017-12-31 0001012477 us-gaap:CommonStockMember 2018-06-30 0001012477 us-gaap:AdditionalPaidInCapitalMember 2018-04-01 2018-06-30 0001012477 us-gaap:TreasuryStockMember 2018-03-31 0001012477 us-gaap:CommonStockMember 2018-01-01 2018-03-31 0001012477 us-gaap:TreasuryStockMember 2018-04-01 2018-06-30 0001012477 2018-03-31 0001012477 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001012477 2018-06-30 0001012477 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-03-31 0001012477 us-gaap:TreasuryStockMember 2018-06-30 0001012477 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001012477 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0001012477 us-gaap:RetainedEarningsMember 2017-12-31 0001012477 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001012477 us-gaap:CommonStockMember 2017-12-31 0001012477 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-03-31 0001012477 us-gaap:RetainedEarningsMember 2018-06-30 0001012477 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0001012477 us-gaap:RetainedEarningsMember 2018-03-31 0001012477 us-gaap:RetainedEarningsMember 2018-04-01 2018-06-30 0001012477 us-gaap:CommonStockMember 2018-12-31 0001012477 2019-01-01 2019-03-31 0001012477 us-gaap:RetainedEarningsMember 2019-06-30 0001012477 us-gaap:RetainedEarningsMember 2018-12-31 0001012477 us-gaap:TreasuryStockMember 2018-12-31 0001012477 us-gaap:CommonStockMember 2019-03-31 0001012477 us-gaap:RetainedEarningsMember 2019-03-31 0001012477 us-gaap:TreasuryStockMember 2019-06-30 0001012477 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001012477 2019-03-31 0001012477 us-gaap:TreasuryStockMember 2019-03-31 0001012477 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001012477 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001012477 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001012477 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0001012477 us-gaap:CommonStockMember 2019-06-30 0001012477 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001012477 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001012477 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001012477 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001012477 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001012477 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001012477 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0001012477 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001012477 avdl:DebtorinPossessionCreditandSecurityFacilityMember avdl:DIPCreditAgreementMember 2019-04-01 2019-06-30 0001012477 avdl:SpecialtyPharmaMember 2019-06-30 0001012477 avdl:SpecialityPharamaMember 2019-04-26 2019-04-26 0001012477 avdl:SpecialityPharamaMember avdl:DebtorinPossessionCreditandSecurityFacilityMember avdl:DIPCreditAgreementMember 2019-02-08 0001012477 avdl:SpecialityPharamaMember us-gaap:InternalRevenueServiceIRSMember us-gaap:SubsequentEventMember 2019-07-02 0001012477 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001012477 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-06-30 0001012477 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2019-06-30 0001012477 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeSecuritiesMember 2018-12-31 0001012477 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001012477 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2019-06-30 0001012477 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:FixedIncomeSecuritiesMember 2019-06-30 0001012477 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001012477 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2018-12-31 0001012477 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001012477 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2019-06-30 0001012477 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-06-30 0001012477 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001012477 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2018-12-31 0001012477 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:EquitySecuritiesMember 2018-12-31 0001012477 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0001012477 avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member us-gaap:SeniorNotesMember 2019-06-30 0001012477 us-gaap:SeniorNotesMember 2019-06-30 0001012477 us-gaap:FixedIncomeSecuritiesMember 2018-12-31 0001012477 us-gaap:MoneyMarketFundsMember 2018-12-31 0001012477 us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0001012477 us-gaap:EquitySecuritiesMember 2018-12-31 0001012477 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2018-12-31 0001012477 us-gaap:EquitySecuritiesMember 2018-01-01 2018-12-31 0001012477 us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2019-06-30 0001012477 us-gaap:MoneyMarketFundsMember 2019-06-30 0001012477 us-gaap:CorporateDebtSecuritiesMember 2019-06-30 0001012477 us-gaap:EquitySecuritiesMember 2019-06-30 0001012477 us-gaap:FixedIncomeSecuritiesMember 2019-06-30 0001012477 us-gaap:EquitySecuritiesMember 2019-04-01 2019-06-30 0001012477 avdl:DebtSecuritiesExcludingMoneyMarketFundsAvailableForSaleMember 2019-06-30 0001012477 us-gaap:DevelopedTechnologyRightsMember avdl:VazculepMember 2019-06-30 0001012477 us-gaap:DevelopedTechnologyRightsMember avdl:VazculepMember 2018-12-31 0001012477 us-gaap:DevelopedTechnologyRightsMember avdl:VazculepMember 2018-01-01 2018-12-31 0001012477 us-gaap:DevelopedTechnologyRightsMember avdl:NoctivaMember 2019-06-30 0001012477 us-gaap:DevelopedTechnologyRightsMember avdl:NoctivaMember 2018-12-31 0001012477 us-gaap:DevelopedTechnologyRightsMember avdl:NoctivaMember 2018-01-01 2018-12-31 0001012477 2018-01-01 2018-12-31 0001012477 srt:MinimumMember 2019-01-01 2019-06-30 0001012477 srt:MaximumMember 2019-01-01 2019-06-30 0001012477 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 0001012477 srt:MaximumMember 2019-06-30 0001012477 avdl:OperatingLeasesCommencedMember 2019-06-30 0001012477 srt:MinimumMember 2019-06-30 0001012477 avdl:BroadfinRoyaltyAgreementMember avdl:FinancingRelatedCostsMember 2019-01-01 2019-06-30 0001012477 avdl:DeerfieldRoyaltyAgreementMember avdl:FinancingRelatedCostsMember 2019-01-01 2019-06-30 0001012477 avdl:BroadfinRoyaltyAgreementMember avdl:FinancingRelatedCostsMember 2019-06-30 0001012477 avdl:EarnOutPaymentsMember us-gaap:AcquisitionRelatedCostsMember 2019-01-01 2019-06-30 0001012477 avdl:EarnOutPaymentsMember us-gaap:AcquisitionRelatedCostsMember 2018-12-31 0001012477 avdl:EarnOutPaymentsMember us-gaap:AcquisitionRelatedCostsMember 2019-06-30 0001012477 avdl:DeerfieldRoyaltyAgreementMember avdl:FinancingRelatedCostsMember 2018-12-31 0001012477 avdl:BroadfinRoyaltyAgreementMember avdl:FinancingRelatedCostsMember 2018-12-31 0001012477 avdl:DeerfieldRoyaltyAgreementMember avdl:FinancingRelatedCostsMember 2019-06-30 0001012477 avdl:EarnOutPaymentsMember us-gaap:AcquisitionRelatedCostsMember 2019-04-01 2019-06-30 0001012477 avdl:DeerfieldRoyaltyAgreementMember avdl:FinancingRelatedCostsMember 2019-03-31 0001012477 avdl:DeerfieldRoyaltyAgreementMember avdl:FinancingRelatedCostsMember 2019-04-01 2019-06-30 0001012477 avdl:BroadfinRoyaltyAgreementMember avdl:FinancingRelatedCostsMember 2019-03-31 0001012477 avdl:BroadfinRoyaltyAgreementMember avdl:FinancingRelatedCostsMember 2019-04-01 2019-06-30 0001012477 avdl:EarnOutPaymentsMember us-gaap:AcquisitionRelatedCostsMember 2019-03-31 0001012477 avdl:EclatPharmaceuticalsMember 2012-03-01 2012-03-31 0001012477 avdl:BroadfinDebtFinancingMember 2013-12-01 2013-12-31 0001012477 avdl:DeerfieldCsfLlcMember srt:AffiliatedEntityMember 2013-02-01 2013-02-28 0001012477 us-gaap:SeniorNotesMember 2018-12-31 0001012477 us-gaap:LoansPayableMember 2018-12-31 0001012477 avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member us-gaap:SeniorNotesMember 2018-12-31 0001012477 us-gaap:LoansPayableMember 2019-06-30 0001012477 avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member 2018-12-31 0001012477 avdl:FourPointFiftyPercentExchangeableSeniorNotesDue2023Member 2019-06-30 0001012477 country:IE 2018-04-01 2018-06-30 0001012477 country:IE 2018-01-01 2018-06-30 0001012477 country:US 2018-04-01 2018-06-30 0001012477 country:US 2018-01-01 2018-06-30 0001012477 country:IE 2019-04-01 2019-06-30 0001012477 country:FR 2019-04-01 2019-06-30 0001012477 country:US 2019-01-01 2019-06-30 0001012477 country:FR 2018-01-01 2018-06-30 0001012477 country:FR 2018-04-01 2018-06-30 0001012477 country:FR 2019-01-01 2019-06-30 0001012477 country:US 2019-04-01 2019-06-30 0001012477 country:IE 2019-01-01 2019-06-30 0001012477 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember avdl:A2016MIPAMember us-gaap:ScenarioForecastMember 2021-01-01 2021-01-31 0001012477 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember avdl:A2016MIPAMember 2018-02-12 2018-02-12 0001012477 avdl:FSCMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember avdl:A2016MIPAMember 2018-02-12 2018-02-12 0001012477 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember avdl:A2016MIPAMember 2018-02-12 0001012477 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember avdl:A2016MIPAMember 2019-06-30 0001012477 avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember 2019-01-01 2019-06-30 0001012477 avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember 2019-06-30 0001012477 avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember 2018-12-31 0001012477 avdl:LyonFranceWorkforceReductionMember 2018-01-01 2018-06-30 0001012477 avdl:LyonFranceWorkforceReductionMember 2019-01-01 2019-06-30 0001012477 avdl:LyonFranceWorkforceReductionMember 2019-06-30 0001012477 avdl:LyonFranceWorkforceReductionMember 2017-12-31 0001012477 avdl:LyonFranceWorkforceReductionMember 2018-12-31 0001012477 avdl:LyonFranceWorkforceReductionMember 2018-06-30 0001012477 avdl:TwoThousandNineteenCorporateRestructuringObligationsMember 2019-06-30 0001012477 us-gaap:AccruedLiabilitiesMember avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember 2018-12-31 0001012477 avdl:TwoThousandNineteenCorporateRestructuringObligationsMember 2019-01-01 2019-06-30 0001012477 avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember us-gaap:ScenarioForecastMember 2019-01-01 2019-12-31 0001012477 avdl:TwoThousandNineteenCorporateRestructuringObligationsMember 2019-04-01 2019-06-30 0001012477 us-gaap:EmployeeSeveranceMember avdl:LyonFranceWorkforceReductionMember 2017-06-30 0001012477 us-gaap:EmployeeSeveranceMember avdl:CorporateWorkforceReductionMember 2019-06-30 0001012477 us-gaap:AccruedLiabilitiesMember avdl:TwoThousandNineteenCorporateFrenchRestructuringObligationMember 2019-06-30 0001012477 avdl:TwoThousandNineteenCorporateRestructuringObligationsMember us-gaap:ScenarioForecastMember 2019-01-01 2019-12-31 0001012477 avdl:TwoThousandNineteenCorporateRestructuringObligationsMember 2018-12-31 0001012477 us-gaap:AccumulatedTranslationAdjustmentMember 2018-04-01 2018-06-30 0001012477 us-gaap:AccumulatedTranslationAdjustmentMember 2018-01-01 2018-06-30 0001012477 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-06-30 0001012477 us-gaap:AccumulatedTranslationAdjustmentMember 2019-04-01 2019-06-30 0001012477 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0001012477 us-gaap:AccumulatedTranslationAdjustmentMember 2018-06-30 0001012477 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-06-30 0001012477 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-04-01 2019-06-30 0001012477 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-03-31 0001012477 us-gaap:AccumulatedTranslationAdjustmentMember 2019-03-31 0001012477 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-03-31 0001012477 us-gaap:AccumulatedTranslationAdjustmentMember 2019-06-30 0001012477 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-06-30 0001012477 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-04-01 2018-06-30 0001012477 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-12-31 0001012477 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-06-30 0001012477 us-gaap:AccumulatedTranslationAdjustmentMember 2017-12-31 0001012477 us-gaap:AccumulatedTranslationAdjustmentMember 2018-03-31 0001012477 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-01-01 2018-06-30 0001012477 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-31 0001012477 avdl:OtherProductsMember 2019-04-01 2019-06-30 0001012477 avdl:BloxiverzMember 2019-01-01 2019-06-30 0001012477 avdl:OtherProductsMember 2019-01-01 2019-06-30 0001012477 avdl:OtherProductsMember 2018-04-01 2018-06-30 0001012477 avdl:AkovazMember 2018-01-01 2018-06-30 0001012477 avdl:VazculepMember 2019-01-01 2019-06-30 0001012477 avdl:BloxiverzMember 2018-04-01 2018-06-30 0001012477 avdl:BloxiverzMember 2019-04-01 2019-06-30 0001012477 avdl:BloxiverzMember 2018-01-01 2018-06-30 0001012477 avdl:VazculepMember 2018-04-01 2018-06-30 0001012477 avdl:VazculepMember 2019-04-01 2019-06-30 0001012477 avdl:VazculepMember 2018-01-01 2018-06-30 0001012477 avdl:OtherProductsMember 2018-01-01 2018-06-30 0001012477 avdl:AkovazMember 2019-04-01 2019-06-30 0001012477 avdl:AkovazMember 2018-04-01 2018-06-30 0001012477 avdl:AkovazMember 2019-01-01 2019-06-30 0001012477 us-gaap:InventoriesMember 2019-06-30 0001012477 avdl:SpecialtyPharmaMember 2019-01-27 2019-01-27 0001012477 us-gaap:ScenarioForecastMember 2019-07-01 2019-09-30 xbrli:pure iso4217:USD xbrli:shares iso4217:USD xbrli:shares avdl:segment 2028000 1591000 3469000 0 1000000 1815000 1009000 789000 6541000 6279000 17456000 7024000 10432000 10837000 0 10837000 -9921000 1757000 50000 22000 28000 0 357000 121000 236000 0 2600000 2200000 0.15 645000 0 11113000 5790000 -0.076 -0.028 -0.025 -0.014 0 0 253000 410000 0.000 0.000 -0.037 -0.020 -1007000 357000 534000 551000 5697000 5413000 288000 508000 168000 292000 1003000 593000 4000000 3000000 22000 235000 174000 268000 194000 328000 0 147000 5894000 6561000 49000 50000 407000 0.2 0.0175 0.00834 0.15 1024000 0 11374000 0 220000 1320000 7194000 1320000 1320000 283000 270000 7272000 7833000 1000000 0.50 0.50 203000 541000 -168000 2414000 2359000 10300000 603000 82000 2911000 2905000 6000 535000 534000 1000 false --12-31 Q2 2019 2019-06-30 10-Q 0001012477 37450300 Yes false Accelerated Filer AVADEL PHARMACEUTICALS PLC false false

3503000

4798000

11330000

10172000

21695000

15737000

-23416000

-22848000

433756000

434254000

26699000

2167000

2134000

2224000

351000

55000

2019000

2918000

1609000

3376000

204000

405000

18831

15300

20359

20502

1000000

190300000

165709000

124851000

97200000

62141000

28449000

51071000

11080000

411000

7000

22000

316000

66000

916000

54000

29000

719000

114000

1180000

79000

13000

53000

79000

132000

1000

2000

91359000

6411000

9400000

52733000

12714000

61367000

3611000

2154000

46314000

5122000

9483000

2929000

1756000

4798000

436000

1161000

735000

426000

90590000

52996000

6339000

9409000

12701000

6339000

9409000

52996000

12701000

62151000

47033000

3664000

2182000

5234000

11080000

3664000

2182000

47033000

5234000

50695000

-12889000

-9921000

-377000

1757000

98925000

52117000

28840000

1041000

2184000

25615000

27593000

976000

2048000

24569000

24247000

866000

1799000

21582000

9325000

17111000

16564000

12477000

9325000

17111000

-4087000

7786000

-1750000

0.01

500000000

42720000

42763000

37313000

37356000

427000

-3842000

78000

-482000

-16067000

-160000

-233000

-8250000

293000

62000

-21055000

667000

-99000

3512000

10104000

3622000

6888000

32015000

77933000

22005000

46609000

1352000

867000

143750000

-26699000

0.0450

263000

-28059000

-25125000

2700000

-167000

-407000

-2840000

23029000

21072000

3810000

1064000

20337000

9439000

9391000

8264000

28840000

24247000

19401000

18202000

15983000

-0.09

-0.42

-0.23

-0.58

-0.09

-0.42

-0.23

-0.58

-93000

48000

0.090

0.145

-0.261

-0.068

0.125

-0.394

-0.119

-0.529

-0.254

-0.015

0.068

0.106

0.069

0.676

0.109

0.016

-0.015

-0.047

-0.018

0.000

-0.002

-0.189

0.005

0.087

0.044

0.010

0.003

-0.004

-0.001

976000

1396000

9145000

4038000

10101000

4166000

956000

128000

P5Y

P15Y

P3Y

815000

814000

85172000

73111000

12061000

1629000

1224000

-478000

18491000

5964000

6620000

5717000

5432000

5985000

6643000

66087000

525000

-3780000

163000

-10962000

7019000

-18343000

362000

-15889000

-2816000

-6824000

-4535000

-12089000

9800000

-20216000

-4250000

-22323000

6357000

-342000

-2669000

1781000

1407000

1491000

2181000

3609000

5129000

57000

-1241000

-723000

-1391000

-473000

-2293000

-853000

-2526000

-2556000

-2005000

-110000

303000

176000

336000

-2000

49000

713000

-98000

-586000

-886000

-38000

-57000

25000

27000

409000

140000

921000

997000

5206000

3127000

-3000000

157000

-579000

-9831000

-3737000

-3247000

1900000

242000

-2124000

2893000

3629000

-1587000

1829000

1629000

1224000

2980000

4577000

3106000

6168000

394000

3234000

3614000

4270000

2127000

4770000

2601000

500000

474000

4757000

1143000

583000

637000

950000

1767000

333000

634000

5232000

958000

692000

763000

1003000

1213000

603000

616000

P7Y

P1Y

187520000

183486000

190300000

165709000

38383000

33580000

-10928000

2114000

115840000

115691000

118736000

118625000

106000

105000

60914000

115734000

118631000

1477000

1700000

90590000

62151000

-1693000

-17000

113160000

55000

-79212000

30336000

-37942000

-22653000

-12236000

-3438000

-15674000

-13018000

-8605000

-21623000

2625000

28840000

24247000

-2785000

-15410000

-4451000

-12618000

394000

739000

4616000

5131000

999000

3617000

394000

704000

5454000

1000000

5046000

0.053

P4Y11M27D

5836000

1191000

695000

767000

1008000

1208000

967000

2798000

1876000

225000

82000

36146000

34573000

78000

-160000

293000

667000

11000

70000

23000

41000

-482000

-233000

62000

-99000

-404000

11000

213000

355000

-404000

-393000

355000

568000

3640000

3677000

14002000

11675000

594000

149000

61000

111000

1402000

1007000

-50000

-357000

91000

-1012000

27637000

2167000

515000

647000

1332000

2016000

1618000

917000

13376000

3019000

132000

277000

2610000

6707000

296000

621000

5790000

20000000

312638000

21991000

99000

29000

0.01

50000000

8836000

5165000

2145000

2594000

143750000

6000

-37000

253525000

52202000

250000

154000

3446000

92000

1911000

934000

15263000

5760000

11890000

21841000

10292000

17621000

50000

203000

1506000

435000

2734000

168000

1939000

963000

1000000

633000

24000

879000

1078000

56000

1102000

343000

879000

1441000

-55000

-8000

20000

-357989000

-379612000

29230000

11875000

5544000

320000

11377000

114000

29116000

62523000

22092000

13035000

2812000

24338000

246000

62277000

17554000

5946000

2358000

-160000

9410000

17554000

33991000

9738000

4926000

444000

18883000

33991000

27843000

52330000

6758000

17204000

3500000

3000000

4358000

406000

41463000

2117000

42066000

4424000

42148000

5407000

42720000

5407000

42763000

5407000

42763000

5407000

3350000

42000

1000

92000

85580000

-64000

-23266000

-23202000

393478000

414000

-262685000

-22361000

86639000

-302000

-23670000

-22953000

427383000

420000

-274921000

-42573000

78546000

-224000

-23659000

-23435000

430141000

421000

-278359000

-49998000

2780000

205000

-23416000

-23621000

433756000

427000

-357989000

-49998000

-9582000

579000

-23203000

-23782000

434199000

427000

-371007000

-49998000

-17777000

872000

-22848000

-23720000

434254000

427000

-379612000

-49998000

61000

105000

5407000

2307000

983000

49998000

20212000

7425000

5315000

1378000

671000

36772000

37666000

37356000

37355000

36772000

37666000

37356000

37355000

3971000

1946000

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Nature of Operations.</font><font style="font-family:inherit;font-size:10pt;">  </font><font style="font-family:inherit;font-size:10pt;">Avadel Pharmaceuticals plc (Nasdaq: AVDL) (“Avadel,” the “Company,” “we,” “our,” or “us”) is a branded specialty pharmaceutical company.  Our primary focus is on the development and potential U.S. Food and Drug Administration (“FDA”) approval for FT218 which is in a Phase 3 clinical trial for the treatment of narcolepsy patients suffering from excessive daytime sleepiness (EDS) and cataplexy.  In addition, we market three sterile injectable drugs used in the hospital setting which were developed under our “unapproved marketed drug” (UMD) program.  The Company is headquartered in Dublin, Ireland with operations in St. Louis, Missouri and Lyon, France. For more information, please visit www.avadel.com.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Avadel is developing FT218, an investigational once-nightly formulation of sodium oxybate based on its propriety Micropump® drug delivery technology, for the treatment of EDS and cataplexy in patients suffering from narcolepsy. FT218 is currently being evaluated in a Phase 3 clinical trial called REST-ON. In addition, the Company submitted a new drug application (“NDA”) in March 2019 on a fourth sterile injectable drug used in the hospital setting (“UMD #4”), which, if approved, could contribute revenues to Avadel starting in 2020. In May 2019, the FDA accepted this NDA, AV001, with a Prescription Drug User Fee Act (PDUFA) target action date of December 15, 2019. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our current marketed products include: </font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-style:italic;">Akovaz®</font><font> (ephedrine sulfate injection, USP), an alpha- and beta-adrenergic agonist and a norepinephrine-releasing agent that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-style:italic;">Bloxiverz®</font><font> (neostigmine methylsulfate injection), a cholinesterase inhibitor, is indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents (NMBAs) after surgery. </font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-style:italic;">Vazculep®</font><font> (phenylephrine hydrochloride injection), an alpha-1 adrenergic receptor agonist indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Each of our</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> Akovaz</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Bloxiverz</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Vazculep</font><font style="font-family:inherit;font-size:10pt;"> products is used primarily in the hospital setting and was developed under our UMD program.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company was incorporated on December 1, 2015 as an Irish private limited company, and re-registered as an Irish public limited company, or plc, on November 21, 2016. Our principal place of business is located at Block 10-1, Blanchardstown Corporate Park, Ballycoolin, Dublin 15, Ireland. Avadel’s phone number is 011-353-1-485-1200. Our website is www.avadel.com, where we make available free of charge our reports (and any amendments thereto) on Forms 10-K, 10-Q and 8-K as soon as reasonably practicable after they are electronically filed with or furnished to the U.S. Securities and Exchange Commission (“SEC”). These filings are also available to the public at www.sec.gov.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is the successor to Flamel Technologies S.A., a French </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">société anonyme</font><font style="font-family:inherit;font-size:10pt;"> (“Flamel”), as the result of the France-to-Ireland redomestication merger of Flamel with and into the Company completed on December 31, 2016 (the “Merger”). In the Merger, we changed our company name to Avadel Pharmaceuticals plc and our jurisdiction of organization to Ireland; we assumed all the assets and liabilities of Flamel; and we issued one Avadel ordinary share (either directly or in the form of an American Depositary Share (ADS)) in exchange for each formerly outstanding share of Flamel, all of which were canceled. Thus, an Avadel ordinary share held (either directly or represented by an ADS) immediately after the Merger continued to represent the same proportional interest in our equity owned by the holder of a share of Flamel immediately prior to the Merger. References in this Annual Report on Form 10-K to “Avadel,” the “Company,” “we,” “our,” “us,” and similar terms shall be deemed to be references to Flamel prior to the completion of the Merger, unless the context otherwise requires. Additional details about the Merger are set forth in Item 1 under the caption “The Reincorporation Merger” of the Company’s Annual Report on Form 10-K filed with the SEC on March 15, 2019. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company currently has five direct wholly-owned subsidiaries: (a) Avadel US Holdings, Inc., (b) Flamel Ireland Limited, which conducts business under the name Avadel Ireland, (c) Avadel Investment Company Limited, (d) Avadel Finance Ireland Designated Activity Company and (e) Avadel France Holding SAS. Avadel US Holdings, Inc., a Delaware corporation, is the holding entity of (i) Avadel Specialty Pharmaceuticals, LLC (currently the subject of a voluntary Chapter 11 bankruptcy proceeding as noted in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Note 3: Subsidiary Bankruptcy and Deconsolidation</font><font style="font-family:inherit;font-size:10pt;">), (ii) Avadel Legacy Pharmaceuticals, LLC, (iii) Avadel Management Corporation, (iv) FSC Holding Company and (v) Avadel Operations Company, Inc. Avadel Finance Ireland Designated Activity Company is the holding entity of Avadel Finance Cayman Limited. Flamel Ireland Limited (operating under the trade name Avadel Ireland) is an Irish corporation which, since December 16, 2014, has been the owner of substantially all of Avadel’s intellectual property. Avadel France Holding SAS, a French </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">société par actions simplifiée</font><font style="font-family:inherit;font-size:10pt;">, is the holding entity of Avadel Research SAS through which Avadel conducts substantially all of its R&D activities.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Various other assets and liabilities are summarized as follows:</font></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:62%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Prepaid Expenses and Other Current Assets:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Valued-added tax recoverable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">671</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,378</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Prepaid and other expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,594</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,145</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Guarantee from Armistice (see </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Note 14</font><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">551</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">534</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income tax receivable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">997</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">921</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Research and development tax credit receivable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">270</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">283</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Short-term deposit</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,350</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">82</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">225</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,165</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8,836</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Basis of Presentation.</font><font style="font-family:inherit;font-size:10pt;"> The unaudited condensed consolidated balance sheet as of </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;">, which is derived from the prior year 2018 audited consolidated financial statements, and the interim unaudited condensed consolidated financial statements presented herein, have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP), the requirements of Form 10-Q and Article 10 of Regulation S-X and, consequently, do not include all information or footnotes required by U.S. GAAP for complete financial statements or all the disclosures normally made in an annual report on Form 10-K. Accordingly, the unaudited condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements and footnotes included in the Company’s 2018 Annual Report on Form 10-K filed with the SEC on March 15, 2019.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The unaudited condensed consolidated financial statements include the accounts of the Company and subsidiaries, and reflect all adjustments (consisting only of normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the dates and periods presented. All material intercompany accounts and transactions have been eliminated. Results for interim periods are not necessarily indicative of the results to be expected during the remainder of the current year or for any future period. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 6, 2019, the Company’s indirect wholly-owned subsidiary, Avadel Specialty Pharmaceuticals, LLC (“Specialty Pharma”), filed a voluntary petition for reorganization under Chapter 11 of the United States (“U.S.”) Code (the “Bankruptcy Code”). in the U.S. District Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”), Case No. 19-10248. Specialty Pharma is operating and managing its business as “debtors-in-possession” under the jurisdiction of the Bankruptcy Court and in accordance with the applicable provisions of the Bankruptcy Code and order of the Bankruptcy Court. As a result of Specialty Pharma’s voluntary bankruptcy filing on February 6, 2019, we no longer controlled the operations of Specialty Pharma; therefore, we deconsolidated Specialty Pharma effective with the bankruptcy filing and the Company recorded its investment in Specialty Pharma under the cost method. See </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Note 3: Subsidiary Bankruptcy and Deconsolidation. </font><font style="font-family:inherit;font-size:10pt;">Our results of operations for the period January 1, 2019 through February 6, 2019 include the results of Specialty Pharma prior to its February 6, 2019 voluntary petition for reorganization under Chapter 11 of the U.S. Bankruptcy Code.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Marketable Securities </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has investments in available-for-sale marketable securities which are recorded at fair market value. The change in the fair value of available-for-sale equity investments is recognized in our unaudited condensed consolidated statements of loss and the change in the fair value of all other available-for-sale investments is recorded as other comprehensive income (loss) in shareholders’ (deficit) equity, net of income tax effects. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables show the Company’s available-for-sale securities’ adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category as of </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;">, respectively:</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">June 30, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Marketable Securities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Adjusted Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unrealized Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equity securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,166</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(128</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,038</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Money market funds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">46,314</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">719</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">47,033</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Corporate bonds</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,611</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">54</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,664</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Government securities - U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,122</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">114</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,234</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other fixed-income securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,154</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">29</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,182</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">61,367</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">916</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(132</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">62,151</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Marketable Securities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Adjusted Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unrealized Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equity securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,101</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(956</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,145</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Money market funds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">52,733</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">316</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(53</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">52,996</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Corporate bonds</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,411</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(79</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,339</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Government securities - U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,714</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">66</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(79</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,701</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other fixed-income securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,400</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,409</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">91,359</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">411</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,180</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">90,590</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We determine realized gains or losses on the sale of marketable securities on a specific identification method. We reflect these gains and losses as a component of investment income in the accompanying unaudited condensed consolidated statements of loss.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We recognized gross realized gains of </font><font style="font-family:inherit;font-size:10pt;">$174</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$22</font><font style="font-family:inherit;font-size:10pt;"> for the three months ended </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, respectively. These realized gains were offset by realized losses of </font><font style="font-family:inherit;font-size:10pt;">$0</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$194</font><font style="font-family:inherit;font-size:10pt;"> for the three months ended </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, respectively. We recognized gross realized gains of </font><font style="font-family:inherit;font-size:10pt;">$268</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$235</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, respectively. These realized gains were offset by realized losses of </font><font style="font-family:inherit;font-size:10pt;">$147</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$328</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, respectively. We reflect these gains and losses as a component of investment income in the accompanying condensed consolidated statements of income (loss).</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the estimated fair value of our investments in marketable debt securities, accounted for as available-for-sale securities and classified by the contractual maturity date of the securities as of </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Maturities</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Marketable Debt Securities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Less than 1 Year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">1-5 Years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">5-10 Years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Greater than 10 Years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Corporate bonds</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">735</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,929</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,664</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Government securities - U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,798</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">436</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,234</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other fixed-income securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">426</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,756</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,182</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,161</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,483</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">436</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,080</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has classified our investment in available-for-sale marketable securities as current assets in the unaudited condensed consolidated balance sheets as the securities need to be available for use, if required, to fund current operations. There are no restrictions on the sale of any securities in our investment portfolio.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Long-Term Debt</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt is summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Principal amount of 4.50% exchangeable senior notes due 2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">143,750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">143,750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: debt discount and issuance costs, net </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(25,125</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(28,059</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net carrying amount of liability component</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">118,625</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">115,691</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">111</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">149</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">     Subtotal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">118,736</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">115,840</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: current maturities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(105</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(106</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">     Long-term debt</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">118,631</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">115,734</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equity component:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equity component of exchangeable notes, net of issuance costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(26,699</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(26,699</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Divestiture of the Pediatric Assets</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 12, 2018, the Company, together with its subsidiaries Avadel Pharmaceuticals (USA), Inc., Avadel Pediatrics, Inc., FSC Therapeutics, LLC (“FSC Therapeutics”), and Avadel US Holdings, Inc. (“Holdings”), as the “Sellers,” entered into an asset purchase agreement (the “Purchase Agreement”) with Cerecor, Inc. (“Cerecor”). The transaction closed on February 16, 2018 wherein Cerecor purchased from the Sellers four pediatric commercial stage assets – Karbinal™ ER, Cefaclor, Flexichamber™ and AcipHex® Sprinkle™, together with certain associated business assets – which were held by FSC.  The Company acquired FSC in February 2016 from Deerfield and certain of its affiliates. Pursuant to the Purchase Agreement, Cerecor assumed the Company’s  remaining payment obligations to Deerfield under the Membership Interest Purchase Agreement, dated as of February 5, 2016, between Holdings, Flamel Technologies SA (the predecessor of the Company) and Deerfield and certain of its affiliates, which payment obligations consist of the following (collectively, the “Assumed Obligations”): (i) a quarterly payment of </font><font style="font-family:inherit;font-size:10pt;">$263</font><font style="font-family:inherit;font-size:10pt;"> beginning in July 2018 and ending in October 2020, amounting to an aggregate payment obligation of </font><font style="font-family:inherit;font-size:10pt;">$2,625</font><font style="font-family:inherit;font-size:10pt;">; (ii) a payment in January 2021 of </font><font style="font-family:inherit;font-size:10pt;">$15,263</font><font style="font-family:inherit;font-size:10pt;">; and (iii) a quarterly royalty payment of </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;"> on net sales of the FSC products through February 5, 2026 (“FSC Product Royalties”), in an aggregate amount of up to approximately </font><font style="font-family:inherit;font-size:10pt;">$10,300</font><font style="font-family:inherit;font-size:10pt;">.  Cerecor also assumed certain contracts and other obligations related to the acquired assets, and in that connection Holdings agreed to pay Cerecor certain make-whole payments associated with obligations Cerecor is assuming related to a certain supply contract related to Karbinal™ ER. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In conjunction with the divestiture, the Company also entered into the following arrangements:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;padding-left:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">License and Development Agreement</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;padding-left:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Also, in connection with the closing under the Purchase Agreement, Flamel Ireland Limited, an Irish limited company operating under the trade name of Avadel Ireland (“Avadel Ireland”) and a wholly-owned subsidiary of the Company, and Cerecor entered into a license and development agreement (the “License and Development Agreement”) pursuant to which, among other things:</font></div><div style="line-height:120%;text-align:justify;padding-left:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:102px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Avadel Ireland will provide Cerecor with four product formulations utilizing Avadel Ireland’s LiquiTime™ technology, and will complete pilot bioequivalence studies for such product formulations within 18 months;</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:102px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cerecor will reimburse Avadel Ireland for development costs of the four LiquiTime™ products in excess of </font><font style="font-family:inherit;font-size:10pt;">$1,000</font><font style="font-family:inherit;font-size:10pt;"> in the aggregate;</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:102px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Upon transfer of the four product formulations, Cerecor will assume all remaining development costs and responsibilities for the product development, clinical studies, NDA applications and associated filing fees; and</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:102px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:102px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Upon regulatory approval and commercial launch of any LiquiTime™ products, Cerecor will pay Avadel Ireland quarterly royalties based on a percentage of net sales of any such products in the mid-single digit range. </font></div></td></tr></table><div style="line-height:120%;padding-left:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-left:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Deerfield Guarantee</font></div><div style="line-height:120%;padding-left:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;padding-left:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the closing under the Purchase Agreement, the Company and Holdings provided their guarantee (the “Deerfield Guarantee”) in favor of Deerfield. Under the Deerfield Guarantee, the Company and Holdings guaranteed to Deerfield the payment by Cerecor of the Assumed Obligations under the Membership Interest Purchase Agreement between the Company and Deerfield dated February 5, 2016. The Assumed Obligations include (i) a quarterly payment of </font><font style="font-family:inherit;font-size:10pt;">$263</font><font style="font-family:inherit;font-size:10pt;"> beginning in July 2018 and ending in October 2020, amounting to an aggregate payment obligation of </font><font style="font-family:inherit;font-size:10pt;">$2,625</font><font style="font-family:inherit;font-size:10pt;">; (ii) a payment in January 2021 of </font><font style="font-family:inherit;font-size:10pt;">$15,263</font><font style="font-family:inherit;font-size:10pt;">; and (iii) a quarterly royalty payment of </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;"> on net sales of the FSC products through February 6, 2026 (“FSC Product Royalties”), in an aggregate amount of up to approximately </font><font style="font-family:inherit;font-size:10pt;">$10,300</font><font style="font-family:inherit;font-size:10pt;">. In addition, under the Deerfield Guarantee, the Company and Holdings guaranteed that Deerfield would receive certain minimum annual FSC Product Royalties through February 6, 2026 (the “Minimum Royalties”). Given the Company’s explicit guarantee to Deerfield, the Company recorded the guarantee in accordance with ASC 460. A valuation was performed, which was based largely on an analysis of the potential timing of each possible cash outflow described above and the likelihood of Cerecor’s default on such payments assuming an S&P credit rating of CCC+. The result of this valuation identified a guarantee liability of </font><font style="font-family:inherit;font-size:10pt;">$6,643</font><font style="font-family:inherit;font-size:10pt;">. This liability is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield. At </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;">, the carrying value of this liability was </font><font style="font-family:inherit;font-size:10pt;">$5,985</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-left:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-left:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Armistice Guarantee</font></div><div style="line-height:120%;padding-left:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;padding-left:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the closing under the Purchase Agreement, Armistice Capital Master Fund, Ltd., the then majority shareholder of Cerecor, guaranteed to Holdings the payment by Cerecor of the Assumed Obligations, including the Minimum Royalties. A valuation of the guarantee asset was performed in accordance with ASC 460 and a guarantee asset of </font><font style="font-family:inherit;font-size:10pt;">$6,620</font><font style="font-family:inherit;font-size:10pt;"> was recorded. This asset is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield noted above. At </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;">, the carrying value of this asset was </font><font style="font-family:inherit;font-size:10pt;">$5,964</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;padding-left:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;padding-left:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair values of the Avadel guarantee to Deerfield and the guarantee received by Avadel from Armistice largely offset and when combined are not material.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on management’s review of ASU 2014-08, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity</font><font style="font-family:inherit;font-size:10pt;">, the disposition of our pediatric assets and related liabilities did not qualify for discontinued operations reporting. Our results of operations for the period January 1, 2018 through February 16, 2018 include the results of FSC, prior to its February 16, 2018 disposition date.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The net impact of this transaction was not material to the unaudited condensed consolidated statements of loss.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurement</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is required to measure certain assets and liabilities at fair value, either upon initial recognition or for subsequent accounting or reporting. For example, we use fair value extensively when accounting for and reporting certain financial instruments, when measuring certain contingent consideration liabilities and in the initial recognition of net assets acquired in a business combination. Fair value is estimated by applying the hierarchy described below, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement.  </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASC 820, “Fair Value Measurements and Disclosures,” defines fair value as a market-based measurement that should be determined based on the assumptions that marketplace participants would use in pricing an asset or liability. When estimating fair value, depending on the nature and complexity of the asset or liability, we may generally use one or each of the following techniques:  </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income approach, which is based on the present value of a future stream of net cash flows. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As a basis for considering the assumptions used in these techniques, the standard establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value as follows:  </font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 1 - Quoted prices for identical assets or liabilities in active markets. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 2 - Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are directly or indirectly observable, or inputs that are derived principally from, or corroborated by, observable market data by correlation or other means. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 3 - Unobservable inputs that reflect estimates and assumptions. </font></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the financial instruments measured at fair value on a recurring basis classified in the fair value hierarchy (Level 1, 2 or 3) based on the inputs used for valuation in the accompanying unaudited condensed consolidated balance sheets:</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="25" rowspan="1"></td></tr><tr><td style="width:34%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">As of June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">As of December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair Value Measurements:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Level 3</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Marketable securities (see </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Note 6</font><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equity securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,038</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,145</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Money market funds</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">47,033</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">52,996</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Corporate bonds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,664</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,339</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Government securities - U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,234</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,701</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other fixed-income securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,182</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,409</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">51,071</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,080</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">62,141</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28,449</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Related party payable (see </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Note 10</font><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,247</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28,840</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,247</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28,840</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A review of fair value hierarchy classifications is conducted on a quarterly basis.  Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. During the periods ended </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;">, respectively, there were no transfers in and out of Level 1, 2, or 3. During the three month periods ended </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, respectively, we did not recognize any other-than-temporary impairment loss.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Some of the Company’s financial instruments, such as cash and cash equivalents, accounts receivable and accounts payable, are reflected in the balance sheet at carrying value, which approximates fair value due to their short-term nature. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Debt</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We estimate the fair value of our </font><font style="font-family:inherit;font-size:10pt;">$143,750</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal amount of </font><font style="font-family:inherit;font-size:10pt;">4.50%</font><font style="font-family:inherit;font-size:10pt;"> exchangeable senior notes due 2023 (the “2023 Notes”), a Level 2 input, based on interest rates that would be currently available to the Company for issuance of similar types of debt instruments with similar terms and remaining maturities or recent trading prices obtained from brokers. The estimated fair value of the 2023 Notes at </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;"> is </font><font style="font-family:inherit;font-size:10pt;">$60,914</font><font style="font-family:inherit;font-size:10pt;"> compared to a book value of </font><font style="font-family:inherit;font-size:10pt;">$118,625</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additionally, the Company’s other debt is reflected in the balance sheet at carrying value. The fair value of these loans is impracticable to estimate as these represent non-interest bearing grants from the French government and are repayable only if the research project is technically or commercially successful.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Note </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">11</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">: </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:normal;">Long-Term Debt</font><font style="font-family:inherit;font-size:10pt;"> for additional information regarding our debt obligations.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Income Taxe</font><font style="font-family:inherit;font-size:10pt;">s </font></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of loss before income taxes are as follows: </font></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:46%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Loss Before Income Taxes:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ireland</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12,089</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(10,962</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(22,323</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,889</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">United States</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,800</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,019</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,357</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,816</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">France</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,535</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">163</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,250</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">362</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total loss before income taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(6,824</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,780</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(20,216</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(18,343</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The items accounting for the difference between the income tax provision computed at the statutory rate and the Company’s effective tax rate are as follows:</font></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Income Tax Rate Reconciliation:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Statutory tax rate </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">International tax rates differential</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Change in valuation allowance</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(52.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(39.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(25.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(11.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Change in fair value of nondeductible contingent consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">67.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Nondeductible stock-based compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Unrecognized tax benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">State and local income taxes, net of federal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Nondeductible interest expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(18.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Effective income tax rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(26.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(6.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income tax benefit - at statutory tax rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(853</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(473</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,526</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,293</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">International tax rates differential</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(723</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">57</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,391</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,241</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Change in valuation allowance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,609</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,491</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,129</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,181</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Change in fair value of nondeductible contingent consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(110</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,556</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">303</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,005</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Nondeductible stock-based compensation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">176</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">336</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Unrecognized tax benefits</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">168</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">288</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">292</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">508</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">State and local income taxes, net of federal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(38</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(57</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Nondeductible interest expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">253</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">410</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(586</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">713</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(886</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(98</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income tax provision (benefit) - at effective income tax rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,781</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(342</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,407</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,669</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The income tax provision was $1,781 for the three months ended June 30, 2019 and a benefit of $342 for the three months ended June 30, 2018. The increase in the income tax provision for the three months ended June 30, 2019 is primarily the result of a decrease in the amount of nontaxable gain from the revaluation of contingent consideration and an increase in the amount of valuation allowances recorded on foreign income tax losses.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The income tax provision was $1,407 for the six months ended June 30, 2019 and a benefit of $2,669 for the six months ended June 30, 2018. The increase in the income tax provision for the six months ended June 30, 2019 is primarily the result of a decrease the amount of nontaxable gain from the revaluation of contingent consideration and an increase in the amount of valuation allowances recorded on foreign income tax losses. </font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The IRS commenced an examination of the Company's U.S. income tax returns for 2016 and 2017 during the second quarter 2019. </font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the estimated fair value of our investments in marketable debt securities, accounted for as available-for-sale securities and classified by the contractual maturity date of the securities as of </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Maturities</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Marketable Debt Securities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Less than 1 Year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">1-5 Years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">5-10 Years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Greater than 10 Years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Corporate bonds</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">735</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,929</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,664</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Government securities - U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,798</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">436</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,234</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other fixed-income securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">426</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,756</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,182</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,161</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,483</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">436</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,080</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of lease costs, which is included in selling, general and administrative expenses in the unaudited condensed consolidated statements of loss for the three and six months ended June 30 were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:95.8984375%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Lease cost:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Three months ended June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Six months ended June 30, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating lease costs </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">394</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">739</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Sublease income </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">61</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">105</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">333</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">634</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) </sup></font><font style="font-family:inherit;font-size:10pt;">Variable lease costs were immaterial for the three and </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:10pt;"> Represents sublease income received for the vacated office facility in Charlotte, North Carolina, which was acquired with the FSC acquisition in February 2016. The lease and sublease agreements terminate in December 2020. The Company also vacated a portion of the office facility in St. Louis, Missouri during May 2019 and started receiving sublease income starting in May 2019. The lease agreement ends in April 2025 and the sublease agreement ends in May 2020 with a one year renewal option.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Maturities of the Company’s operating lease liabilities were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:81%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Maturities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Operating Leases</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Remaining six months of 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">603</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,213</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,003</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">763</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">692</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">958</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,232</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: interest</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">616</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Present value of lease liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,616</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Leases</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU 2016-02, “Leases” which supersedes ASC 840 “Leases” and creates a new topic, ASC 842 “Leases.” This update requires lessees to recognize on their balance sheet a lease liability and a lease asset for all leases, including operating leases, with a term greater than 12 months. On January 1, 2019, the Company adopted the ASU using the modified retrospective transition approach and elected the transition option to recognize the adjustment in the period of adoption rather than in the earliest period presented. As January 1, 2019, adoption of the new guidance resulted in the initial recognition of operating lease right-of-use assets of </font><font style="font-family:inherit;font-size:10pt;">$5,046</font><font style="font-family:inherit;font-size:10pt;"> and operating lease liabilities of </font><font style="font-family:inherit;font-size:10pt;">$5,131</font><font style="font-family:inherit;font-size:10pt;">. At </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;">, the balances of the operating lease right-of-use asset and total operating lease liability are </font><font style="font-family:inherit;font-size:10pt;">$5,454</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$4,616</font><font style="font-family:inherit;font-size:10pt;">, respectively, of which </font><font style="font-family:inherit;font-size:10pt;">$999</font><font style="font-family:inherit;font-size:10pt;"> of the operating lease liability is current.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company leases certain facilities for office and manufacturing purposes, comprising approximately 99% of the total lease population. All leased facilities are classified as operating leases with remaining lease terms between </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">seven years</font><font style="font-family:inherit;font-size:10pt;">. The Company determines if a contract is a lease at the inception of the arrangement. The Company reviews all options to extend, terminate, or purchase its right-of-use assets at the inception of the lease and will include these options in the lease term when they are reasonably certain of being exercised. For all of the Company’s leases, lease and non-lease components are accounted for as a single lease component, as all non-lease components are immaterial to break out separately. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of lease costs, which is included in selling, general and administrative expenses in the unaudited condensed consolidated statements of loss for the three and six months ended June 30 were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:95.8984375%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Lease cost:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Three months ended June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Six months ended June 30, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating lease costs </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">394</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">739</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Sublease income </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">61</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">105</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">333</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">634</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) </sup></font><font style="font-family:inherit;font-size:10pt;">Variable lease costs were immaterial for the three and </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font><font style="font-family:inherit;font-size:10pt;"> Represents sublease income received for the vacated office facility in Charlotte, North Carolina, which was acquired with the FSC acquisition in February 2016. The lease and sublease agreements terminate in December 2020. The Company also vacated a portion of the office facility in St. Louis, Missouri during May 2019 and started receiving sublease income starting in May 2019. The lease agreement ends in April 2025 and the sublease agreement ends in May 2020 with a one year renewal option.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the three and six months ended </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;">, the Company reduced its operating lease liabilities by </font><font style="font-family:inherit;font-size:10pt;">$394</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$704</font><font style="font-family:inherit;font-size:10pt;"> for cash paid. In addition, during the six months ended June 30, 2019, new operating leases commenced resulting in the recognition of operating lease right-of-use assets and liabilities of </font><font style="font-family:inherit;font-size:10pt;">$1,000</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0</font><font style="font-family:inherit;font-size:10pt;">, respectively, as the entire lease payment was paid on March 31, 2019. There were no new leases during the three months ended June 30, 2019. As of </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;">, the Company is aware of one additional embedded lease that has not yet commenced and will not commence until the time of FDA approval of the product (if approved). Once FDA approval is given and the start date is determined, annual production suite fees of approximately </font><font style="font-family:inherit;font-size:10pt;">$3,000</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">$4,000</font><font style="font-family:inherit;font-size:10pt;"> would commence and at that time, and an operating lease right-of-use asset and corresponding operating lease liability will be recorded. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;">, our operating leases have a weighted-average remaining lease term of </font><font style="font-family:inherit;font-size:10pt;">5.0 years</font><font style="font-family:inherit;font-size:10pt;"> and a weighted-average discount rate of </font><font style="font-family:inherit;font-size:10pt;">5.3%</font><font style="font-family:inherit;font-size:10pt;">. Nearly all of Avadel’s lease contracts do not provide a readily determinable implicit rate. For these contracts, Avadel’s estimated incremental borrowing rate is based on information available at the inception of the lease.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Maturities of the Company’s operating lease liabilities were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:81%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Maturities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Operating Leases</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Remaining six months of 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">603</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,213</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,003</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">763</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">692</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">958</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total lease payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,232</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: interest</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">616</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Present value of lease liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,616</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the prior lease guidance, minimum rental commitments for non-cancelable leases as of December 31, 2018 were: </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:81%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Lease Commitment:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Operating Leases</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,191</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,208</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,008</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">767</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">695</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">967</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total minimum lease payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,836</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Newly Issued Accounting Standards</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recent Accounting Guidance Not Yet Adopted</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU 2018-13, “</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurement (Topic 820): Disclosure Framework— Changes to the Disclosure Requirement for Fair Value Measurement</font><font style="font-family:inherit;font-size:10pt;">” which amends certain disclosure requirements over Level 1, Level 2 and Level 3 fair value measurements. The amendments in ASU 2018-13 are effective for fiscal years beginning after December 15, 2019, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2018-13.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued ASU 2017-04, “</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles - Goodwill and Other: Simplifying the Test for Goodwill Impairment.</font><font style="font-family:inherit;font-size:10pt;">” This update eliminates step 2 from the goodwill impairment test, and requires the goodwill impairment test to be performed by comparing the fair value of a reporting unit with its carrying amount. An impairment charge should be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. This guidance is effective for the Company in the first quarter of 2020. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The Company will assess the timing of adoption and impact of this guidance to future impairment considerations.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Newly Issued Accounting Standards</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recent Accounting Guidance Not Yet Adopted</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU 2018-13, “</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurement (Topic 820): Disclosure Framework— Changes to the Disclosure Requirement for Fair Value Measurement</font><font style="font-family:inherit;font-size:10pt;">” which amends certain disclosure requirements over Level 1, Level 2 and Level 3 fair value measurements. The amendments in ASU 2018-13 are effective for fiscal years beginning after December 15, 2019, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2018-13.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued ASU 2017-04, “</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles - Goodwill and Other: Simplifying the Test for Goodwill Impairment.</font><font style="font-family:inherit;font-size:10pt;">” This update eliminates step 2 from the goodwill impairment test, and requires the goodwill impairment test to be performed by comparing the fair value of a reporting unit with its carrying amount. An impairment charge should be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. This guidance is effective for the Company in the first quarter of 2020. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The Company will assess the timing of adoption and impact of this guidance to future impairment considerations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:62%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other Non-Current Liabilities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Provision for retirement indemnity</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,024</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Customer allowances </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">867</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,352</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Unrecognized tax benefits</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,315</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,315</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Guarantee to Deerfield (see </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Note 14</font><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,432</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,717</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">61</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">594</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,675</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14,002</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Long-Term Related Party Payable </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term related party payable and related activity are reported at fair value and consist of the following at </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Activity during the Six Months Ended </font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Changes in Fair Value of Related Party Payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Long-Term Related Party Payable: </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance,</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Payments to</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Related Parties</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Operating Expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance, June 30, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisition-related contingent consideration:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Earn-out payments - Éclat Pharmaceuticals (a)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25,615</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5,790</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,757</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21,582</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Financing-related:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Royalty agreement - Deerfield (b)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,184</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(621</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">236</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,799</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Royalty agreement - Broadfin (c)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,041</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(296</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">121</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">866</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total related party payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28,840</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(6,707</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,757</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">357</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,247</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: current portion</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,439</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8,264</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total long-term related party payable</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">19,401</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15,983</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term related party payable and related activity are reported at fair value and consist of the following at </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;"> and March 31, 2019:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Activity during the Three Months Ended </font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Changes in Fair Value of Related Party Payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Long-Term Related Party Payable: </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance,</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Payments to</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Related Parties</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Operating Expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance, June 30, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisition-related contingent consideration:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Earn-out payments - Éclat Pharmaceuticals (a)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,569</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,610</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(377</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21,582</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Financing-related:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Royalty agreement - Deerfield (b)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,048</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(277</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,799</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Royalty agreement - Broadfin (c)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">976</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(132</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">866</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total related party payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27,593</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(377</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,247</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: current portion</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,391</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8,264</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total long-term related party payable</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,202</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15,983</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(a) In March 2012, the Company acquired all of the membership interests of Éclat from Breaking Stick Holdings, L.L.C. (“Breaking Stick”, formerly Éclat Holdings), an affiliate of Deerfield. Breaking Stick is majority owned by Deerfield, with a minority interest owned by the Company’s former CEO, and certain other current and former employees. As part of the consideration, the Company committed to provide quarterly earn-out payments equal to </font><font style="font-family:inherit;font-size:10pt;">20%</font><font style="font-family:inherit;font-size:10pt;"> of any gross profit generated by certain Éclat products. These payments will continue in perpetuity, to the extent gross profit of the related products also continue in perpetuity.</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of a February 2013 debt financing transaction conducted with Deerfield, the Company received cash of </font><font style="font-family:inherit;font-size:10pt;">$2,600</font><font style="font-family:inherit;font-size:10pt;"> in exchange for entering into a royalty agreement whereby the Company shall pay quarterly a </font><font style="font-family:inherit;font-size:10pt;">1.75%</font><font style="font-family:inherit;font-size:10pt;"> royalty on the net sales of certain Éclat products until December 31, 2024. In connection with such debt financing transaction, the Company granted Deerfield a security interest in the product registration rights of the Eclat products. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of a December 2013 debt financing transaction conducted with Broadfin Healthcare Master Fund, a related party and current shareholder, the Company received cash of </font><font style="font-family:inherit;font-size:10pt;">$2,200</font><font style="font-family:inherit;font-size:10pt;"> in exchange for entering into a royalty agreement whereby the Company shall pay quarterly a </font><font style="font-family:inherit;font-size:10pt;">0.834%</font><font style="font-family:inherit;font-size:10pt;"> royalty on the net sales of certain Éclat products until December 31, 2024.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;">, the fair value of each related party payable listed in (a), (b) and (c) above was estimated using a discounted cash flow model based on estimated and projected annual net revenues or gross profit, as appropriate, of each of the specified Éclat products using an appropriate risk-adjusted discount rate of </font><font style="font-family:inherit;font-size:10pt;">15%</font><font style="font-family:inherit;font-size:10pt;">. These fair value measurements are based on significant inputs not observable in the market and thus represent a level 3 measurement as defined in ASC 820. Subsequent changes in the fair value of the acquisition-related related party payables, resulting primarily from management’s revision of key assumptions, will be recorded in the unaudited condensed consolidated statements of loss in the line items entitled “Changes in fair value of related party contingent consideration” for items noted in (b) above and in “Other expense - changes in fair value of related party payable” for items (b) and (c) above. See </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Note 1: Summary of Significant Accounting Policies </font><font style="font-family:inherit;font-size:10pt;">under the caption Acquisition-related Contingent Consideration and Financing-related Royalty Agreements in Part II, Item 8 of the Company’s 2018 Annual Report on Form 10-K for more information on key assumptions used to determine the fair value of these liabilities. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has chosen to make a fair value election pursuant to ASC 825, “Financial Instruments” for its royalty agreements detailed in items (b) and (c) above. These financing-related liabilities are recorded at fair market value on the unaudited condensed consolidated balance sheets and the periodic change in fair market value is recorded as a component of “Other expense – change in fair value of related party payable” on the unaudited condensed consolidated statements of loss.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes changes to the related party payables, a recurring Level 3 measurement, for the </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;">-month periods ended </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, respectively:</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:79%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Related Party Payable Rollforward:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance, December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">98,925</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Payments of related party payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13,376</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Fair value adjustments </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(10,928</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Expiration of warrants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,167</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Disposition of the pediatric assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(20,337</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance, June 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">52,117</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance, December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28,840</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Payments of related party payable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(6,707</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Fair value adjustments </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,114</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance, June 30, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,247</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) </sup></font><font style="font-family:inherit;font-size:10pt;">Fair value adjustments are reported as changes in fair value of related party contingent consideration and other expense - changes in fair value of related party payable in the unaudited condensed consolidated statements of loss.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restructuring Costs</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">2019 French Restructuring</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the second quarter of 2019, the Company initiated a plan to substantially reduce all of its workforce at its Vénissieux, France site (“2019 French Restructuring”). This reduction is an effort to align the Group’s cost structure with our ongoing and future planned projects. The reduction in workforce is projected to be substantially complete by the end of calendar year 2019, and to result in employee severance, benefits and other costs of up to approximately </font><font style="font-family:inherit;font-size:10pt;">$3,500</font><font style="font-family:inherit;font-size:10pt;">, which are likely to be recognized through December 31, 2019. Restructuring charges associated with this plan of </font><font style="font-family:inherit;font-size:10pt;">$1,939</font><font style="font-family:inherit;font-size:10pt;"> were recognized during the three and </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended June 30, 2019. Included in the 2019 French Restructuring charges of </font><font style="font-family:inherit;font-size:10pt;">$1,939</font><font style="font-family:inherit;font-size:10pt;"> were charges for employee severance, benefits and other costs of </font><font style="font-family:inherit;font-size:10pt;">$2,414</font><font style="font-family:inherit;font-size:10pt;">, a charge of </font><font style="font-family:inherit;font-size:10pt;">$525</font><font style="font-family:inherit;font-size:10pt;"> related to fixed asset impairment, as well as a benefit of </font><font style="font-family:inherit;font-size:10pt;">$1,000</font><font style="font-family:inherit;font-size:10pt;"> related to the reversal of the French retirement indemnity obligation. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth activities for the Company’s cost reduction plan obligations for the three and </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:86%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019 French Restructuring Obligation:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance of restructuring accrual at January 1,</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Charges for employee severance, benefits and other costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,414</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,332</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Foreign currency impact</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance of restructuring accrual at June 30, </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,102</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2019 French Restructuring liabilities of </font><font style="font-family:inherit;font-size:10pt;">$1,078</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$24</font><font style="font-family:inherit;font-size:10pt;"> are included in the unaudited condensed consolidated balance sheet in accrued expenses and accounts payable at </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">2019 Corporate Restructuring</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the first quarter of 2019, the Company announced a plan to reduce its Corporate workforce by more than </font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;"> (“2019 Corporate Restructuring”). The reduction in workforce is primarily a result of the exit of Noctiva during the first quarter of 2019 (see </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Note </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">3</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">: Subsidiary Bankruptcy and Deconsolidation</font><font style="font-family:inherit;font-size:10pt;">), as well as an effort to better align the Company’s remaining cost structure at our U.S. and Ireland locations with our ongoing and future planned projects. The reduction in workforce is projected to be substantially complete by the end of calendar year 2019, and to result in employee severance, benefits and other costs of up to approximately </font><font style="font-family:inherit;font-size:10pt;">$3,000</font><font style="font-family:inherit;font-size:10pt;">, which are likely to be recognized through December 31, 2019. The restructuring benefit associated with this plan of </font><font style="font-family:inherit;font-size:10pt;">$435</font><font style="font-family:inherit;font-size:10pt;"> and restructuring charges of </font><font style="font-family:inherit;font-size:10pt;">$963</font><font style="font-family:inherit;font-size:10pt;"> were recognized during the three and </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;">, respectively. Included in the 2019 Corporate Restructuring benefit of </font><font style="font-family:inherit;font-size:10pt;">$435</font><font style="font-family:inherit;font-size:10pt;"> for the three months ended June 30, 2019 were charges for employee severance, benefit and other costs of </font><font style="font-family:inherit;font-size:10pt;">$541</font><font style="font-family:inherit;font-size:10pt;">, as well as a benefit of </font><font style="font-family:inherit;font-size:10pt;">$976</font><font style="font-family:inherit;font-size:10pt;"> related to share based compensation forfeitures related to the employees affected by the global reduction in workforce. Included in the 2019 Corporate Restructuring charges of </font><font style="font-family:inherit;font-size:10pt;">$963</font><font style="font-family:inherit;font-size:10pt;"> for the six months ended June 30, 2019, were charges for employee severance, benefit and other costs of </font><font style="font-family:inherit;font-size:10pt;">$2,359</font><font style="font-family:inherit;font-size:10pt;">, as well as a benefit of </font><font style="font-family:inherit;font-size:10pt;">$1,396</font><font style="font-family:inherit;font-size:10pt;"> related to share based compensation forfeitures related to the employees affected by the global reduction in workforce. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth activities for the Company’s cost reduction plan obligations for the </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:86%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019 Corporate Restructuring Obligation:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance of restructuring accrual at January 1,</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Charges for employee severance, benefits and other costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,359</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance of restructuring accrual at June 30, </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">343</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019 Corporate Restructuring liabilities of </font><font style="font-family:inherit;font-size:10pt;">$343</font><font style="font-family:inherit;font-size:10pt;"> are included in the unaudited condensed consolidated balance sheet in accrued expenses at </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">2017 French Restructuring</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the first quarter of 2017, the Company announced a plan to reduce its workforce at the Venissieux, France site by approximately </font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;"> (“2017 French Restructuring”).  This reduction was an effort to align the Company’s cost structure with our ongoing and future planned projects. In July 2017, the Company completed negotiations with the works council for our French operations and received approval from the French Labor Commission (DIRECCTE) to implement the plan. The reduction was substantially complete at </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;">. The 2017 French restructuring costs for the three months ended June 30, 2019 and 2018 were immaterial. The 2017 French Restructuring income of </font><font style="font-family:inherit;font-size:10pt;">$168</font><font style="font-family:inherit;font-size:10pt;"> and restructuring charges of </font><font style="font-family:inherit;font-size:10pt;">$203</font><font style="font-family:inherit;font-size:10pt;"> were recognized during the </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, respectively. The following table sets forth activities for the Company’s cost reduction plan obligations for the </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:72%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017 French Restructuring Obligation:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance of restructuring accrual at January 1,</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">879</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Charges for employee severance, benefits and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(168</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">203</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(647</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(515</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Foreign currency impact</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(55</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance of restructuring accrual at June 30, </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">56</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">633</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2017 French Restructuring accrual is included in the unaudited condensed consolidated balance sheet in accrued expenses and other non-current liabilities at </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue.</font><font style="font-family:inherit;font-size:10pt;"> Revenue includes sales of pharmaceutical products, licensing fees, and, if any, milestone payments for research and development (“R&D”) achievements. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;">Accounting Standards Codification (“ASC”) Topic 606, </font><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;font-style:italic;">“Revenue from Contracts with Customers”</font><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;"> applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. Under ASC 606, an entity recognizes revenue when the performance obligations to the customer have been satisfied through the transfer of control of the goods or services. To determine the appropriate revenue recognition for arrangements that the Company believes are within the scope of ASC 606, we perform the following five steps: (i) Identify the contract(s) with a customer; (ii) Identify the performance obligations in the contract; (iii) Determine the transaction price; (iv) Allocate the transaction price to the performance obligations in the contract; and (v) Recognize revenue when (or as) the entity satisfies a performance obligation. The Company applies the five-step model to contracts only when the Company and its customer’s rights and obligations under the contract can be determined, the contract has commercial substance, and it is probable that the Company will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. For contracts that are determined to be within the scope of ASC 606, the Company identifies the promised goods or services in the contract to determine if they are separate performance obligations or if they should be bundled with other goods and services into a single performance obligation. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Product Sales and Services </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;">The Company sells products primarily through wholesalers and considers these wholesalers to be its customers. Under ASC 606, revenue from product sales is recognized when the customer obtains control of the Company’s product, which occurs typically upon receipt by the customer. As is customary in the pharmaceutical industry, the Company’s gross product sales are subject to a variety of price adjustments in arriving at reported net product sales. These adjustments include estimates of product returns, chargebacks, payment discounts, rebates, and other sales allowances and are estimated based on analysis of historical data for the product or comparable products, future expectations for such products and other judgments and analysis. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">License Revenue </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;">The Company from time to time may enter into out-licensing agreements which are within the scope of ASC 606 under which it licenses to third parties certain rights to its products or intellectual property. The terms of these arrangements typically include payment to the Company of one or more of the following: non-refundable, upfront license fees; development, regulatory, and commercial milestone payments; and sales-based royalty payments. Each of these payments results in license revenue.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;">For a complete discussion of the accounting for net product revenue and license revenues, see </font><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;font-style:italic;">Note </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">4</font><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;font-style:italic;">: Revenue Recognition</font><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;">.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Revenue Recognition</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company generates revenue primarily from the sale of pharmaceutical products to customers. From time to time the Company also generates revenue from licensing arrangements whereby the Company provides access to certain of its intellectual property.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;font-style:italic;">Product Sales and Services </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective January 1, 2018, the Company implemented ASC 606, “</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue From Contracts With Customers</font><font style="font-family:inherit;font-size:10pt;">”. The Company sells products primarily through wholesalers and considers these wholesalers to be its customers. Under ASC 606, revenue from product sales is recognized when the customer obtains control of the Company’s product and the Company’s performance obligations are met, which occurs typically upon receipt of delivery to the customer. As is customary in the pharmaceutical industry, the Company’s gross product sales are subject to a variety of price adjustments in arriving at reported net product sales. These adjustments include estimates for product returns, chargebacks, payment discounts, rebates, and other sales allowances and are estimated when the product is delivered based on analysis of historical data for the product or comparable products, as well as future expectations for such products.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;font-style:italic;">Reserves to reduce Gross Revenues to Net Revenues</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues from product sales are recorded at the net selling price, which includes estimated reserves to reduce gross product sales to net product sales resulting from product returns, chargebacks, payment discounts, rebates, and other sales allowances that are offered within contracts between the Company and its customers and end users. These reserves are based on the amounts earned or to be claimed on the related sales and are classified as reductions of accounts receivable if the amount is payable to the customer, except in the case of the estimated reserve for future expired product returns, which are classified as a liability. The reserves are classified as a liability if the amount is payable to a party other than a customer. Where appropriate, these estimated reserves take into consideration relevant factors such as the Company’s historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company’s best estimates to reduce gross selling price to net selling price to which it expects to be entitled based on the terms of its contracts. The actual selling price ultimately received may differ from the Company’s estimates. If actual results in the future vary from the Company’s estimates, the Company adjusts these estimates, which would affect net product revenue and earnings in the period such variances become known.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;font-style:italic;">Product Returns</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consistent with industry practice, the Company maintains a returns policy, that generally offers customers a right of return for product that has been purchased from the Company. The Company estimates the amount of product returns and records this estimate as a reduction of revenue in the period the related product revenue is recognized. The Company currently estimates product return liabilities based on analysis of historical data for the product or comparable products, as well as future expectations for such products </font><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;">and other judgments and analysis. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;font-style:italic;">Chargebacks, Discounts and Rebates </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chargebacks, discounts and rebates represent the estimated obligations resulting from contractual commitments to sell products to its customers or end users at prices lower than the list prices charged to our wholesale customers. Customers charge the Company for the difference between the gross selling price they pay for the product and the ultimate contractual price agreed to between the Company and these end users. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue and accounts receivable. Chargebacks, discounts and rebates are estimated at the time of sale to the customer.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;font-style:italic;font-weight:bold;">Revenue from licensing arrangements</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The terms of the Company’s licensing agreements may contain multiple performance obligations, including certain R&D activities. The terms of these arrangements typically include payment to the Company of one or more of the following: non-refundable, up-front license fees; development, regulatory and commercial milestone payments. Each of these payments results in license revenues. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;font-style:italic;">License of Intellectual Property</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If the license to the Company’s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, up-front fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are bundled with other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, up-front fees. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;font-style:italic;font-weight:bold;">Disaggregation of revenue</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s primary source of revenue is from the sale of pharmaceutical products, which are equally affected by the same economic factors as it relates to the nature, amount, timing, and uncertainty of revenue and cash flows. For further detail about the Company’s revenues by product, see </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Note </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">18</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">: Company Operations by Product</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;font-style:italic;font-weight:bold;">Contract Balances</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company does not recognize revenue in advance of invoicing its customers and therefore has no related contract assets.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A receivable is recognized in the period the Company sells its products and when the Company’s right to consideration is unconditional. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;">There were </font><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;">no</font><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;"> material deferred contract costs at </font><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;font-style:italic;font-weight:bold;">Transaction Price Allocated to the Remaining Performance Obligation</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For product sales, the Company generally satisfies its performance obligations within the same period the product is delivered. Product sales recognized in 2019 from performance obligations satisfied (or partially satisfied) in previous periods were immaterial.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For certain licenses of intellectual property, specifically those with performance obligations satisfied over time, the Company allocates a portion of the transaction price to that performance obligation and recognizes revenue using an appropriate measure of progress towards development of the product. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has elected certain of the practical expedients from the disclosure requirement for remaining performance obligations for specific situations in which an entity need not estimate variable consideration to recognize revenue. Accordingly, the Company applies the practical expedient in ASC 606 to its stand-alone contracts and does not disclose information about variable consideration from remaining performance obligations for which the Company recognizes revenue.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:62%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Accrued Expenses </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,946</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,971</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued social charges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">789</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,009</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued restructuring (see </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Note 15</font><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,441</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">879</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Customer allowances</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,279</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,541</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued contract research organization charges</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,815</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued contract manufacturing organization costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,591</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,028</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accrued contract sales organization and marketing costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,469</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,876</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,798</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15,737</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21,695</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table shows the components of accumulated other comprehensive loss for the three and </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, respectively, net of tax effects: </font></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Accumulated Other Comprehensive Loss:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Foreign currency translation adjustment:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Beginning balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(23,782</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(22,953</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(23,621</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(23,202</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net other comprehensive (loss) income </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">62</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(482</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(99</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(233</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(23,720</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(23,435</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(23,720</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(23,435</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Unrealized gain (loss) on marketable securities, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Beginning balance</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">579</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(302</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">205</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(64</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net other comprehensive income (loss), net of ($23), ($11), ($41) and ($70) tax, respectively</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">293</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">78</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">667</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(160</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance at June 30,</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">872</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(224</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">872</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(224</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Accumulated other comprehensive loss at June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(22,848</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(23,659</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(22,848</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(23,659</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt is summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:58%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Principal amount of 4.50% exchangeable senior notes due 2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">143,750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">143,750</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: debt discount and issuance costs, net </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(25,125</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(28,059</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net carrying amount of liability component</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">118,625</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">115,691</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">111</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">149</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">     Subtotal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">118,736</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">115,840</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: current maturities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(105</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(106</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">     Long-term debt</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">118,631</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">115,734</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equity component:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equity component of exchangeable notes, net of issuance costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(26,699</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(26,699</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A reconciliation of basic and diluted net loss per share, together with the related shares outstanding in thousands is as follows: </font></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Net Loss Per Share:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8,605</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,438</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(21,623</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,674</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Weighted average shares:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Basic shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">37,356</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36,772</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">37,355</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">37,666</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Effect of dilutive securities—employee and director equity awards outstanding and 2023 Notes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Diluted shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">37,356</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36,772</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">37,355</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">37,666</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss per share - basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.23</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.09</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.58</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.42</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Net loss per share - diluted </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.23</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.09</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.58</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.42</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The items accounting for the difference between the income tax provision computed at the statutory rate and the Company’s effective tax rate are as follows:</font></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Income Tax Rate Reconciliation:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Statutory tax rate </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">International tax rates differential</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Change in valuation allowance</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(52.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(39.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(25.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(11.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Change in fair value of nondeductible contingent consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">67.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Nondeductible stock-based compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Unrecognized tax benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">State and local income taxes, net of federal</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Nondeductible interest expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">8.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(18.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Effective income tax rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(26.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(6.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> %</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income tax benefit - at statutory tax rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(853</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(473</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,526</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,293</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">International tax rates differential</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(723</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">57</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,391</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,241</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Change in valuation allowance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,609</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,491</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,129</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,181</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Change in fair value of nondeductible contingent consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(110</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,556</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">303</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,005</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Nondeductible stock-based compensation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">176</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">336</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Unrecognized tax benefits</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">168</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">288</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">292</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">508</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">State and local income taxes, net of federal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(38</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(57</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Nondeductible interest expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">253</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">410</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(586</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">713</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(886</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(98</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Income tax provision (benefit) - at effective income tax rate</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,781</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(342</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,407</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,669</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the financial instruments measured at fair value on a recurring basis classified in the fair value hierarchy (Level 1, 2 or 3) based on the inputs used for valuation in the accompanying unaudited condensed consolidated balance sheets:</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="25" rowspan="1"></td></tr><tr><td style="width:34%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">As of June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">As of December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair Value Measurements:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Level 3</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Marketable securities (see </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Note 6</font><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equity securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,038</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,145</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Money market funds</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">47,033</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">52,996</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Corporate bonds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,664</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,339</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Government securities - U.S.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,234</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,701</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other fixed-income securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,182</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,409</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">51,071</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,080</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">62,141</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28,449</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Related party payable (see </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Note 10</font><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,247</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28,840</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,247</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28,840</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s amortizable and unamortizable intangible assets at </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;"> are as follows: </font></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="29" rowspan="1"></td></tr><tr><td style="width:26%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Goodwill and Intangible Assets:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Net Carrying</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Impairment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Net Carrying</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Amount</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Amortizable intangible assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquired developed technology - Noctiva</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">73,111</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7,024</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(66,087</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquired developed technology - Vazculep</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,061</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(10,837</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,224</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,061</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(10,432</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,629</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total amortizable intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,061</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(10,837</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,224</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">85,172</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(17,456</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(66,087</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,629</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Unamortizable intangible assets:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Goodwill</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,491</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,491</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,491</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,491</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total unamortizable intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,491</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,491</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,491</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,491</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"> </font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under the prior lease guidance, minimum rental commitments for non-cancelable leases as of December 31, 2018 were: </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:81%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Lease Commitment:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Operating Leases</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,191</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,208</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,008</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">767</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">695</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Thereafter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">967</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total minimum lease payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,836</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of loss before income taxes are as follows: </font></div><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:46%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Loss Before Income Taxes:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Ireland</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12,089</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(10,962</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(22,323</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(15,889</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">United States</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,800</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7,019</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,357</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,816</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">France</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,535</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">163</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4,250</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">362</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total loss before income taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(6,824</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,780</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(20,216</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(18,343</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The principal categories of inventories, net reserves of </font><font style="font-family:inherit;font-size:10pt;">$1,143</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$4,757</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;">, respectively, are comprised of the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:62%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Inventory:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Finished goods</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,127</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,270</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">474</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">500</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,601</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,770</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:62%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other Non-Current Assets:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Deferred tax assets, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21,072</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">23,029</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Long-term deposits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,477</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,477</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Guarantee from Armistice (see </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Note 14</font><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,413</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,697</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Right of use assets at contract manufacturing organizations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,561</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,894</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">49</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total </font><font style="font-family:inherit;font-size:9pt;font-weight:bold;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">34,573</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36,146</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term related party payable and related activity are reported at fair value and consist of the following at </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Activity during the Six Months Ended </font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Changes in Fair Value of Related Party Payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Long-Term Related Party Payable: </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance,</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Payments to</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Related Parties</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Operating Expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance, June 30, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisition-related contingent consideration:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Earn-out payments - Éclat Pharmaceuticals (a)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25,615</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5,790</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,757</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21,582</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Financing-related:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Royalty agreement - Deerfield (b)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,184</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(621</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">236</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,799</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Royalty agreement - Broadfin (c)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,041</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(296</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">121</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">866</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total related party payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28,840</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(6,707</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,757</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">357</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,247</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: current portion</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,439</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8,264</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total long-term related party payable</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">19,401</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15,983</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term related party payable and related activity are reported at fair value and consist of the following at </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;"> and March 31, 2019:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Activity during the Three Months Ended </font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">June 30, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Changes in Fair Value of Related Party Payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Long-Term Related Party Payable: </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance,</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">March 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Payments to</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Related Parties</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Operating Expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Other</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance, June 30, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Acquisition-related contingent consideration:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Earn-out payments - Éclat Pharmaceuticals (a)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,569</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,610</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(377</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">21,582</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Financing-related:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Royalty agreement - Deerfield (b)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,048</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(277</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,799</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Royalty agreement - Broadfin (c)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">976</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(132</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">866</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total related party payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">27,593</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(3,019</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(377</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">50</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,247</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Less: current portion</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(9,391</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8,264</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total long-term related party payable</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,202</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">15,983</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;padding-left:24px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(a) In March 2012, the Company acquired all of the membership interests of Éclat from Breaking Stick Holdings, L.L.C. (“Breaking Stick”, formerly Éclat Holdings), an affiliate of Deerfield. Breaking Stick is majority owned by Deerfield, with a minority interest owned by the Company’s former CEO, and certain other current and former employees. As part of the consideration, the Company committed to provide quarterly earn-out payments equal to </font><font style="font-family:inherit;font-size:10pt;">20%</font><font style="font-family:inherit;font-size:10pt;"> of any gross profit generated by certain Éclat products. These payments will continue in perpetuity, to the extent gross profit of the related products also continue in perpetuity.</font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of a February 2013 debt financing transaction conducted with Deerfield, the Company received cash of </font><font style="font-family:inherit;font-size:10pt;">$2,600</font><font style="font-family:inherit;font-size:10pt;"> in exchange for entering into a royalty agreement whereby the Company shall pay quarterly a </font><font style="font-family:inherit;font-size:10pt;">1.75%</font><font style="font-family:inherit;font-size:10pt;"> royalty on the net sales of certain Éclat products until December 31, 2024. In connection with such debt financing transaction, the Company granted Deerfield a security interest in the product registration rights of the Eclat products. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of a December 2013 debt financing transaction conducted with Broadfin Healthcare Master Fund, a related party and current shareholder, the Company received cash of </font><font style="font-family:inherit;font-size:10pt;">$2,200</font><font style="font-family:inherit;font-size:10pt;"> in exchange for entering into a royalty agreement whereby the Company shall pay quarterly a </font><font style="font-family:inherit;font-size:10pt;">0.834%</font><font style="font-family:inherit;font-size:10pt;"> royalty on the net sales of certain Éclat products until December 31, 2024.</font></div></td></tr></table></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes changes to the related party payables, a recurring Level 3 measurement, for the </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;">-month periods ended </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, respectively:</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:79%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Related Party Payable Rollforward:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance, December 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">98,925</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Payments of related party payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13,376</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Fair value adjustments </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(10,928</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Expiration of warrants</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,167</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Disposition of the pediatric assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(20,337</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance, June 30, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">52,117</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance, December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28,840</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Payments of related party payable</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(6,707</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Fair value adjustments </font><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,114</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance, June 30, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,247</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) </sup></font><font style="font-family:inherit;font-size:10pt;">Fair value adjustments are reported as changes in fair value of related party contingent consideration and other expense - changes in fair value of related party payable in the unaudited condensed consolidated statements of loss.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth activities for the Company’s cost reduction plan obligations for the three and </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:86%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019 French Restructuring Obligation:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance of restructuring accrual at January 1,</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Charges for employee severance, benefits and other costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,414</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,332</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Foreign currency impact</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance of restructuring accrual at June 30, </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,102</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth activities for the Company’s cost reduction plan obligations for the </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:72%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2017 French Restructuring Obligation:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance of restructuring accrual at January 1,</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">879</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Charges for employee severance, benefits and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(168</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">203</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(647</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(515</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Foreign currency impact</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(55</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance of restructuring accrual at June 30, </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">56</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">633</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth activities for the Company’s cost reduction plan obligations for the </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-bottom:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:86%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019 Corporate Restructuring Obligation:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance of restructuring accrual at January 1,</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Charges for employee severance, benefits and other costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,359</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2,016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Balance of restructuring accrual at June 30, </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">343</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents a summary of total revenues by these products: </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Three Months Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Six Months Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues by Product:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Bloxiverz</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,358</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,544</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,926</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">13,035</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Vazculep</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,410</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,377</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18,883</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">24,338</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Akovaz</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,946</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">11,875</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,738</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22,092</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(160</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">320</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">444</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,812</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total product sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17,554</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">29,116</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">33,991</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">62,277</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">License revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">114</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">246</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total revenues</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">17,554</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">29,230</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">33,991</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">62,523</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated amortization of intangible assets for the next </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> years is as follows: </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:86%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Estimated Annual Amortization Expense: </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Amount</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">815</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">814</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Summary of Significant Accounting Policies</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Nature of Operations.</font><font style="font-family:inherit;font-size:10pt;">  </font><font style="font-family:inherit;font-size:10pt;">Avadel Pharmaceuticals plc (Nasdaq: AVDL) (“Avadel,” the “Company,” “we,” “our,” or “us”) is a branded specialty pharmaceutical company.  Our primary focus is on the development and potential U.S. Food and Drug Administration (“FDA”) approval for FT218 which is in a Phase 3 clinical trial for the treatment of narcolepsy patients suffering from excessive daytime sleepiness (EDS) and cataplexy.  In addition, we market three sterile injectable drugs used in the hospital setting which were developed under our “unapproved marketed drug” (UMD) program.  The Company is headquartered in Dublin, Ireland with operations in St. Louis, Missouri and Lyon, France. For more information, please visit www.avadel.com.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Avadel is developing FT218, an investigational once-nightly formulation of sodium oxybate based on its propriety Micropump® drug delivery technology, for the treatment of EDS and cataplexy in patients suffering from narcolepsy. FT218 is currently being evaluated in a Phase 3 clinical trial called REST-ON. In addition, the Company submitted a new drug application (“NDA”) in March 2019 on a fourth sterile injectable drug used in the hospital setting (“UMD #4”), which, if approved, could contribute revenues to Avadel starting in 2020. In May 2019, the FDA accepted this NDA, AV001, with a Prescription Drug User Fee Act (PDUFA) target action date of December 15, 2019. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our current marketed products include: </font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-style:italic;">Akovaz®</font><font> (ephedrine sulfate injection, USP), an alpha- and beta-adrenergic agonist and a norepinephrine-releasing agent that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-style:italic;">Bloxiverz®</font><font> (neostigmine methylsulfate injection), a cholinesterase inhibitor, is indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents (NMBAs) after surgery. </font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-style:italic;">Vazculep®</font><font> (phenylephrine hydrochloride injection), an alpha-1 adrenergic receptor agonist indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Each of our</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> Akovaz</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Bloxiverz</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Vazculep</font><font style="font-family:inherit;font-size:10pt;"> products is used primarily in the hospital setting and was developed under our UMD program.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company was incorporated on December 1, 2015 as an Irish private limited company, and re-registered as an Irish public limited company, or plc, on November 21, 2016. Our principal place of business is located at Block 10-1, Blanchardstown Corporate Park, Ballycoolin, Dublin 15, Ireland. Avadel’s phone number is 011-353-1-485-1200. Our website is www.avadel.com, where we make available free of charge our reports (and any amendments thereto) on Forms 10-K, 10-Q and 8-K as soon as reasonably practicable after they are electronically filed with or furnished to the U.S. Securities and Exchange Commission (“SEC”). These filings are also available to the public at www.sec.gov.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is the successor to Flamel Technologies S.A., a French </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">société anonyme</font><font style="font-family:inherit;font-size:10pt;"> (“Flamel”), as the result of the France-to-Ireland redomestication merger of Flamel with and into the Company completed on December 31, 2016 (the “Merger”). In the Merger, we changed our company name to Avadel Pharmaceuticals plc and our jurisdiction of organization to Ireland; we assumed all the assets and liabilities of Flamel; and we issued one Avadel ordinary share (either directly or in the form of an American Depositary Share (ADS)) in exchange for each formerly outstanding share of Flamel, all of which were canceled. Thus, an Avadel ordinary share held (either directly or represented by an ADS) immediately after the Merger continued to represent the same proportional interest in our equity owned by the holder of a share of Flamel immediately prior to the Merger. References in this Annual Report on Form 10-K to “Avadel,” the “Company,” “we,” “our,” “us,” and similar terms shall be deemed to be references to Flamel prior to the completion of the Merger, unless the context otherwise requires. Additional details about the Merger are set forth in Item 1 under the caption “The Reincorporation Merger” of the Company’s Annual Report on Form 10-K filed with the SEC on March 15, 2019. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company currently has five direct wholly-owned subsidiaries: (a) Avadel US Holdings, Inc., (b) Flamel Ireland Limited, which conducts business under the name Avadel Ireland, (c) Avadel Investment Company Limited, (d) Avadel Finance Ireland Designated Activity Company and (e) Avadel France Holding SAS. Avadel US Holdings, Inc., a Delaware corporation, is the holding entity of (i) Avadel Specialty Pharmaceuticals, LLC (currently the subject of a voluntary Chapter 11 bankruptcy proceeding as noted in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Note 3: Subsidiary Bankruptcy and Deconsolidation</font><font style="font-family:inherit;font-size:10pt;">), (ii) Avadel Legacy Pharmaceuticals, LLC, (iii) Avadel Management Corporation, (iv) FSC Holding Company and (v) Avadel Operations Company, Inc. Avadel Finance Ireland Designated Activity Company is the holding entity of Avadel Finance Cayman Limited. Flamel Ireland Limited (operating under the trade name Avadel Ireland) is an Irish corporation which, since December 16, 2014, has been the owner of substantially all of Avadel’s intellectual property. Avadel France Holding SAS, a French </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">société par actions simplifiée</font><font style="font-family:inherit;font-size:10pt;">, is the holding entity of Avadel Research SAS through which Avadel conducts substantially all of its R&D activities.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Basis of Presentation.</font><font style="font-family:inherit;font-size:10pt;"> The unaudited condensed consolidated balance sheet as of </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;">, which is derived from the prior year 2018 audited consolidated financial statements, and the interim unaudited condensed consolidated financial statements presented herein, have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP), the requirements of Form 10-Q and Article 10 of Regulation S-X and, consequently, do not include all information or footnotes required by U.S. GAAP for complete financial statements or all the disclosures normally made in an annual report on Form 10-K. Accordingly, the unaudited condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements and footnotes included in the Company’s 2018 Annual Report on Form 10-K filed with the SEC on March 15, 2019.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The unaudited condensed consolidated financial statements include the accounts of the Company and subsidiaries, and reflect all adjustments (consisting only of normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the dates and periods presented. All material intercompany accounts and transactions have been eliminated. Results for interim periods are not necessarily indicative of the results to be expected during the remainder of the current year or for any future period. </font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 6, 2019, the Company’s indirect wholly-owned subsidiary, Avadel Specialty Pharmaceuticals, LLC (“Specialty Pharma”), filed a voluntary petition for reorganization under Chapter 11 of the United States (“U.S.”) Code (the “Bankruptcy Code”). in the U.S. District Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”), Case No. 19-10248. Specialty Pharma is operating and managing its business as “debtors-in-possession” under the jurisdiction of the Bankruptcy Court and in accordance with the applicable provisions of the Bankruptcy Code and order of the Bankruptcy Court. As a result of Specialty Pharma’s voluntary bankruptcy filing on February 6, 2019, we no longer controlled the operations of Specialty Pharma; therefore, we deconsolidated Specialty Pharma effective with the bankruptcy filing and the Company recorded its investment in Specialty Pharma under the cost method. See </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Note 3: Subsidiary Bankruptcy and Deconsolidation. </font><font style="font-family:inherit;font-size:10pt;">Our results of operations for the period January 1, 2019 through February 6, 2019 include the results of Specialty Pharma prior to its February 6, 2019 voluntary petition for reorganization under Chapter 11 of the U.S. Bankruptcy Code.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our results of operations for the period January 1, 2018 through February 16, 2018 include the results of FSC Therapeutics and FSC Laboratories, Inc., (collectively “FSC”), prior to its February 16, 2018 disposition date. See </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Note </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">14</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">: </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:normal;">Divestiture of the Pediatric Assets</font><font style="font-family:inherit;font-size:10pt;">, for additional information. All intercompany accounts and transactions have been eliminated.</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue.</font><font style="font-family:inherit;font-size:10pt;"> Revenue includes sales of pharmaceutical products, licensing fees, and, if any, milestone payments for research and development (“R&D”) achievements. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;">Accounting Standards Codification (“ASC”) Topic 606, </font><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;font-style:italic;">“Revenue from Contracts with Customers”</font><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;"> applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. Under ASC 606, an entity recognizes revenue when the performance obligations to the customer have been satisfied through the transfer of control of the goods or services. To determine the appropriate revenue recognition for arrangements that the Company believes are within the scope of ASC 606, we perform the following five steps: (i) Identify the contract(s) with a customer; (ii) Identify the performance obligations in the contract; (iii) Determine the transaction price; (iv) Allocate the transaction price to the performance obligations in the contract; and (v) Recognize revenue when (or as) the entity satisfies a performance obligation. The Company applies the five-step model to contracts only when the Company and its customer’s rights and obligations under the contract can be determined, the contract has commercial substance, and it is probable that the Company will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. For contracts that are determined to be within the scope of ASC 606, the Company identifies the promised goods or services in the contract to determine if they are separate performance obligations or if they should be bundled with other goods and services into a single performance obligation. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Product Sales and Services </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;">The Company sells products primarily through wholesalers and considers these wholesalers to be its customers. Under ASC 606, revenue from product sales is recognized when the customer obtains control of the Company’s product, which occurs typically upon receipt by the customer. As is customary in the pharmaceutical industry, the Company’s gross product sales are subject to a variety of price adjustments in arriving at reported net product sales. These adjustments include estimates of product returns, chargebacks, payment discounts, rebates, and other sales allowances and are estimated based on analysis of historical data for the product or comparable products, future expectations for such products and other judgments and analysis. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">License Revenue </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;">The Company from time to time may enter into out-licensing agreements which are within the scope of ASC 606 under which it licenses to third parties certain rights to its products or intellectual property. The terms of these arrangements typically include payment to the Company of one or more of the following: non-refundable, upfront license fees; development, regulatory, and commercial milestone payments; and sales-based royalty payments. Each of these payments results in license revenue.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;">For a complete discussion of the accounting for net product revenue and license revenues, see </font><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;font-style:italic;">Note </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">4</font><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;font-style:italic;">: Revenue Recognition</font><font style="font-family:inherit;font-size:10pt;color:#0d0d0d;">.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Subsequent Events </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Subsequent to June 30, 2019, the Company became aware of market conditions that could have a material impact on the estimated and projected annual net revenues and gross profit of certain hospital products that were used to estimate the total related party payable. The Company believes the effect of this change in estimate could reduce the total related party payable by approximately </font><font style="font-family:inherit;font-size:10pt;">$3,000</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables show the Company’s available-for-sale securities’ adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category as of </font><font style="font-family:inherit;font-size:10pt;">June 30, 2019</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;">, respectively:</font></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">June 30, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Marketable Securities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Adjusted Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unrealized Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equity securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,166</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(128</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4,038</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Money market funds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">46,314</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">719</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">47,033</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Corporate bonds</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,611</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">54</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3,664</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Government securities - U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,122</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">114</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5,234</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other fixed-income securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,154</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">29</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,182</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">61,367</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">916</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(132</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">62,151</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:12px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">December 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Marketable Securities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Adjusted Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unrealized Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Equity securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">10,101</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(956</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,145</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Money market funds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">52,733</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">316</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(53</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">52,996</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Corporate bonds</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,411</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(79</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6,339</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Government securities - U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,714</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">66</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(79</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12,701</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Other fixed-income securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,400</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(13</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">9,409</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">91,359</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">411</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1,180</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">90,590</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div></div>

EX-101.SCH 7 avdl-20190630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2120100 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2420402 - Disclosure - Commitments and Contingencies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2420403 - Disclosure - Commitments and Contingencies - Purchase Commitments (Details) link:presentationLink link:calculationLink link:definitionLink 2320301 - Disclosure - Commitments and Contingencies - (Tables) link:presentationLink link:calculationLink link:definitionLink 2418402 - Disclosure - Comprehensive Income (Loss) - Components (Details) link:presentationLink link:calculationLink link:definitionLink 2318301 - Disclosure - Comprehensive Income (Loss) (Tables) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 2418403 - Disclosure - Comprehensive Loss - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2115100 - Disclosure - Divestiture of the Pediatric Assets link:presentationLink link:calculationLink link:definitionLink 2415401 - Disclosure - Divestiture of the Pediatric Assets - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Fair Value Measurement link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Fair Value Measurement Fair Value Measurement - Measured on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Fair Value Measurement (Tables) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - Goodwill and Intangible Assets link:presentationLink link:calculationLink link:definitionLink 2409404 - Disclosure - Goodwill and Intangible Assets - Estimated Future Amortization (Details) link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - Goodwill and Intangible Assets - Gross Value and Net Carrying Amount (Details) link:presentationLink link:calculationLink link:definitionLink 2409403 - Disclosure - Goodwill and Intangible Assets - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - Goodwill and Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2413403 - Disclosure - Income Taxes - Income (Loss) Before Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - Income Taxes - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2413404 - Disclosure - Income Taxes - Reconciliation of Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 2410403 - Disclosure - Leases - Components of lease costs (Details) link:presentationLink link:calculationLink link:definitionLink 2410404 - Disclosure - Leases - Maturities of operating lease liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2410404 - Disclosure - Leases - Maturities of operating lease liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - Leases - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2410405 - Disclosure - Leases - Schedule of Future Minimum Rental Payments for Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Long-Term Debt link:presentationLink link:calculationLink link:definitionLink 2412402 - Disclosure - Long-Term Debt Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2412402 - Disclosure - Long-Term Debt Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2312301 - Disclosure - Long-Term Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - Long-Term Related Party Payable link:presentationLink link:calculationLink link:definitionLink 2411403 - Disclosure - Long-Term Related Party Payable - Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2411404 - Disclosure - Long-Term Related Party Payable Long-Term Related Party Payable - Payable Balance (Details) link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - Long-Term Related Party Payable - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - Long-Term Related Party Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Marketable Securities link:presentationLink link:calculationLink link:definitionLink 2407404 - Disclosure - Marketable Securities Marketable Securities - Schedule of Maturities (Details) link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Marketable Securities - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - Marketable Securities - Summary of Marketable Securities (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Marketable Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Net Loss Per Share link:presentationLink link:calculationLink link:definitionLink 2417403 - Disclosure - Net Loss Per Share - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2417402 - Disclosure - Net Loss Per Share - Reconciliation of Basic and Diluted Calculation (Details) link:presentationLink link:calculationLink link:definitionLink 2317301 - Disclosure - Net Loss Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - Newly Issued Accounting Pronouncements link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - Other Assets and Liabilities link:presentationLink link:calculationLink link:definitionLink 2414404 - Disclosure - Other Assets and Liabilities - Accrued Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 2414403 - Disclosure - Other Assets and Liabilities - Other Non-Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2414405 - Disclosure - Other Assets and Liabilities - Other Non-Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - Other Assets and Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - Restructuring Costs link:presentationLink link:calculationLink link:definitionLink 2416402 - Disclosure - Restructuring Costs - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2416403 - Disclosure - Restructuring Costs - Severance Obligation (Details) link:presentationLink link:calculationLink link:definitionLink 2316301 - Disclosure - Restructuring Costs (Tables) link:presentationLink link:calculationLink link:definitionLink 2119100 - Disclosure - Revenue by Product link:presentationLink link:calculationLink link:definitionLink 2419402 - Disclosure - Revenue by Product - Summary of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 2319301 - Disclosure - Revenue by Product (Tables) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Revenue Recognition link:presentationLink link:calculationLink link:definitionLink 2404401 - Disclosure - Revenue Recognition - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2122100 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 2422401 - Disclosure - Subsequent Events - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Subsidiary Bankruptcy and Deconsolidation link:presentationLink link:calculationLink link:definitionLink 2403401 - Disclosure - Subsidiary Bankruptcy and Deconsolidation (Details) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 1003501 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 1002501 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF LOSS link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ (DEFICIT) EQUITY Statement link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 avdl-20190630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 avdl-20190630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 avdl-20190630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Other Liabilities Disclosure [Abstract] Prepaid Expenses and Other Current Assets: Prepaid Expense and Other Assets, Current [Abstract] Valued-added tax recoverable Value Added Tax Receivable, Current Prepaid and other expenses Prepaid Expense, Current Guarantee from Armistice Guarantee, Current Guarantee, Current Income tax receivable Income Taxes Receivable, Current Research and development tax credit receivable Research And Development Tax Credit Receivable, Current Research And Development Tax Credit Receivable, Current Short-term deposit Short-term Investments Other Other Assets, Current Total Prepaid Expense and Other Assets, Current Statement of Financial Position [Abstract] Preferred shares, nominal value (in usd per share) Preferred Stock, Par or Stated Value Per Share Preferred shares, shares authorized (in shares) Preferred Stock, Shares Authorized Preferred shares, shares issued (in shares) Preferred Stock, Shares Issued Preferred shares, shares outstanding (in shares) Preferred Stock, Shares Outstanding Ordinary shares, nominal value (in usd per share) Common Stock, Par or Stated Value Per Share Ordinary shares, shares authorized (in shares) Common Stock, Shares Authorized Ordinary shares, shares issued (in shares) Common Stock, Shares, Issued Ordinary shares, shares outstanding (in shares) Common Stock, Shares, Outstanding Treasury stock, shares held (in shares) Treasury Stock, Shares Stockholders' Equity Note [Abstract] Comprehensive Loss Comprehensive Income (Loss) Note [Text Block] Income Tax Disclosure [Abstract] Income Taxes Income Tax Disclosure [Text Block] Debt Disclosure [Abstract] Schedule of Debt Schedule of Long-term Debt Instruments [Table Text Block] Statement of Comprehensive Income [Abstract] Other comprehensive income (loss), tax Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Parent Inventory Disclosure [Abstract] Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Schedule of Components of Income Before Income Tax Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Schedule of Effective Income Tax Rate Reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Other Assets and Liabilities Other Liabilities Disclosure [Text Block] Statement of Stockholders' Equity [Abstract] Statement [Table] Statement [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Ordinary shares Common Stock [Member] Additional paid-in capital Additional Paid-in Capital [Member] Accumulated deficit Retained Earnings [Member] Accumulated other comprehensive (loss) income AOCI Attributable to Parent [Member] Treasury Shares Treasury Stock [Member] Statement [Line Items] Statement [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Beginning balance (in shares) Shares, Outstanding Beginning balance Stockholders' Equity Attributable to Parent Net loss Net Income (Loss) Attributable to Parent Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax Vesting of restricted shares (in shares) Stock Issued During Period, Shares, Other Vesting of restricted shares Stock Issued During Period, Value, Other Employee share purchase plan share issuance (in shares) Stock Issued During Period, Shares, Employee Stock Ownership Plan Employee share purchase plan share issuance Stock Issued During Period, Value, Employee Stock Purchase Plan Stock-based compensation expense Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Exercise of warrants (in shares) Stock Issued During Period, Shares, Expiration Of Warrants Stock Issued During Period, Shares, Expiration Of Warrants Exercise of warrants Stock Issued During Period, Value, Expiration Of Warrants Stock Issued During Period, Value, Expiration Of Warrants Expiration of warrants Adjustments to Additional Paid in Capital, Other Equity component of 2023 Notes Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt Share repurchases (in shares) Treasury Stock, Shares, Acquired Share repurchases Treasury Stock, Value, Acquired, Cost Method Ending balance (in shares) Ending balance Revenue from Contract with Customer [Abstract] Revenue Recognition Revenue from Contract with Customer [Text Block] Segment Reporting [Abstract] Schedule of Segment Reporting Information, Revenue by Product Schedule of Segment Reporting Information, by Segment [Table Text Block] Investments, Debt and Equity Securities [Abstract] Marketable securities, realized gain Marketable Securities, Realized Gain Marketable Securities, Realized Gain Marketable securities, realized loss Marketable Securities, Realized Loss Marketable Securities, Realized Loss Fair Value Disclosures [Abstract] Fair Value Measurement Fair Value Disclosures [Text Block] Subsequent Events [Abstract] Subsequent Event [Table] Subsequent Event [Table] Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Scenario, Forecast Scenario, Forecast [Member] Subsequent Event [Line Items] Subsequent Event [Line Items] Increase (decrease) in related party payable Increase (Decrease) in Accounts Payable, Related Parties Reorganizations [Abstract] Subsidiary Bankruptcy and Deconsolidation Reorganization under Chapter 11 of US Bankruptcy Code Disclosure [Text Block] Commitments and Contingencies Disclosure [Abstract] Contractual Obligation, Fiscal Year Maturity Schedule Contractual Obligation, Fiscal Year Maturity Schedule [Table Text Block] Effective Income Tax Rate Reconciliation, Percent [Abstract] Effective Income Tax Rate Reconciliation, Percent [Abstract] Statutory tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent International tax rates differential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Change in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Change in fair value of nondeductible contingent consideration Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent Nondeductible stock-based compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Compensation Cost, Percent Unrecognized tax benefits Effective Income Tax Rate Reconciliation Deferred Charge From IP Transfer Effective income tax rate reconciliation deferred charge from IP transfer. State and local income taxes, net of federal Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Nondeductible interest expense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Interest Expense, Percent Effective Income Tax Rate Reconciliation, Nondeductible Expense, Interest Expense, Percent Other Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Effective Income Tax Rate Reconciliation, Amount [Abstract] Effective Income Tax Rate Reconciliation, Amount [Abstract] Income tax benefit - at statutory tax rate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount International tax rates differential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount Change in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Change in fair value of nondeductible contingent consideration Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount Nondeductible stock-based compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Compensation Cost, Amount Unrecognized tax benefits Income Tax Reconciliation Nondeductible Expense Deferred Charge From IP Transfer Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible deferred charges from IP transfer costs. State and local income taxes, net of federal Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount Nondeductible interest expense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Interest Expense, Amount Effective Income Tax Rate Reconciliation, Nondeductible Expense, Interest Expense, Amount Other Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount Income tax provision (benefit) - at effective income tax rate Income Tax Expense (Benefit) Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Leases [Abstract] Leases Lessee, Operating Leases [Text Block] Discontinued Operations and Disposal Groups [Abstract] Divestiture of the Pediatric Assets Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Income Statement [Abstract] Product and Service [Axis] Product and Service [Axis] Product and Service [Domain] Product and Service [Domain] Product sales Product [Member] License revenue License [Member] Revenues: Revenues [Abstract] Total revenues Revenue from Contract with Customer, Excluding Assessed Tax Operating expenses: Costs and Expenses [Abstract] Cost of products Cost of Goods and Services Sold Research and development expenses Research and Development Expense Selling, general and administrative expenses Selling, General and Administrative Expense Intangible asset amortization Amortization of Intangible Assets Changes in fair value of related party contingent consideration Business Combination, Acquisition Related Costs Restructuring costs Restructuring Charges Total operating expenses Costs and Expenses Operating loss Operating Income (Loss) Investment and other income, net Investment Income, Net Interest expense Interest Expense, Debt Loss on deconsolidation of subsidiary Deconsolidation, Gain (Loss), Amount Other (expense) income - changes in fair value of related party payable Other Nonoperating Income (Expense) Loss before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Income tax provision (benefit) Net loss Net income (loss) per share - basic (in dollars per share) Earnings Per Share, Basic Net income (loss) per share - diluted (in dollars per share) Earnings Per Share, Diluted Weighted average number of shares outstanding - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Weighted average number of shares outstanding - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Accrued Expenses Accrued Liabilities, Current [Abstract] Accrued compensation Workers' Compensation Liability, Current Accrued social charges Accrued Social Charges Carrying value as of the balance sheet date of obligations incurred through that date and payable for accrued social charges. Accrued restructuring (see Note 15) Restructuring Reserve, Current Customer allowances Accrued trade discounts and rebates Carrying value as of the balance sheet date of obligations incurred through that date and payable for accrued discounts and rebates Accrued contract research organization charges Accrued Contract Research Organization Charges Accrued Contract Research Organization Charges Accrued contract manufacturing organization costs Accrued Contract Manufacturing Organization Liabilities Accrued Contract Manufacturing Organization Liabilities Accrued contract sales organization and marketing costs Accrued Contract Research Organization Accrued Contract Research Organization Other Other Accrued Liabilities, Current Total Accrued Liabilities, Current Statement of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Loss on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Amortization of premiums on marketable securities Marketable Securities, Gain (Loss) Remeasurement of related party acquisition-related contingent consideration Acquisition Related Contingent Consideration Remeasurement Represents the remeasurement of acquisition related contingent considerations Remeasurement of related party financing-related contingent consideration Financing Related Contingent Consideration Remeasurement Represents the remeasurement of financing related contingent considerations Amortization of debt discount and debt issuance costs Amortization of Debt Issuance Costs and Discounts Change in deferred tax and income tax deferred charge Increase (Decrease) in Income Taxes Stock-based compensation expense Share-based Compensation Loss on deconsolidation of subsidiary Cash Divested from Deconsolidation Other adjustments Other Operating Activities, Cash Flow Statement Net changes in assets and liabilities Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Inventories Increase (Decrease) in Inventories Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Research and development tax credit receivable Increase (Decrease) In Research and Development Tax Credit Receivable The increase (decrease) during the reporting period in research and development tax credit receivable. Accounts payable & other current liabilities Increase (Decrease) in Accounts Payable Accrued expenses Increase (Decrease) in Accrued Liabilities Earn-out payments for related party contingent consideration in excess of acquisition-date fair value Earn Out Payment In Excess Of Acquisition Date Fair Value Represents the Earn Out Payment In Excess Of Acquisition Date Fair Value Royalty payments for related party payable in excess of original fair value Payments for Royalties Other assets and liabilities Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Proceeds from the disposal of property and equipment Proceeds from Sale of Property, Plant, and Equipment Purchase of intangible asset Payments to Acquire Intangible Assets Proceeds from sales of marketable securities Proceeds from Sale of Debt Securities, Available-for-sale Purchases of marketable securities Payments to Acquire Marketable Securities Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Earn-out payments for related party contingent consideration Earn Out Payment Represents the amount of acquisition earn out payment made. Proceeds from debt issuance Proceeds from Issuance of Long-term Debt Payments for debt issuance costs Repayments of Long-term Debt Share repurchases Payments for Repurchase of Common Stock Proceeds from issuance of ordinary shares and warrants Proceeds from Warrant Exercises Other financing activities, net Proceeds from (Payments for) Other Financing Activities Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Effect of foreign currency exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash and Cash Equivalents Net change in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash and cash equivalents at January 1, Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash and cash equivalents at June 30, Supplemental disclosures of cash flow information: Supplemental Cash Flow Information [Abstract] Interest paid Interest Paid, Excluding Capitalized Interest, Operating Activities Income taxes paid Income Taxes Paid EX-101.PRE 11 avdl-20190630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 12 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information - shares	6 Months Ended
Document And Entity Information - shares	Jun. 30, 2019	Aug. 06, 2019
Document And Entity Information [Abstract]
Entity Registrant Name	AVADEL PHARMACEUTICALS PLC
Entity Central Index Key	0001012477
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Document Type	10-Q
Document Period End Date	Jun. 30, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q2
Amendment Flag	false
Entity Current Reporting Status	Yes
Entity Emerging Growth Company	false
Entity Smaller Reporting Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		37,450,300

XML 13 R2.htm IDEA: XBRL DOCUMENT

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF LOSS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Revenues:
Total revenues	$ 17,554	$ 29,230	$ 33,991	$ 62,523
Operating expenses:
Cost of products	3,622	3,512	6,888	10,104
Research and development expenses	10,292	11,890	17,621	21,841
Selling, general and administrative expenses	6,758	27,843	17,204	52,330
Intangible asset amortization	204	1,609	405	3,376
Changes in fair value of related party contingent consideration	(377)	(12,889)	1,757	(9,921)
Restructuring costs	1,506	50	2,734	203
Total operating expenses	22,005	32,015	46,609	77,933
Operating loss	(4,451)	(2,785)	(12,618)	(15,410)
Investment and other income, net	950	583	1,767	637
Interest expense	(3,106)	(2,980)	(6,168)	(4,577)
Loss on deconsolidation of subsidiary	(167)	0	(2,840)	0
Other (expense) income - changes in fair value of related party payable	(50)	1,402	(357)	1,007
Loss before income taxes	(6,824)	(3,780)	(20,216)	(18,343)
Income tax provision (benefit)	1,781	(342)	1,407	(2,669)
Net loss	$ (8,605)	$ (3,438)	$ (21,623)	$ (15,674)
Net income (loss) per share - basic (in dollars per share)	$ (0.23)	$ (0.09)	$ (0.58)	$ (0.42)
Net income (loss) per share - diluted (in dollars per share)	$ (0.23)	$ (0.09)	$ (0.58)	$ (0.42)
Weighted average number of shares outstanding - basic (in shares)	37,356	36,772	37,355	37,666
Weighted average number of shares outstanding - diluted (in shares)	37,356	36,772	37,355	37,666
Product sales
Revenues:
Total revenues	$ 17,554	$ 29,116	$ 33,991	$ 62,277
License revenue
Revenues:
Total revenues	$ 0	$ 114	$ 0	$ 246

XML 14 R3.htm IDEA: XBRL DOCUMENT

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Other Comprehensive Income (Loss), Tax [Abstract]
Net loss	$ (8,605)	$ (3,438)	$ (21,623)	$ (15,674)
Other comprehensive (loss) income, net of tax:
Foreign currency translation gain (loss)	62	(482)	(99)	(233)
Net other comprehensive income (loss), net of ($23), ($11), ($41) and ($70) tax, respectively	293	78	667	(160)
Total other comprehensive income (loss), net of tax	355	(404)	568	(393)
Total comprehensive loss	$ (8,250)	$ (3,842)	$ (21,055)	$ (16,067)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

XML 15 R4.htm IDEA: XBRL DOCUMENT

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Statement of Comprehensive Income [Abstract]
Other comprehensive income (loss), tax	$ (23)	$ (11)	$ (41)	$ (70)

XML 16 R5.htm IDEA: XBRL DOCUMENT

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 17,111	$ 9,325
Marketable securities	62,151	90,590
Accounts receivable	10,172	11,330
Inventories	2,601	4,770
Prepaid expenses and other current assets	5,165	8,836
Total current assets	97,200	124,851
Property and equipment, net	934	1,911
Operating lease right-of-use assets	5,454
Goodwill	18,491	18,491
Intangible assets, net	1,224	1,629
Research and development tax credit receivable	7,833	7,272
Other non-current assets	34,573	36,146
Total assets	165,709	190,300
Current liabilities:
Current portion of long-term debt	105	106
Current portion of long-term related party payable	8,264	9,439
Current portion of operating lease liability	999
Accounts payable	4,798	3,503
Accrued expenses	15,737	21,695
Other current liabilities	3,677	3,640
Total current liabilities	33,580	38,383
Long-term debt, less current portion	118,631	115,734
Long-term related party payable, less current portion	15,983	19,401
Long-term operating lease liability	3,617
Other non-current liabilities	11,675	14,002
Total liabilities	183,486	187,520
Shareholders’ (deficit) equity:
Preferred shares, nominal value of $0.01 per share; 50,000 shares authorized; none issued or outstanding at June 30, 2019 and December 31, 2018, respectively	0	0
Ordinary shares, nominal value of $0.01 per share; 500,000 shares authorized; 42,763 issued and 37,356 outstanding at June 30, 2019 and 42,720 issued and 37,313 outstanding at December 31, 2018	427	427
Treasury shares, at cost, 5,407 shares held at June 30, 2019 and December 31, 2018, respectively	(49,998)	(49,998)
Additional paid-in capital	434,254	433,756
Accumulated deficit	(379,612)	(357,989)
Accumulated other comprehensive loss	(22,848)	(23,416)
Total shareholders’ (deficit) equity	(17,777)	2,780
Total liabilities and shareholders’ (deficit) equity	$ 165,709	$ 190,300

XML 17 R6.htm IDEA: XBRL DOCUMENT

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2019	Dec. 31, 2017
Statement of Financial Position [Abstract]
Preferred shares, nominal value (in usd per share)	$ 0.01	$ 0.01
Preferred shares, shares authorized (in shares)	50,000,000	50,000,000
Preferred shares, shares issued (in shares)	0	0
Preferred shares, shares outstanding (in shares)	0	0
Ordinary shares, nominal value (in usd per share)	$ 0.01	$ 0.01
Ordinary shares, shares authorized (in shares)	500,000,000	500,000,000
Ordinary shares, shares issued (in shares)	42,763,000	42,720,000
Ordinary shares, shares outstanding (in shares)	37,356,000	37,313,000
Treasury stock, shares held (in shares)	5,407,000	5,407,000

XML 18 R7.htm IDEA: XBRL DOCUMENT

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ (DEFICIT) EQUITY Statement - USD ($) shares in Thousands, $ in Thousands	Total	Ordinary shares	Additional paid-in capital	Accumulated deficit	Accumulated other comprehensive (loss) income	Treasury Shares
Beginning balance (in shares) at Dec. 31, 2017		41,463				2,117
Beginning balance at Dec. 31, 2017	$ 85,580	$ 414	$ 393,478	$ (262,685)	$ (23,266)	$ (22,361)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(12,236)			(12,236)
Other comprehensive income (loss)	(404)				(404)
Stock-based compensation expense	2,134		2,134
Exercise of warrants (in shares)		603
Exercise of warrants	2,911	$ 6	2,905
Expiration of warrants	2,167		2,167
Equity component of 2023 Notes	26,699		26,699
Share repurchases (in shares)						2,307
Share repurchases	(20,212)					$ (20,212)
Ending balance (in shares) at Mar. 31, 2018		42,066				4,424
Ending balance at Mar. 31, 2018	86,639	$ 420	427,383	(274,921)	(23,670)	$ (42,573)
Beginning balance (in shares) at Dec. 31, 2017		41,463				2,117
Beginning balance at Dec. 31, 2017	85,580	$ 414	393,478	(262,685)	(23,266)	$ (22,361)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(15,674)
Ending balance (in shares) at Jun. 30, 2018		42,148				5,407
Ending balance at Jun. 30, 2018	78,546	$ 421	430,141	(278,359)	(23,659)	$ (49,998)
Beginning balance (in shares) at Mar. 31, 2018		42,066				4,424
Beginning balance at Mar. 31, 2018	86,639	$ 420	427,383	(274,921)	(23,670)	$ (42,573)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(3,438)			(3,438)
Other comprehensive income (loss)	11				11
Stock-based compensation expense	2,224		2,224
Exercise of warrants (in shares)		82
Exercise of warrants	535	$ 1	534
Share repurchases (in shares)						983
Share repurchases	(7,425)					$ (7,425)
Ending balance (in shares) at Jun. 30, 2018		42,148				5,407
Ending balance at Jun. 30, 2018	78,546	$ 421	430,141	(278,359)	(23,659)	$ (49,998)
Beginning balance (in shares) at Dec. 31, 2018		42,720				5,407
Beginning balance at Dec. 31, 2018	2,780	$ 427	433,756	(357,989)	(23,416)	$ (49,998)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(13,018)			(13,018)
Other comprehensive income (loss)	213				213
Vesting of restricted shares (in shares)		1
Vesting of restricted shares	0
Employee share purchase plan share issuance (in shares)		42
Employee share purchase plan share issuance	92		92
Stock-based compensation expense	351		351
Ending balance (in shares) at Mar. 31, 2019		42,763				5,407
Ending balance at Mar. 31, 2019	(9,582)	$ 427	434,199	(371,007)	(23,203)	$ (49,998)
Beginning balance (in shares) at Dec. 31, 2018		42,720				5,407
Beginning balance at Dec. 31, 2018	2,780	$ 427	433,756	(357,989)	(23,416)	$ (49,998)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(21,623)
Ending balance (in shares) at Jun. 30, 2019		42,763				5,407
Ending balance at Jun. 30, 2019	(17,777)	$ 427	434,254	(379,612)	(22,848)	$ (49,998)
Beginning balance (in shares) at Mar. 31, 2019		42,763				5,407
Beginning balance at Mar. 31, 2019	(9,582)	$ 427	434,199	(371,007)	(23,203)	$ (49,998)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(8,605)			(8,605)
Other comprehensive income (loss)	355				355
Stock-based compensation expense	55		55
Ending balance (in shares) at Jun. 30, 2019		42,763				5,407
Ending balance at Jun. 30, 2019	$ (17,777)	$ 427	$ 434,254	$ (379,612)	$ (22,848)	$ (49,998)

XML 19 R8.htm IDEA: XBRL DOCUMENT

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Cash flows from operating activities:
Net loss	$ (21,623)	$ (15,674)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	1,064	3,810
Loss on disposal of property and equipment	478	0
Amortization of premiums on marketable securities	17	1,693
Remeasurement of related party acquisition-related contingent consideration	1,757	(9,921)
Remeasurement of related party financing-related contingent consideration	357	(1,007)
Amortization of debt discount and debt issuance costs	2,918	2,019
Change in deferred tax and income tax deferred charge	1,900	(3,247)
Stock-based compensation expense	406	4,358
Loss on deconsolidation of subsidiary	1,750	0
Other adjustments	(1,012)	91
Net changes in assets and liabilities
Accounts receivable	579	(157)
Inventories	2,124	(242)
Prepaid expenses and other current assets	(1,829)	1,587
Research and development tax credit receivable	(593)	(1,003)
Accounts payable & other current liabilities	3,127	5,206
Accrued expenses	(3,737)	(9,831)
Earn-out payments for related party contingent consideration in excess of acquisition-date fair value	(5,790)	(11,113)
Royalty payments for related party payable in excess of original fair value	(917)	(1,618)
Other assets and liabilities	(3,629)	(2,893)
Net cash used in operating activities	(22,653)	(37,942)
Cash flows from investing activities:
Purchases of property and equipment	(29)	(99)
Proceeds from the disposal of property and equipment	154	0
Purchase of intangible asset	0	(20,000)
Proceeds from sales of marketable securities	52,202	253,525
Purchases of marketable securities	(21,991)	(312,638)
Net cash provided by (used in) investing activities	30,336	(79,212)
Cash flows from financing activities:
Earn-out payments for related party contingent consideration	0	(645)
Proceeds from debt issuance	0	143,750
Payments for debt issuance costs	0	(5,760)
Share repurchases	0	(27,637)
Proceeds from issuance of ordinary shares and warrants	92	3,446
Other financing activities, net	(37)	6
Net cash provided by financing activities	55	113,160
Effect of foreign currency exchange rate changes on cash and cash equivalents	48	(93)
Net change in cash and cash equivalents	7,786	(4,087)
Cash and cash equivalents at January 1,	9,325	16,564
Cash and cash equivalents at June 30,	17,111	12,477
Supplemental disclosures of cash flow information:
Interest paid	3,234	394
Income taxes paid	$ 140	$ 409

XML 20 R9.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2019

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Our current marketed products include:


•	Akovaz® (ephedrine sulfate injection, USP), an alpha- and beta-adrenergic agonist and a norepinephrine-releasing agent that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.


•	Bloxiverz® (neostigmine methylsulfate injection), a cholinesterase inhibitor, is indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents (NMBAs) after surgery.


•	Vazculep® (phenylephrine hydrochloride injection), an alpha-1 adrenergic receptor agonist indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.

Each of our Akovaz, Bloxiverz and Vazculep products is used primarily in the hospital setting and was developed under our UMD program.

Revenue. Revenue includes sales of pharmaceutical products, licensing fees, and, if any, milestone payments for research and development (“R&D”) achievements.

Product Sales and Services

The Company sells products primarily through wholesalers and considers these wholesalers to be its customers. Under ASC 606, revenue from product sales is recognized when the customer obtains control of the Company’s product, which occurs typically upon receipt by the customer. As is customary in the pharmaceutical industry, the Company’s gross product sales are subject to a variety of price adjustments in arriving at reported net product sales. These adjustments include estimates of product returns, chargebacks, payment discounts, rebates, and other sales allowances and are estimated based on analysis of historical data for the product or comparable products, future expectations for such products and other judgments and analysis.

License Revenue

For a complete discussion of the accounting for net product revenue and license revenues, see Note 4: Revenue Recognition.

XML 21 R10.htm IDEA: XBRL DOCUMENT

Newly Issued Accounting Pronouncements	6 Months Ended
Newly Issued Accounting Pronouncements	Jun. 30, 2019
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Newly Issued Accounting Pronouncements	Newly Issued Accounting Standards Recent Accounting Guidance Not Yet Adopted In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework— Changes to the Disclosure Requirement for Fair Value Measurement” which amends certain disclosure requirements over Level 1, Level 2 and Level 3 fair value measurements. The amendments in ASU 2018-13 are effective for fiscal years beginning after December 15, 2019, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2018-13. In January 2017, the FASB issued ASU 2017-04, “Intangibles - Goodwill and Other: Simplifying the Test for Goodwill Impairment.” This update eliminates step 2 from the goodwill impairment test, and requires the goodwill impairment test to be performed by comparing the fair value of a reporting unit with its carrying amount. An impairment charge should be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. This guidance is effective for the Company in the first quarter of 2020. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The Company will assess the timing of adoption and impact of this guidance to future impairment considerations.

XML 22 R11.htm IDEA: XBRL DOCUMENT

Subsidiary Bankruptcy and Deconsolidation	6 Months Ended
Subsidiary Bankruptcy and Deconsolidation	Jun. 30, 2019
Reorganizations [Abstract]
Subsidiary Bankruptcy and Deconsolidation	Subsidiary Bankruptcy and Deconsolidation Bankruptcy Filing and Deconsolidation As a result of Specialty Pharma’s bankruptcy filing on February 6, 2019, Avadel has ceded authority for managing the business to the Bankruptcy Court, and Avadel management cannot carry on Specialty Pharma’s activities in the ordinary course of business without Bankruptcy Court approval. Avadel manages the day-to-day operations of Specialty Pharma, but does not have discretion to make significant capital or operating budgetary changes or decisions and purchase or sell significant assets, as Specialty Pharma’s material decisions are subject to review by the Bankruptcy Court. For these reasons, we have concluded that Avadel has lost control of Specialty Pharma, and no longer has significant influence over Specialty Pharma during the pendency of the bankruptcy. Therefore, we deconsolidated Specialty Pharma effective with the filing of the Chapter 11 bankruptcy in February 2019. In order to deconsolidate Specialty Pharma, the carrying values of the assets and certain liabilities of Specialty Pharma were removed from our unaudited condensed consolidated balance sheet as of February 5, 2019, and we recorded our investment in Specialty Pharma at its estimated fair value of $0. As the estimated fair value of our investment in Specialty Pharma was lower than its net book value immediately prior to the deconsolidation, we recorded a non-cash charge of approximately $167 and 2,840 for the three and six months ended June 30, 2019, respectively, associated with the deconsolidation of Specialty Pharma. Subsequent to the deconsolidation of Specialty Pharma, we are accounting for our investment in Specialty Pharma using the cost method of accounting because Avadel does not exercise significant influence over the operations of Specialty Pharma due to the Chapter 11 filing. On April 26, 2019, Specialty Pharma sold its intangible assets and remaining inventory to an unaffiliated third party in exchange for aggregate cash proceeds of approximately $250, pursuant to an order approving such sale which was issued by the Bankruptcy Court on April 15, 2019. As a result of such sale, Specialty Pharma has completed its divestment of the assets of the Noctiva business. On July 2, 2019, Specialty Pharma was made aware of a $50,695 claim made by the Internal Revenue Service (IRS) as part of the bankruptcy claims process against Specialty Pharma. Specialty Pharma files its U.S. federal tax return as a member of the Company’s consolidated U.S. tax group. As such, the IRS claim was filed against Specialty Pharma in the bankruptcy proceedings due to IRS tax law requirements for joint and several liability of all members in a consolidated U.S. tax group. Both Specialty Pharma and the Company disagree with the merits of the IRS claim, and intend to defend their positions vigorously. DIP Financing – Related Party Relationship In connection with the bankruptcy filing, Specialty Pharma entered into a Debtor in Possession Credit and Security Agreement with Avadel US Holdings (“DIP Credit Agreement”) dated as of February 8, 2019, in an aggregate amount of up to $2,700, of which the funds are to be used by Specialty Pharma solely to fund operations through February 6, 2020. As of June 30, 2019, the Company had funded $407 under the DIP Credit Agreement. As the Company has assessed that it is unlikely that Specialty Pharma will pay back the loan to Avadel, the $407 has been recorded as part of the loss on deconsolidation of subsidiary within the unaudited condensed consolidated statements of loss. At June 30, 2019 the fair value of the remaining commitment under the DIP Credit Agreement is not material.

XML 23 R12.htm IDEA: XBRL DOCUMENT

Revenue Recognition	6 Months Ended
Revenue Recognition	Jun. 30, 2019
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition The Company generates revenue primarily from the sale of pharmaceutical products to customers. From time to time the Company also generates revenue from licensing arrangements whereby the Company provides access to certain of its intellectual property. Product Sales and Services Effective January 1, 2018, the Company implemented ASC 606, “Revenue From Contracts With Customers”. The Company sells products primarily through wholesalers and considers these wholesalers to be its customers. Under ASC 606, revenue from product sales is recognized when the customer obtains control of the Company’s product and the Company’s performance obligations are met, which occurs typically upon receipt of delivery to the customer. As is customary in the pharmaceutical industry, the Company’s gross product sales are subject to a variety of price adjustments in arriving at reported net product sales. These adjustments include estimates for product returns, chargebacks, payment discounts, rebates, and other sales allowances and are estimated when the product is delivered based on analysis of historical data for the product or comparable products, as well as future expectations for such products. Reserves to reduce Gross Revenues to Net Revenues Revenues from product sales are recorded at the net selling price, which includes estimated reserves to reduce gross product sales to net product sales resulting from product returns, chargebacks, payment discounts, rebates, and other sales allowances that are offered within contracts between the Company and its customers and end users. These reserves are based on the amounts earned or to be claimed on the related sales and are classified as reductions of accounts receivable if the amount is payable to the customer, except in the case of the estimated reserve for future expired product returns, which are classified as a liability. The reserves are classified as a liability if the amount is payable to a party other than a customer. Where appropriate, these estimated reserves take into consideration relevant factors such as the Company’s historical experience, current contractual and statutory requirements, specific known market events and trends, industry data and forecasted customer buying and payment patterns. Overall, these reserves reflect the Company’s best estimates to reduce gross selling price to net selling price to which it expects to be entitled based on the terms of its contracts. The actual selling price ultimately received may differ from the Company’s estimates. If actual results in the future vary from the Company’s estimates, the Company adjusts these estimates, which would affect net product revenue and earnings in the period such variances become known. Product Returns Consistent with industry practice, the Company maintains a returns policy, that generally offers customers a right of return for product that has been purchased from the Company. The Company estimates the amount of product returns and records this estimate as a reduction of revenue in the period the related product revenue is recognized. The Company currently estimates product return liabilities based on analysis of historical data for the product or comparable products, as well as future expectations for such products and other judgments and analysis. Chargebacks, Discounts and Rebates Chargebacks, discounts and rebates represent the estimated obligations resulting from contractual commitments to sell products to its customers or end users at prices lower than the list prices charged to our wholesale customers. Customers charge the Company for the difference between the gross selling price they pay for the product and the ultimate contractual price agreed to between the Company and these end users. These reserves are established in the same period that the related revenue is recognized, resulting in a reduction of product revenue and accounts receivable. Chargebacks, discounts and rebates are estimated at the time of sale to the customer. Revenue from licensing arrangements The terms of the Company’s licensing agreements may contain multiple performance obligations, including certain R&D activities. The terms of these arrangements typically include payment to the Company of one or more of the following: non-refundable, up-front license fees; development, regulatory and commercial milestone payments. Each of these payments results in license revenues. License of Intellectual Property If the license to the Company’s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, up-front fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are bundled with other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, up-front fees. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition. Disaggregation of revenue The Company’s primary source of revenue is from the sale of pharmaceutical products, which are equally affected by the same economic factors as it relates to the nature, amount, timing, and uncertainty of revenue and cash flows. For further detail about the Company’s revenues by product, see Note 18: Company Operations by Product. Contract Balances The Company does not recognize revenue in advance of invoicing its customers and therefore has no related contract assets. A receivable is recognized in the period the Company sells its products and when the Company’s right to consideration is unconditional. There were no material deferred contract costs at June 30, 2019. Transaction Price Allocated to the Remaining Performance Obligation For product sales, the Company generally satisfies its performance obligations within the same period the product is delivered. Product sales recognized in 2019 from performance obligations satisfied (or partially satisfied) in previous periods were immaterial. For certain licenses of intellectual property, specifically those with performance obligations satisfied over time, the Company allocates a portion of the transaction price to that performance obligation and recognizes revenue using an appropriate measure of progress towards development of the product. The Company has elected certain of the practical expedients from the disclosure requirement for remaining performance obligations for specific situations in which an entity need not estimate variable consideration to recognize revenue. Accordingly, the Company applies the practical expedient in ASC 606 to its stand-alone contracts and does not disclose information about variable consideration from remaining performance obligations for which the Company recognizes revenue.

XML 24 R13.htm IDEA: XBRL DOCUMENT

Fair Value Measurement

6 Months Ended

Jun. 30, 2019

Fair Value Disclosures [Abstract]

Fair Value Measurement


•	Income approach, which is based on the present value of a future stream of net cash flows.


•	Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities.

As a basis for considering the assumptions used in these techniques, the standard establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value as follows:


•	Level 1 - Quoted prices for identical assets or liabilities in active markets.


•	Level 2 - Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are directly or indirectly observable, or inputs that are derived principally from, or corroborated by, observable market data by correlation or other means.


•	Level 3 - Unobservable inputs that reflect estimates and assumptions.



	As of June 30, 2019						As of December 31, 2018
Fair Value Measurements:	Level 1		Level 2		Level 3		Level 1		Level 2		Level 3

Marketable securities (see Note 6)
Equity securities	$	4,038	$	—	$	—	$	9,145	$	—	$	—
Money market funds	47,033		—		—		52,996		—		—
Corporate bonds	—		3,664		—		—		6,339		—
Government securities - U.S.	—		5,234		—		—		12,701		—
Other fixed-income securities	—		2,182		—		—		9,409		—
Total assets	$	51,071	$	11,080	$	—	$	62,141	$	28,449	$	—

Related party payable (see Note 10)	$	—	$	—	$	24,247	$	—	$	—	$	28,840
Total liabilities	$	—	$	—	$	24,247	$	—	$	—	$	28,840

Debt

See Note 11: Long-Term Debt for additional information regarding our debt obligations.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 25 R14.htm IDEA: XBRL DOCUMENT

Marketable Securities

6 Months Ended

Jun. 30, 2019

Investments, Debt and Equity Securities [Abstract]

Marketable Securities



	June 30, 2019
Marketable Securities:	Adjusted Cost		Unrealized Gains		Unrealized Losses			Fair Value

Equity securities	$	4,166	$	—	$	(128	)	$	4,038
Money market funds	46,314		719		—			47,033
Corporate bonds	3,611		54		(1		)	3,664
Government securities - U.S.	5,122		114		(2		)	5,234
Other fixed-income securities	2,154		29		(1		)	2,182
Total	$	61,367	$	916	$	(132	)	$	62,151



	December 31, 2018
Marketable Securities:	Adjusted Cost		Unrealized Gains		Unrealized Losses			Fair Value

Equity securities	$	10,101	$	—	$	(956	)	$	9,145
Money market funds	52,733		316		(53		)	52,996
Corporate bonds	6,411		7		(79		)	6,339
Government securities - U.S.	12,714		66		(79		)	12,701
Other fixed-income securities	9,400		22		(13		)	9,409
Total	$	91,359	$	411	$	(1,180	)	$	90,590



	Maturities
Marketable Debt Securities:	Less than 1 Year		1-5 Years		5-10 Years		Greater than 10 Years		Total

Corporate bonds	$	735	$	2,929	$	—	$	—	$	3,664
Government securities - U.S.	—		4,798		—		436		5,234
Other fixed-income securities	426		1,756		—		—		2,182
Total	$	1,161	$	9,483	$	—	$	436	$	11,080

XML 26 R15.htm IDEA: XBRL DOCUMENT

Inventories

6 Months Ended

Jun. 30, 2019

Inventory Disclosure [Abstract]

Inventories

The principal categories of inventories, net reserves of $1,143 and $4,757 at June 30, 2019 and December 31, 2018, respectively, are comprised of the following:



Inventory:	June 30, 2019		December 31, 2018

Finished goods	$	2,127	$	4,270
Raw materials	474		500
Total	$	2,601	$	4,770

Total net reserves decreased by $3,614 during the six months ended June 30, 2019 driven largely by the deconsolidation of Specialty Pharma.

XML 27 R16.htm IDEA: XBRL DOCUMENT

Goodwill and Intangible Assets

6 Months Ended

Jun. 30, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

The Company’s amortizable and unamortizable intangible assets at June 30, 2019 and December 31, 2018 are as follows:



	June 30, 2019							December 31, 2018
Goodwill and Intangible Assets:	Gross Value		Accumulated Amortization			Net Carrying Amount		Gross Value		Accumulated Amortization			Impairment			Net Carrying Amount

Amortizable intangible assets:
Acquired developed technology - Noctiva	$	—	$	—		$	—	$	73,111	$	(7,024	)	$	(66,087	)	$	—
Acquired developed technology - Vazculep	12,061		(10,837		)	1,224		12,061		(10,432		)	—			1,629
Total amortizable intangible assets	$	12,061	$	(10,837	)	$	1,224	$	85,172	$	(17,456	)	$	(66,087	)	$	1,629

Unamortizable intangible assets:
Goodwill	$	18,491	$	—		$	18,491	$	18,491	$	—		$	—		$	18,491
Total unamortizable intangible assets	$	18,491	$	—		$	18,491	$	18,491	$	—		$	—		$	18,491



Estimated Annual Amortization Expense:	Amount

2019	$	815
2020	814
2021	—
2022	—
2023	—

XML 28 R17.htm IDEA: XBRL DOCUMENT

Leases

6 Months Ended

Jun. 30, 2019

Leases [Abstract]

Leases



Lease cost:	Three months ended June 30, 2019		Six months ended June 30, 2019

Operating lease costs ⁽¹⁾	$	394	$	739
Sublease income ⁽²⁾	61		105
Total lease cost	$	333	$	634

⁽¹⁾Variable lease costs were immaterial for the three and six months ended June 30, 2019.

Maturities of the Company’s operating lease liabilities were as follows:



Maturities:	Operating Leases

Remaining six months of 2019	$	603
2020	1,213
2021	1,003
2022	763
2023	692
Thereafter	958
Total lease payments	5,232
Less: interest	616
Present value of lease liabilities	$	4,616

Under the prior lease guidance, minimum rental commitments for non-cancelable leases as of December 31, 2018 were:



Lease Commitment:	Operating Leases

2019	$	1,191
2020	1,208
2021	1,008
2022	767
2023	695
Thereafter	967
Total minimum lease payments	$	5,836

XML 29 R18.htm IDEA: XBRL DOCUMENT

Long-Term Related Party Payable

6 Months Ended

Jun. 30, 2019

Debt Disclosure [Abstract]

Long-Term Related Party Payable

Long-term related party payable and related activity are reported at fair value and consist of the following at June 30, 2019 and December 31, 2018:



				Activity during the Six Months Ended June 30, 2019
							Changes in Fair Value of Related Party Payable
Long-Term Related Party Payable:	Balance, December 31, 2018			Payments to Related Parties			Operating Expense		Other Expense		Balance, June 30, 2019

Acquisition-related contingent consideration:
Earn-out payments - Éclat Pharmaceuticals (a)	$	25,615		$	(5,790	)	$	1,757	$	—	$	21,582
Financing-related:
Royalty agreement - Deerfield (b)	2,184			(621		)	—		236		1,799
Royalty agreement - Broadfin (c)	1,041			(296		)	—		121		866
Total related party payable	28,840			$	(6,707	)	$	1,757	$	357	24,247
Less: current portion	(9,439		)								(8,264		)
Total long-term related party payable	$	19,401									$	15,983

Long-term related party payable and related activity are reported at fair value and consist of the following at June 30, 2019 and March 31, 2019:



				Activity during the Three Months Ended June 30, 2019
							Changes in Fair Value of Related Party Payable
Long-Term Related Party Payable:	Balance, March 31, 2019			Payments to Related Parties			Operating Expense			Other Expense		Balance, June 30, 2019

Acquisition-related contingent consideration:
Earn-out payments - Éclat Pharmaceuticals (a)	$	24,569		$	(2,610	)	$	(377	)	$	—	$	21,582
Financing-related:
Royalty agreement - Deerfield (b)	2,048			(277		)	—			28		1,799
Royalty agreement - Broadfin (c)	976			(132		)	—			22		866
Total related party payable	27,593			$	(3,019	)	$	(377	)	$	50	24,247
Less: current portion	(9,391		)									(8,264		)
Total long-term related party payable	$	18,202										$	15,983

(b)


(c)	As part of a December 2013 debt financing transaction conducted with Broadfin Healthcare Master Fund, a related party and current shareholder, the Company received cash of $2,200 in exchange for entering into a royalty agreement whereby the Company shall pay quarterly a 0.834% royalty on the net sales of certain Éclat products until December 31, 2024.

The following table summarizes changes to the related party payables, a recurring Level 3 measurement, for the six-month periods ended June 30, 2019 and 2018, respectively:



Related Party Payable Rollforward:	Balance

Balance, December 31, 2017	$	98,925
Payments of related party payable	(13,376		)
Fair value adjustments ⁽¹⁾	(10,928		)
Expiration of warrants	(2,167		)
Disposition of the pediatric assets	(20,337		)
Balance, June 30, 2018	$	52,117

Balance, December 31, 2018	$	28,840
Payments of related party payable	(6,707		)
Fair value adjustments ⁽¹⁾	2,114
Balance, June 30, 2019	$	24,247

XML 30 R19.htm IDEA: XBRL DOCUMENT

Long-Term Debt

6 Months Ended

Jun. 30, 2019

Debt Disclosure [Abstract]

Long-Term Debt

Long-term debt is summarized as follows:



	June 30, 2019			December 31, 2018
Principal amount of 4.50% exchangeable senior notes due 2023	$	143,750		$	143,750
Less: debt discount and issuance costs, net	(25,125		)	(28,059		)
Net carrying amount of liability component	118,625			115,691
Other debt	111			149
Subtotal	118,736			115,840
Less: current maturities	(105		)	(106		)
Long-term debt	$	118,631		$	115,734

Equity component:
Equity component of exchangeable notes, net of issuance costs	$	(26,699	)	$	(26,699	)

XML 31 R20.htm IDEA: XBRL DOCUMENT

Income Taxes

6 Months Ended

Jun. 30, 2019

Income Tax Disclosure [Abstract]

Income Taxes

The components of loss before income taxes are as follows:



	Three Months Ended June 30,						Six Months Ended June 30,
Loss Before Income Taxes:	2019			2018			2019			2018

Ireland	$	(12,089	)	$	(10,962	)	$	(22,323	)	$	(15,889	)
United States	9,800			7,019			6,357			(2,816		)
France	(4,535		)	163			(4,250		)	362
Total loss before income taxes	$	(6,824	)	$	(3,780	)	$	(20,216	)	$	(18,343	)

The items accounting for the difference between the income tax provision computed at the statutory rate and the Company’s effective tax rate are as follows:



	Three Months Ended June 30,						Six Months Ended June 30,
Income Tax Rate Reconciliation:	2019			2018			2019			2018

Statutory tax rate	12.5		%	12.5		%	12.5		%	12.5		%
International tax rates differential	10.6		%	(1.5		)%	6.9		%	6.8		%
Change in valuation allowance	(52.9		)%	(39.4		)%	(25.4		)%	(11.9		)%
Change in fair value of nondeductible contingent consideration	1.6		%	67.6		%	(1.5		)%	10.9		%
Nondeductible stock-based compensation	—		%	(4.7		)%	(0.2		)%	(1.8		)%
Unrecognized tax benefits	(2.5		)%	(7.6		)%	(1.4		)%	(2.8		)%
State and local income taxes, net of federal	(0.4		)%	1.0		%	(0.1		)%	0.3		%
Nondeductible interest expense	(3.7		)%	—		%	(2.0		)%	—		%
Other	8.7		%	(18.9		)%	4.4		%	0.5		%
Effective income tax rate	(26.1		)%	9.0		%	(6.8		)%	14.5		%

Income tax benefit - at statutory tax rate	$	(853	)	$	(473	)	$	(2,526	)	$	(2,293	)
International tax rates differential	(723		)	57			(1,391		)	(1,241		)
Change in valuation allowance	3,609			1,491			5,129			2,181
Change in fair value of nondeductible contingent consideration	(110		)	(2,556		)	303			(2,005		)
Nondeductible stock-based compensation	(2		)	176			49			336
Unrecognized tax benefits	168			288			292			508
State and local income taxes, net of federal	25			(38		)	27			(57		)
Nondeductible interest expense	253			—			410			—
Other	(586		)	713			(886		)	(98		)
Income tax provision (benefit) - at effective income tax rate	$	1,781		$	(342	)	$	1,407		$	(2,669	)

The IRS commenced an examination of the Company's U.S. income tax returns for 2016 and 2017 during the second quarter 2019.

XML 32 R21.htm IDEA: XBRL DOCUMENT

Other Assets and Liabilities

6 Months Ended

Jun. 30, 2019

Other Liabilities Disclosure [Abstract]

Other Assets and Liabilities

Various other assets and liabilities are summarized as follows:



Prepaid Expenses and Other Current Assets:	June 30, 2019		December 31, 2018

Valued-added tax recoverable	$	671	$	1,378
Prepaid and other expenses	2,594		2,145
Guarantee from Armistice (see Note 14)	551		534
Income tax receivable	997		921
Research and development tax credit receivable	270		283
Short-term deposit	—		3,350
Other	82		225
Total	$	5,165	$	8,836



Other Non-Current Assets:	June 30, 2019		December 31, 2018

Deferred tax assets, net	$	21,072	$	23,029
Long-term deposits	1,477		1,477
Guarantee from Armistice (see Note 14)	5,413		5,697
Right of use assets at contract manufacturing organizations	6,561		5,894
Other	50		49
Total	$	34,573	$	36,146



Accrued Expenses	June 30, 2019		December 31, 2018

Accrued compensation	$	1,946	$	3,971
Accrued social charges	789		1,009
Accrued restructuring (see Note 15)	1,441		879
Customer allowances	6,279		6,541
Accrued contract research organization charges	1,815		1,000
Accrued contract manufacturing organization costs	1,591		2,028
Accrued contract sales organization and marketing costs	—		3,469
Other	1,876		2,798
Total	$	15,737	$	21,695



Other Non-Current Liabilities:	June 30, 2019		December 31, 2018

Provision for retirement indemnity	$	—	$	1,024
Customer allowances	867		1,352
Unrecognized tax benefits	5,315		5,315
Guarantee to Deerfield (see Note 14)	5,432		5,717
Other	61		594
Total	$	11,675	$	14,002

XML 33 R22.htm IDEA: XBRL DOCUMENT

Divestiture of the Pediatric Assets

6 Months Ended

Jun. 30, 2019

Discontinued Operations and Disposal Groups [Abstract]

Divestiture of the Pediatric Assets

On February 12, 2018, the Company, together with its subsidiaries Avadel Pharmaceuticals (USA), Inc., Avadel Pediatrics, Inc., FSC Therapeutics, LLC (“FSC Therapeutics”), and Avadel US Holdings, Inc. (“Holdings”), as the “Sellers,” entered into an asset purchase agreement (the “Purchase Agreement”) with Cerecor, Inc. (“Cerecor”). The transaction closed on February 16, 2018 wherein Cerecor purchased from the Sellers four pediatric commercial stage assets – Karbinal™ ER, Cefaclor, Flexichamber™ and AcipHex® Sprinkle™, together with certain associated business assets – which were held by FSC. The Company acquired FSC in February 2016 from Deerfield and certain of its affiliates. Pursuant to the Purchase Agreement, Cerecor assumed the Company’s remaining payment obligations to Deerfield under the Membership Interest Purchase Agreement, dated as of February 5, 2016, between Holdings, Flamel Technologies SA (the predecessor of the Company) and Deerfield and certain of its affiliates, which payment obligations consist of the following (collectively, the “Assumed Obligations”): (i) a quarterly payment of $263 beginning in July 2018 and ending in October 2020, amounting to an aggregate payment obligation of $2,625; (ii) a payment in January 2021 of $15,263; and (iii) a quarterly royalty payment of 15% on net sales of the FSC products through February 5, 2026 (“FSC Product Royalties”), in an aggregate amount of up to approximately $10,300. Cerecor also assumed certain contracts and other obligations related to the acquired assets, and in that connection Holdings agreed to pay Cerecor certain make-whole payments associated with obligations Cerecor is assuming related to a certain supply contract related to Karbinal™ ER.

In conjunction with the divestiture, the Company also entered into the following arrangements:

License and Development Agreement


•	Avadel Ireland will provide Cerecor with four product formulations utilizing Avadel Ireland’s LiquiTime™ technology, and will complete pilot bioequivalence studies for such product formulations within 18 months;


•	Cerecor will reimburse Avadel Ireland for development costs of the four LiquiTime™ products in excess of $1,000 in the aggregate;


•	Upon transfer of the four product formulations, Cerecor will assume all remaining development costs and responsibilities for the product development, clinical studies, NDA applications and associated filing fees; and


•	Upon regulatory approval and commercial launch of any LiquiTime™ products, Cerecor will pay Avadel Ireland quarterly royalties based on a percentage of net sales of any such products in the mid-single digit range.

Deerfield Guarantee

Armistice Guarantee

The fair values of the Avadel guarantee to Deerfield and the guarantee received by Avadel from Armistice largely offset and when combined are not material.

Based on management’s review of ASU 2014-08, Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity, the disposition of our pediatric assets and related liabilities did not qualify for discontinued operations reporting. Our results of operations for the period January 1, 2018 through February 16, 2018 include the results of FSC, prior to its February 16, 2018 disposition date.

The net impact of this transaction was not material to the unaudited condensed consolidated statements of loss.

XML 34 R23.htm IDEA: XBRL DOCUMENT

Restructuring Costs

6 Months Ended

Jun. 30, 2019

Restructuring and Related Activities [Abstract]

Restructuring Costs

2019 French Restructuring

The following table sets forth activities for the Company’s cost reduction plan obligations for the three and six months ended June 30, 2019:



2019 French Restructuring Obligation:	2019

Balance of restructuring accrual at January 1,	$	—
Charges for employee severance, benefits and other costs	2,414
Payments	(1,332		)
Foreign currency impact	20
Balance of restructuring accrual at June 30,	$	1,102

The 2019 French Restructuring liabilities of $1,078 and $24 are included in the unaudited condensed consolidated balance sheet in accrued expenses and accounts payable at June 30, 2019, respectively.

2019 Corporate Restructuring

The following table sets forth activities for the Company’s cost reduction plan obligations for the six months ended June 30, 2019:



2019 Corporate Restructuring Obligation:	2019

Balance of restructuring accrual at January 1,	$	—
Charges for employee severance, benefits and other costs	2,359
Payments	(2,016		)
Balance of restructuring accrual at June 30,	$	343

2019 Corporate Restructuring liabilities of $343 are included in the unaudited condensed consolidated balance sheet in accrued expenses at June 30, 2019.

2017 French Restructuring



2017 French Restructuring Obligation:	2019			2018

Balance of restructuring accrual at January 1,	$	879		$	1,000
Charges for employee severance, benefits and other	(168		)	203
Payments	(647		)	(515		)
Foreign currency impact	(8		)	(55		)
Balance of restructuring accrual at June 30,	$	56		$	633

The 2017 French Restructuring accrual is included in the unaudited condensed consolidated balance sheet in accrued expenses and other non-current liabilities at June 30, 2019 and 2018.

XML 35 R24.htm IDEA: XBRL DOCUMENT

Net Loss Per Share

6 Months Ended

Jun. 30, 2019

Earnings Per Share [Abstract]

Net Loss Per Share

The dilutive effect of the warrants, stock options, RSU’s and ordinary shares expected to be issued under or ESPP has been calculated using the treasury stock method.

A reconciliation of basic and diluted net loss per share, together with the related shares outstanding in thousands is as follows:



	Three Months Ended June 30,						Six Months Ended June 30,
Net Loss Per Share:	2019			2018			2019			2018

Net loss	$	(8,605	)	$	(3,438	)	$	(21,623	)	$	(15,674	)

Weighted average shares:
Basic shares	37,356			36,772			37,355			37,666
Effect of dilutive securities—employee and director equity awards outstanding and 2023 Notes	—			—			—			—
Diluted shares	37,356			36,772			37,355			37,666

Net loss per share - basic	$	(0.23	)	$	(0.09	)	$	(0.58	)	$	(0.42	)
Net loss per share - diluted	$	(0.23	)	$	(0.09	)	$	(0.58	)	$	(0.42	)

XML 36 R25.htm IDEA: XBRL DOCUMENT

Comprehensive Loss

6 Months Ended

Jun. 30, 2019

Stockholders' Equity Note [Abstract]

Comprehensive Loss

The following table shows the components of accumulated other comprehensive loss for the three and six months ended June 30, 2019 and 2018, respectively, net of tax effects:



	Three Months Ended June 30,						Six Months Ended June 30,
Accumulated Other Comprehensive Loss:	2019			2018			2019			2018

Foreign currency translation adjustment:
Beginning balance	$	(23,782	)	$	(22,953	)	$	(23,621	)	$	(23,202	)
Net other comprehensive (loss) income	62			(482		)	(99		)	(233		)
Balance at June 30,	$	(23,720	)	$	(23,435	)	$	(23,720	)	$	(23,435	)

Unrealized gain (loss) on marketable securities, net
Beginning balance	$	579		$	(302	)	$	205		$	(64	)
Net other comprehensive income (loss), net of ($23), ($11), ($41) and ($70) tax, respectively	293			78			667			(160		)
Balance at June 30,	$	872		$	(224	)	$	872		$	(224	)
Accumulated other comprehensive loss at June 30,	$	(22,848	)	$	(23,659	)	$	(22,848	)	$	(23,659	)

The effect on the Company’s unaudited condensed consolidated financial statements of amounts reclassified out of accumulated other comprehensive loss was immaterial for all periods presented.

XML 37 R26.htm IDEA: XBRL DOCUMENT

Revenue by Product

6 Months Ended

Jun. 30, 2019

Segment Reporting [Abstract]

Revenue by Product

The following table presents a summary of total revenues by these products:



	Three Months Ended June 30,					Six Months Ended June 30,
Revenues by Product:	2019			2018		2019		2018

Bloxiverz	$	2,358		$	5,544	$	4,926	$	13,035
Vazculep	9,410			11,377		18,883		24,338
Akovaz	5,946			11,875		9,738		22,092
Other	(160		)	320		444		2,812
Total product sales	17,554			29,116		33,991		62,277
License revenue	—			114		—		246
Total revenues	$	17,554		$	29,230	$	33,991	$	62,523

XML 38 R27.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

6 Months Ended

Jun. 30, 2019

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Litigation

Litigation Related to Noctiva

Material Commitments



Purchase Commitments:	Balance

2019	$	7,194
2020	1,320
2021	1,320
2022	1,320
2023	220
Thereafter	—
Total	$	11,374

XML 39 R28.htm IDEA: XBRL DOCUMENT

Subsequent Events	6 Months Ended
Subsequent Events	Jun. 30, 2019
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Subsequent to June 30, 2019, the Company became aware of market conditions that could have a material impact on the estimated and projected annual net revenues and gross profit of certain hospital products that were used to estimate the total related party payable. The Company believes the effect of this change in estimate could reduce the total related party payable by approximately $3,000.

XML 40 R29.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2019

Accounting Policies [Abstract]

Nature of Operations

Our current marketed products include:


•	Akovaz® (ephedrine sulfate injection, USP), an alpha- and beta-adrenergic agonist and a norepinephrine-releasing agent that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.


•	Bloxiverz® (neostigmine methylsulfate injection), a cholinesterase inhibitor, is indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents (NMBAs) after surgery.


•	Vazculep® (phenylephrine hydrochloride injection), an alpha-1 adrenergic receptor agonist indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.

Each of our Akovaz, Bloxiverz and Vazculep products is used primarily in the hospital setting and was developed under our UMD program.

Basis of Presentation

Newly Issued Accounting Pronouncements

Newly Issued Accounting Standards

Recent Accounting Guidance Not Yet Adopted

Revenue

Revenue. Revenue includes sales of pharmaceutical products, licensing fees, and, if any, milestone payments for research and development (“R&D”) achievements.

Product Sales and Services

License Revenue

For a complete discussion of the accounting for net product revenue and license revenues, see Note 4: Revenue Recognition.

Revenue Recognition

Product Sales and Services

Reserves to reduce Gross Revenues to Net Revenues

Product Returns

Chargebacks, Discounts and Rebates

Revenue from licensing arrangements

License of Intellectual Property

Disaggregation of revenue

Contract Balances

The Company does not recognize revenue in advance of invoicing its customers and therefore has no related contract assets.

A receivable is recognized in the period the Company sells its products and when the Company’s right to consideration is unconditional.

There were no material deferred contract costs at June 30, 2019.

Transaction Price Allocated to the Remaining Performance Obligation

XML 41 R30.htm IDEA: XBRL DOCUMENT

Fair Value Measurement (Tables)

6 Months Ended

Jun. 30, 2019

Fair Value Disclosures [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis



	As of June 30, 2019						As of December 31, 2018
Fair Value Measurements:	Level 1		Level 2		Level 3		Level 1		Level 2		Level 3

Marketable securities (see Note 6)
Equity securities	$	4,038	$	—	$	—	$	9,145	$	—	$	—
Money market funds	47,033		—		—		52,996		—		—
Corporate bonds	—		3,664		—		—		6,339		—
Government securities - U.S.	—		5,234		—		—		12,701		—
Other fixed-income securities	—		2,182		—		—		9,409		—
Total assets	$	51,071	$	11,080	$	—	$	62,141	$	28,449	$	—

Related party payable (see Note 10)	$	—	$	—	$	24,247	$	—	$	—	$	28,840
Total liabilities	$	—	$	—	$	24,247	$	—	$	—	$	28,840

XML 42 R31.htm IDEA: XBRL DOCUMENT

Marketable Securities (Tables)

6 Months Ended

Jun. 30, 2019

Investments, Debt and Equity Securities [Abstract]

Schedule of Available-for-sale and Equity Securities



	June 30, 2019
Marketable Securities:	Adjusted Cost		Unrealized Gains		Unrealized Losses			Fair Value

Equity securities	$	4,166	$	—	$	(128	)	$	4,038
Money market funds	46,314		719		—			47,033
Corporate bonds	3,611		54		(1		)	3,664
Government securities - U.S.	5,122		114		(2		)	5,234
Other fixed-income securities	2,154		29		(1		)	2,182
Total	$	61,367	$	916	$	(132	)	$	62,151



	December 31, 2018
Marketable Securities:	Adjusted Cost		Unrealized Gains		Unrealized Losses			Fair Value

Equity securities	$	10,101	$	—	$	(956	)	$	9,145
Money market funds	52,733		316		(53		)	52,996
Corporate bonds	6,411		7		(79		)	6,339
Government securities - U.S.	12,714		66		(79		)	12,701
Other fixed-income securities	9,400		22		(13		)	9,409
Total	$	91,359	$	411	$	(1,180	)	$	90,590

Schedule of Contractual Maturity Dates



	Maturities
Marketable Debt Securities:	Less than 1 Year		1-5 Years		5-10 Years		Greater than 10 Years		Total

Corporate bonds	$	735	$	2,929	$	—	$	—	$	3,664
Government securities - U.S.	—		4,798		—		436		5,234
Other fixed-income securities	426		1,756		—		—		2,182
Total	$	1,161	$	9,483	$	—	$	436	$	11,080

XML 43 R32.htm IDEA: XBRL DOCUMENT

Inventories (Tables)

6 Months Ended

Jun. 30, 2019

Inventory Disclosure [Abstract]

Schedule of Inventory

The principal categories of inventories, net reserves of $1,143 and $4,757 at June 30, 2019 and December 31, 2018, respectively, are comprised of the following:



Inventory:	June 30, 2019		December 31, 2018

Finished goods	$	2,127	$	4,270
Raw materials	474		500
Total	$	2,601	$	4,770

XML 44 R33.htm IDEA: XBRL DOCUMENT

Goodwill and Intangible Assets (Tables)

6 Months Ended

Jun. 30, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Finite-Lived Intangible Assets

The Company’s amortizable and unamortizable intangible assets at June 30, 2019 and December 31, 2018 are as follows:



	June 30, 2019							December 31, 2018
Goodwill and Intangible Assets:	Gross Value		Accumulated Amortization			Net Carrying Amount		Gross Value		Accumulated Amortization			Impairment			Net Carrying Amount

Amortizable intangible assets:
Acquired developed technology - Noctiva	$	—	$	—		$	—	$	73,111	$	(7,024	)	$	(66,087	)	$	—
Acquired developed technology - Vazculep	12,061		(10,837		)	1,224		12,061		(10,432		)	—			1,629
Total amortizable intangible assets	$	12,061	$	(10,837	)	$	1,224	$	85,172	$	(17,456	)	$	(66,087	)	$	1,629

Unamortizable intangible assets:
Goodwill	$	18,491	$	—		$	18,491	$	18,491	$	—		$	—		$	18,491
Total unamortizable intangible assets	$	18,491	$	—		$	18,491	$	18,491	$	—		$	—		$	18,491

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense

Estimated amortization of intangible assets for the next five years is as follows:



Estimated Annual Amortization Expense:	Amount

2019	$	815
2020	814
2021	—
2022	—
2023	—

XML 45 R34.htm IDEA: XBRL DOCUMENT

Leases (Tables)

6 Months Ended

Jun. 30, 2019

Leases [Abstract]

Components of lease costs



Lease cost:	Three months ended June 30, 2019		Six months ended June 30, 2019

Operating lease costs ⁽¹⁾	$	394	$	739
Sublease income ⁽²⁾	61		105
Total lease cost	$	333	$	634

⁽¹⁾Variable lease costs were immaterial for the three and six months ended June 30, 2019.

Maturities of operating lease liabilities

Maturities of the Company’s operating lease liabilities were as follows:



Maturities:	Operating Leases

Remaining six months of 2019	$	603
2020	1,213
2021	1,003
2022	763
2023	692
Thereafter	958
Total lease payments	5,232
Less: interest	616
Present value of lease liabilities	$	4,616

Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]

Under the prior lease guidance, minimum rental commitments for non-cancelable leases as of December 31, 2018 were:



Lease Commitment:	Operating Leases

2019	$	1,191
2020	1,208
2021	1,008
2022	767
2023	695
Thereafter	967
Total minimum lease payments	$	5,836

XML 46 R35.htm IDEA: XBRL DOCUMENT

Long-Term Related Party Payable (Tables)

6 Months Ended

Jun. 30, 2019

Debt Disclosure [Abstract]

Schedule of Related Party Transactions

Long-term related party payable and related activity are reported at fair value and consist of the following at June 30, 2019 and December 31, 2018:



				Activity during the Six Months Ended June 30, 2019
							Changes in Fair Value of Related Party Payable
Long-Term Related Party Payable:	Balance, December 31, 2018			Payments to Related Parties			Operating Expense		Other Expense		Balance, June 30, 2019

Acquisition-related contingent consideration:
Earn-out payments - Éclat Pharmaceuticals (a)	$	25,615		$	(5,790	)	$	1,757	$	—	$	21,582
Financing-related:
Royalty agreement - Deerfield (b)	2,184			(621		)	—		236		1,799
Royalty agreement - Broadfin (c)	1,041			(296		)	—		121		866
Total related party payable	28,840			$	(6,707	)	$	1,757	$	357	24,247
Less: current portion	(9,439		)								(8,264		)
Total long-term related party payable	$	19,401									$	15,983

Long-term related party payable and related activity are reported at fair value and consist of the following at June 30, 2019 and March 31, 2019:



				Activity during the Three Months Ended June 30, 2019
							Changes in Fair Value of Related Party Payable
Long-Term Related Party Payable:	Balance, March 31, 2019			Payments to Related Parties			Operating Expense			Other Expense		Balance, June 30, 2019

Acquisition-related contingent consideration:
Earn-out payments - Éclat Pharmaceuticals (a)	$	24,569		$	(2,610	)	$	(377	)	$	—	$	21,582
Financing-related:
Royalty agreement - Deerfield (b)	2,048			(277		)	—			28		1,799
Royalty agreement - Broadfin (c)	976			(132		)	—			22		866
Total related party payable	27,593			$	(3,019	)	$	(377	)	$	50	24,247
Less: current portion	(9,391		)									(8,264		)
Total long-term related party payable	$	18,202										$	15,983

(b)


(c)	As part of a December 2013 debt financing transaction conducted with Broadfin Healthcare Master Fund, a related party and current shareholder, the Company received cash of $2,200 in exchange for entering into a royalty agreement whereby the Company shall pay quarterly a 0.834% royalty on the net sales of certain Éclat products until December 31, 2024.

The following table summarizes changes to the related party payables, a recurring Level 3 measurement, for the six-month periods ended June 30, 2019 and 2018, respectively:



Related Party Payable Rollforward:	Balance

Balance, December 31, 2017	$	98,925
Payments of related party payable	(13,376		)
Fair value adjustments ⁽¹⁾	(10,928		)
Expiration of warrants	(2,167		)
Disposition of the pediatric assets	(20,337		)
Balance, June 30, 2018	$	52,117

Balance, December 31, 2018	$	28,840
Payments of related party payable	(6,707		)
Fair value adjustments ⁽¹⁾	2,114
Balance, June 30, 2019	$	24,247

XML 47 R36.htm IDEA: XBRL DOCUMENT

Long-Term Debt (Tables)

6 Months Ended

Jun. 30, 2019

Debt Disclosure [Abstract]

Schedule of Debt

Long-term debt is summarized as follows:



	June 30, 2019			December 31, 2018
Principal amount of 4.50% exchangeable senior notes due 2023	$	143,750		$	143,750
Less: debt discount and issuance costs, net	(25,125		)	(28,059		)
Net carrying amount of liability component	118,625			115,691
Other debt	111			149
Subtotal	118,736			115,840
Less: current maturities	(105		)	(106		)
Long-term debt	$	118,631		$	115,734

Equity component:
Equity component of exchangeable notes, net of issuance costs	$	(26,699	)	$	(26,699	)

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

+ Details

XML 48 R37.htm IDEA: XBRL DOCUMENT

Income Taxes (Tables)

6 Months Ended

Jun. 30, 2019

Income Tax Disclosure [Abstract]

Schedule of Components of Income Before Income Tax

The components of loss before income taxes are as follows:



	Three Months Ended June 30,						Six Months Ended June 30,
Loss Before Income Taxes:	2019			2018			2019			2018

Ireland	$	(12,089	)	$	(10,962	)	$	(22,323	)	$	(15,889	)
United States	9,800			7,019			6,357			(2,816		)
France	(4,535		)	163			(4,250		)	362
Total loss before income taxes	$	(6,824	)	$	(3,780	)	$	(20,216	)	$	(18,343	)

Schedule of Effective Income Tax Rate Reconciliation

The items accounting for the difference between the income tax provision computed at the statutory rate and the Company’s effective tax rate are as follows:



	Three Months Ended June 30,						Six Months Ended June 30,
Income Tax Rate Reconciliation:	2019			2018			2019			2018

Statutory tax rate	12.5		%	12.5		%	12.5		%	12.5		%
International tax rates differential	10.6		%	(1.5		)%	6.9		%	6.8		%
Change in valuation allowance	(52.9		)%	(39.4		)%	(25.4		)%	(11.9		)%
Change in fair value of nondeductible contingent consideration	1.6		%	67.6		%	(1.5		)%	10.9		%
Nondeductible stock-based compensation	—		%	(4.7		)%	(0.2		)%	(1.8		)%
Unrecognized tax benefits	(2.5		)%	(7.6		)%	(1.4		)%	(2.8		)%
State and local income taxes, net of federal	(0.4		)%	1.0		%	(0.1		)%	0.3		%
Nondeductible interest expense	(3.7		)%	—		%	(2.0		)%	—		%
Other	8.7		%	(18.9		)%	4.4		%	0.5		%
Effective income tax rate	(26.1		)%	9.0		%	(6.8		)%	14.5		%

Income tax benefit - at statutory tax rate	$	(853	)	$	(473	)	$	(2,526	)	$	(2,293	)
International tax rates differential	(723		)	57			(1,391		)	(1,241		)
Change in valuation allowance	3,609			1,491			5,129			2,181
Change in fair value of nondeductible contingent consideration	(110		)	(2,556		)	303			(2,005		)
Nondeductible stock-based compensation	(2		)	176			49			336
Unrecognized tax benefits	168			288			292			508
State and local income taxes, net of federal	25			(38		)	27			(57		)
Nondeductible interest expense	253			—			410			—
Other	(586		)	713			(886		)	(98		)
Income tax provision (benefit) - at effective income tax rate	$	1,781		$	(342	)	$	1,407		$	(2,669	)

XML 49 R38.htm IDEA: XBRL DOCUMENT

Other Assets and Liabilities (Tables)

6 Months Ended

Jun. 30, 2019

Other Liabilities Disclosure [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Various other assets and liabilities are summarized as follows:



Prepaid Expenses and Other Current Assets:	June 30, 2019		December 31, 2018

Valued-added tax recoverable	$	671	$	1,378
Prepaid and other expenses	2,594		2,145
Guarantee from Armistice (see Note 14)	551		534
Income tax receivable	997		921
Research and development tax credit receivable	270		283
Short-term deposit	—		3,350
Other	82		225
Total	$	5,165	$	8,836

Schedule of Other Assets, Noncurrent



Other Non-Current Assets:	June 30, 2019		December 31, 2018

Deferred tax assets, net	$	21,072	$	23,029
Long-term deposits	1,477		1,477
Guarantee from Armistice (see Note 14)	5,413		5,697
Right of use assets at contract manufacturing organizations	6,561		5,894
Other	50		49
Total	$	34,573	$	36,146

Schedule of Accrued Liabilities



Accrued Expenses	June 30, 2019		December 31, 2018

Accrued compensation	$	1,946	$	3,971
Accrued social charges	789		1,009
Accrued restructuring (see Note 15)	1,441		879
Customer allowances	6,279		6,541
Accrued contract research organization charges	1,815		1,000
Accrued contract manufacturing organization costs	1,591		2,028
Accrued contract sales organization and marketing costs	—		3,469
Other	1,876		2,798
Total	$	15,737	$	21,695

Schedule Of Long Term Liabilities



Other Non-Current Liabilities:	June 30, 2019		December 31, 2018

Provision for retirement indemnity	$	—	$	1,024
Customer allowances	867		1,352
Unrecognized tax benefits	5,315		5,315
Guarantee to Deerfield (see Note 14)	5,432		5,717
Other	61		594
Total	$	11,675	$	14,002

XML 50 R39.htm IDEA: XBRL DOCUMENT

Restructuring Costs (Tables)

6 Months Ended

Jun. 30, 2019

Restructuring and Related Activities [Abstract]

Schedule of Restructuring and Related Costs

The following table sets forth activities for the Company’s cost reduction plan obligations for the three and six months ended June 30, 2019:



2019 French Restructuring Obligation:	2019

Balance of restructuring accrual at January 1,	$	—
Charges for employee severance, benefits and other costs	2,414
Payments	(1,332		)
Foreign currency impact	20
Balance of restructuring accrual at June 30,	$	1,102

The following table sets forth activities for the Company’s cost reduction plan obligations for the six months ended June 30, 2019 and 2018:



2017 French Restructuring Obligation:	2019			2018

Balance of restructuring accrual at January 1,	$	879		$	1,000
Charges for employee severance, benefits and other	(168		)	203
Payments	(647		)	(515		)
Foreign currency impact	(8		)	(55		)
Balance of restructuring accrual at June 30,	$	56		$	633

The following table sets forth activities for the Company’s cost reduction plan obligations for the six months ended June 30, 2019:



2019 Corporate Restructuring Obligation:	2019

Balance of restructuring accrual at January 1,	$	—
Charges for employee severance, benefits and other costs	2,359
Payments	(2,016		)
Balance of restructuring accrual at June 30,	$	343

XML 51 R40.htm IDEA: XBRL DOCUMENT

Net Loss Per Share (Tables)

6 Months Ended

Jun. 30, 2019

Earnings Per Share [Abstract]

Schedule of Earnings Per Share Reconciliation

A reconciliation of basic and diluted net loss per share, together with the related shares outstanding in thousands is as follows:



	Three Months Ended June 30,						Six Months Ended June 30,
Net Loss Per Share:	2019			2018			2019			2018

Net loss	$	(8,605	)	$	(3,438	)	$	(21,623	)	$	(15,674	)

Weighted average shares:
Basic shares	37,356			36,772			37,355			37,666
Effect of dilutive securities—employee and director equity awards outstanding and 2023 Notes	—			—			—			—
Diluted shares	37,356			36,772			37,355			37,666

Net loss per share - basic	$	(0.23	)	$	(0.09	)	$	(0.58	)	$	(0.42	)
Net loss per share - diluted	$	(0.23	)	$	(0.09	)	$	(0.58	)	$	(0.42	)

XML 52 R41.htm IDEA: XBRL DOCUMENT

Comprehensive Income (Loss) (Tables)

6 Months Ended

Jun. 30, 2019

Stockholders' Equity Note [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss)

The following table shows the components of accumulated other comprehensive loss for the three and six months ended June 30, 2019 and 2018, respectively, net of tax effects:



	Three Months Ended June 30,						Six Months Ended June 30,
Accumulated Other Comprehensive Loss:	2019			2018			2019			2018

Foreign currency translation adjustment:
Beginning balance	$	(23,782	)	$	(22,953	)	$	(23,621	)	$	(23,202	)
Net other comprehensive (loss) income	62			(482		)	(99		)	(233		)
Balance at June 30,	$	(23,720	)	$	(23,435	)	$	(23,720	)	$	(23,435	)

Unrealized gain (loss) on marketable securities, net
Beginning balance	$	579		$	(302	)	$	205		$	(64	)
Net other comprehensive income (loss), net of ($23), ($11), ($41) and ($70) tax, respectively	293			78			667			(160		)
Balance at June 30,	$	872		$	(224	)	$	872		$	(224	)
Accumulated other comprehensive loss at June 30,	$	(22,848	)	$	(23,659	)	$	(22,848	)	$	(23,659	)

XML 53 R42.htm IDEA: XBRL DOCUMENT

Revenue by Product (Tables)

6 Months Ended

Jun. 30, 2019

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, Revenue by Product

The following table presents a summary of total revenues by these products:



	Three Months Ended June 30,					Six Months Ended June 30,
Revenues by Product:	2019			2018		2019		2018

Bloxiverz	$	2,358		$	5,544	$	4,926	$	13,035
Vazculep	9,410			11,377		18,883		24,338
Akovaz	5,946			11,875		9,738		22,092
Other	(160		)	320		444		2,812
Total product sales	17,554			29,116		33,991		62,277
License revenue	—			114		—		246
Total revenues	$	17,554		$	29,230	$	33,991	$	62,523

XML 54 R43.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies - (Tables)

6 Months Ended

Jun. 30, 2019

Commitments and Contingencies Disclosure [Abstract]

Contractual Obligation, Fiscal Year Maturity Schedule



Purchase Commitments:	Balance

2019	$	7,194
2020	1,320
2021	1,320
2022	1,320
2023	220
Thereafter	—
Total	$	11,374

XML 55 R44.htm IDEA: XBRL DOCUMENT

Subsidiary Bankruptcy and Deconsolidation (Details) - USD ($)		3 Months Ended		6 Months Ended
	Apr. 26, 2019	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Jul. 02, 2019	Feb. 08, 2019
Business Acquisition, Contingent Consideration [Line Items]
Gain (loss) on deconsolidation of subsidiary		$ (167,000)	$ 0	$ (2,840,000)	$ 0
DIP Credit Agreement \| Debtor in Possession Credit and Security Facility
Business Acquisition, Contingent Consideration [Line Items]
Gain (loss) on deconsolidation of subsidiary		(407,000)
Payments for debtor in possession financing		407,000
Speciality Pharama
Business Acquisition, Contingent Consideration [Line Items]
Aggregate cash proceeds of intangible assets and remaining inventory	$ 250,000
Speciality Pharama \| Internal Revenue Service (IRS) \| Subsequent Event
Business Acquisition, Contingent Consideration [Line Items]
Bankruptcy claims, amount of filed claims likely to be denied						$ 50,695,000
Speciality Pharama \| DIP Credit Agreement \| Debtor in Possession Credit and Security Facility
Business Acquisition, Contingent Consideration [Line Items]
DIP financing, amount arranged							$ 2,700,000
Specialty Pharma
Business Acquisition, Contingent Consideration [Line Items]
Equity method investments, fair value		$ 0		$ 0

XML 56 R45.htm IDEA: XBRL DOCUMENT

Revenue Recognition - Narrative (Details)	Jun. 30, 2019 USD ($)
Revenue from Contract with Customer [Abstract]
Deferred contract costs	$ 0

XML 57 R46.htm IDEA: XBRL DOCUMENT

Fair Value Measurement Fair Value Measurement - Measured on Recurring Basis (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	$ 62,151	$ 90,590
Book value of long-term debt	118,736	115,840
Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Book value of long-term debt	$ 118,625	$ 115,691
4.50% Exchangeable Senior Notes Due 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt instrument, interest rate, stated percentage	4.50%	4.50%
4.50% Exchangeable Senior Notes Due 2023 \| Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-term debt	$ 143,750	$ 143,750
Debt instrument, interest rate, stated percentage	4.50%
Long-term debt, fair value	$ 60,914
Equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	4,038	9,145
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	47,033	52,996
Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	3,664	6,339
Government securities - U.S.
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	5,234	12,701
Other fixed-income securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	2,182	9,409
Fair Value Measurements, Recurring \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets	51,071	62,141
Fair Value Measurements, Recurring \| Level 1 \| Equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	4,038	9,145
Fair Value Measurements, Recurring \| Level 1 \| Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	47,033	52,996
Fair Value Measurements, Recurring \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets	11,080	28,449
Fair Value Measurements, Recurring \| Level 2 \| Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	3,664	6,339
Fair Value Measurements, Recurring \| Level 2 \| Government securities - U.S.
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	5,234	12,701
Fair Value Measurements, Recurring \| Level 2 \| Other fixed-income securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	2,182	9,409
Fair Value Measurements, Recurring \| Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Related party payable	24,247	28,840
Total liabilities	$ 24,247	$ 28,840

XML 58 R47.htm IDEA: XBRL DOCUMENT

Marketable Securities - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Investments, Debt and Equity Securities [Abstract]
Marketable securities, realized gain	$ 174	$ 22	$ 268	$ 235
Marketable securities, realized loss	$ 0	$ 194	$ 147	$ 328

XML 59 R48.htm IDEA: XBRL DOCUMENT

Marketable Securities - Summary of Marketable Securities (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Jun. 30, 2019	Dec. 31, 2018
Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]
Adjusted Cost	$ 61,367	$ 91,359
Unrealized Gains	916	411
Unrealized Losses	(132)	(1,180)
Fair Value	62,151	90,590
Equity securities
Debt Securities, Trading, and Equity Securities, FV-NI [Abstract]
Adjusted Cost	4,166	10,101
Unrealized Gains	0	0
Unrealized Losses	(128)	(956)
Fair Value	4,038	9,145
Money market funds
Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]
Adjusted Cost	46,314	52,733
Unrealized Gains	719	316
Unrealized Losses	0	(53)
Fair Value	47,033	52,996
Corporate bonds
Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]
Adjusted Cost	3,611	6,411
Unrealized Gains	54	7
Unrealized Losses	(1)	(79)
Fair Value	3,664	6,339
Government securities - U.S.
Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]
Adjusted Cost	5,122	12,714
Unrealized Gains	114	66
Unrealized Losses	(2)	(79)
Fair Value	5,234	12,701
Other fixed-income securities
Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]
Adjusted Cost	2,154	9,400
Unrealized Gains	29	22
Unrealized Losses	(1)	(13)
Fair Value	$ 2,182	$ 9,409

XML 60 R49.htm IDEA: XBRL DOCUMENT

Marketable Securities Marketable Securities - Schedule of Maturities (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Debt Securities, Available-for-sale [Line Items]
Fair Value	$ 62,151	$ 90,590
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Less than 1 Year	735
1-5 Years	2,929
5-10 Years	0
Greater than 10 Years	0
Fair Value	3,664	6,339
Government securities - U.S.
Debt Securities, Available-for-sale [Line Items]
Less than 1 Year	0
1-5 Years	4,798
5-10 Years	0
Greater than 10 Years	436
Fair Value	5,234	12,701
Other fixed-income securities
Debt Securities, Available-for-sale [Line Items]
Less than 1 Year	426
1-5 Years	1,756
5-10 Years	0
Greater than 10 Years	0
Fair Value	2,182	$ 9,409
Debt Securities, Excluding Money Market Funds, Available For Sale
Debt Securities, Available-for-sale [Line Items]
Less than 1 Year	1,161
1-5 Years	9,483
5-10 Years	0
Greater than 10 Years	436
Fair Value	$ 11,080

XML 61 R50.htm IDEA: XBRL DOCUMENT

Inventories (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Inventory Disclosure [Abstract]
Inventory reserves	$ 1,143	$ 4,757
Increase in inventory reserves	3,614
Inventory:
Finished goods	2,127	4,270
Raw materials	474	500
Total	$ 2,601	$ 4,770

XML 62 R51.htm IDEA: XBRL DOCUMENT

Goodwill and Intangible Assets - Gross Value and Net Carrying Amount (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Jun. 30, 2019
Amortizable intangible assets:
Gross Value	$ 85,172	$ 12,061
Accumulated Amortization	(17,456)	(10,837)
Impairment	(66,087)
Net Carrying Amount	1,629	1,224
Unamortizable intangible assets:
Gross Value	18,491	18,491
Accumulated Amortization	0	0
Net Carrying Amount	18,491	18,491
Developed technology \| Noctiva
Amortizable intangible assets:
Gross Value	73,111	0
Accumulated Amortization	(7,024)	0
Impairment	(66,087)
Net Carrying Amount	0	0
Developed technology \| Vazculep
Amortizable intangible assets:
Gross Value	12,061	12,061
Accumulated Amortization	(10,432)	(10,837)
Impairment	0
Net Carrying Amount	$ 1,629	$ 1,224

XML 63 R52.htm IDEA: XBRL DOCUMENT

Goodwill and Intangible Assets - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible asset amortization	$ 204	$ 1,609	$ 405	$ 3,376
Finite-Lived Intangible Assets [Line Items]
Fixed asset impairment					$ 66,087
Noctiva \| Developed technology
Finite-Lived Intangible Assets [Line Items]
Fixed asset impairment					$ 66,087

XML 64 R53.htm IDEA: XBRL DOCUMENT

Goodwill and Intangible Assets - Estimated Future Amortization (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2019 USD ($)
Finite-Lived Intangible Assets [Line Items]
Estimated useful life (in years)	5 years
Estimated Annual Amortization Expense:
2019	$ 815
2020	814
2021	0
2022	0
2023	$ 0
Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated useful life (in years)	3 years
Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated useful life (in years)	15 years

XML 65 R54.htm IDEA: XBRL DOCUMENT

Leases - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
Leases - Narrative (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Jun. 30, 2019	Jan. 01, 2019
Lessee, Lease, Description [Line Items]
Operating lease right-of-use assets	$ 5,454	$ 5,454
Operating lease liabilities	4,616	4,616
Current portion of operating lease liability	999	999
Operating lease payments	$ 394	$ 704
Operating lease, weighted average remaining lease term (in years)	4 years 11 months 27 days	4 years 11 months 27 days
Operating lease, weighted average discount rate, percent	5.30%	5.30%
Minimum
Lessee, Lease, Description [Line Items]
Lessee, operating lease, lease not yet commenced, operating lease expense	$ 3,000	$ 3,000
Operating lease, term of contract	1 year	1 year
Maximum
Lessee, Lease, Description [Line Items]
Lessee, operating lease, lease not yet commenced, operating lease expense	$ 4,000	$ 4,000
Operating lease, term of contract	7 years	7 years
Operating Leases Commenced
Lessee, Lease, Description [Line Items]
Operating lease right-of-use assets	$ 1,000	$ 1,000
Operating lease liabilities	$ 0	$ 0
Accounting Standards Update 2016-02
Lessee, Lease, Description [Line Items]
Operating lease right-of-use assets			$ 5,046
Operating lease liabilities			$ 5,131

XML 66 R55.htm IDEA: XBRL DOCUMENT

Leases - Components of lease costs (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2019
Leases [Abstract]
Operating lease costs	$ 394	$ 739
Sublease income	61	105
Total lease cost	$ 333	$ 634

XML 67 R56.htm IDEA: XBRL DOCUMENT

Leases - Maturities of operating lease liabilities (Details) $ in Thousands	Jun. 30, 2019 USD ($)
Leases [Abstract]
Remaining six months of 2019	$ 603
2020	1,213
2021	1,003
2022	763
2023	692
Thereafter	958
Total lease payments	5,232
Less: interest	616
Operating lease liabilities	$ 4,616

XML 68 R57.htm IDEA: XBRL DOCUMENT

Leases - Schedule of Future Minimum Rental Payments for Operating Leases (Details) $ in Thousands	Dec. 31, 2018 USD ($)
Leases [Abstract]
2019	$ 1,191
2020	1,208
2021	1,008
2022	767
2023	695
Thereafter	967
Total minimum lease payments	$ 5,836

XML 69 R58.htm IDEA: XBRL DOCUMENT

Long-Term Related Party Payable - Narrative (Details) - USD ($) $ in Thousands	1 Months Ended
	Dec. 31, 2013	Feb. 28, 2013	Mar. 31, 2012	Jun. 30, 2019
Minimum
Line of Credit Facility [Line Items]
Discounted cash flow risk adjusted discount rate				15.00%
Broadfin Debt Financing
Line of Credit Facility [Line Items]
Cash consideration received on royalty agreement	$ 2,200
Percentage of royalty payable on net sales	0.834%
Affiliated Entity \| Deerfield FSC LLC
Line of Credit Facility [Line Items]
Cash consideration received on royalty agreement		$ 2,600
Percentage of royalty payable on net sales		1.75%
Eclat Pharmaceuticals
Line of Credit Facility [Line Items]
Percentage of earn-out payments			20.00%

XML 70 R59.htm IDEA: XBRL DOCUMENT

Long-Term Related Party Payable - Activity (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Mar. 31, 2019	Dec. 31, 2018
Acquisition-related contingent consideration:
Related party payable, beginning balance	$ 27,593		$ 28,840	$ 98,925
Payments to Related Parties	(3,019)		(6,707)	(13,376)
Operating Expense	(377)	$ (12,889)	1,757	(9,921)
Other Expense	50		357
Related party payable, ending balance	24,247	$ 52,117	24,247	$ 52,117
Less: Current portion	(8,264)		(8,264)		$ (9,391)	$ (9,439)
Long-term related party payable	15,983		15,983		$ 18,202	$ 19,401
Acquisition-related contingent consideration: \| Earn-out payments
Acquisition-related contingent consideration:
Related party payable, beginning balance	24,569		25,615
Payments to Related Parties	(2,610)		(5,790)
Operating Expense	(377)		1,757
Other Expense	0		0
Related party payable, ending balance	21,582		21,582
Financing-related: \| Royalty agreement - Deerfield
Acquisition-related contingent consideration:
Related party payable, beginning balance	2,048		2,184
Payments to Related Parties	(277)		(621)
Operating Expense	0		0
Other Expense	28		236
Related party payable, ending balance	1,799		1,799
Financing-related: \| Royalty agreement - Broadfin
Acquisition-related contingent consideration:
Related party payable, beginning balance	976		1,041
Payments to Related Parties	(132)		(296)
Operating Expense	0		0
Other Expense	22		121
Related party payable, ending balance	$ 866		$ 866

XML 71 R60.htm IDEA: XBRL DOCUMENT

Long-Term Related Party Payable Long-Term Related Party Payable - Payable Balance (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2019	Jun. 30, 2018
Related Party Payable Rollforward:
Related party payable, beginning balance	$ 27,593	$ 28,840	$ 98,925
Payment of related party payable	(3,019)	(6,707)	(13,376)
Fair value adjustments		2,114	(10,928)
Expiration of warrants			(2,167)
Disposition of the pediatric assets			(20,337)
Related party payable, ending balance	$ 24,247	$ 24,247	$ 52,117

XML 72 R61.htm IDEA: XBRL DOCUMENT

Long-Term Debt Schedule of Debt (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Net carrying amount of liability component	$ 118,736	$ 115,840
Other debt	61	594
Less: current maturities	(105)	(106)
Long-term debt, less current portion	118,631	115,734
Senior Notes
Debt Instrument [Line Items]
Less: debt discount and issuance costs, net	(25,125)	(28,059)
Net carrying amount of liability component	118,625	115,691
Equity component of exchangeable notes, net of issuance costs	(26,699)	(26,699)
Loans Payable
Debt Instrument [Line Items]
Other debt	$ 111	$ 149
4.50% Exchangeable Senior Notes Due 2023
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	4.50%	4.50%
4.50% Exchangeable Senior Notes Due 2023 \| Senior Notes
Debt Instrument [Line Items]
Long-term debt	$ 143,750	$ 143,750
Debt instrument, interest rate, stated percentage	4.50%

XML 73 R62.htm IDEA: XBRL DOCUMENT

Income Taxes - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
Income Taxes - Narrative (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Income Tax Disclosure [Abstract]
Income tax provision (benefit)	$ 1,781	$ (342)	$ 1,407	$ (2,669)

XML 74 R63.htm IDEA: XBRL DOCUMENT

Income Taxes - Income (Loss) Before Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Income Taxes [Line Items]
Total income before income taxes	$ (6,824)	$ (3,780)	$ (20,216)	$ (18,343)
Ireland
Income Taxes [Line Items]
Total income before income taxes	(12,089)	(10,962)	(22,323)	(15,889)
United States
Income Taxes [Line Items]
Total income before income taxes	9,800	7,019	6,357	(2,816)
France
Income Taxes [Line Items]
Total income before income taxes	$ (4,535)	$ 163	$ (4,250)	$ 362

XML 75 R64.htm IDEA: XBRL DOCUMENT

Income Taxes - Reconciliation of Tax Rate (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Effective Income Tax Rate Reconciliation, Percent [Abstract]
Statutory tax rate	12.50%	12.50%	12.50%	12.50%
International tax rates differential	10.60%	(1.50%)	6.90%	6.80%
Change in valuation allowance	(52.90%)	(39.40%)	(25.40%)	(11.90%)
Change in fair value of nondeductible contingent consideration	1.60%	67.60%	(1.50%)	10.90%
Nondeductible stock-based compensation	0.00%	(4.70%)	(0.20%)	(1.80%)
Unrecognized tax benefits	(2.50%)	(7.60%)	(1.40%)	(2.80%)
State and local income taxes, net of federal	(0.40%)	1.00%	(0.10%)	0.30%
Nondeductible interest expense	(3.70%)	0.00%	(2.00%)	0.00%
Other	8.70%	(18.90%)	4.40%	0.50%
Effective income tax rate	(26.10%)	9.00%	(6.80%)	14.50%
Effective Income Tax Rate Reconciliation, Amount [Abstract]
Income tax benefit - at statutory tax rate	$ (853)	$ (473)	$ (2,526)	$ (2,293)
International tax rates differential	(723)	57	(1,391)	(1,241)
Change in valuation allowance	3,609	1,491	5,129	2,181
Change in fair value of nondeductible contingent consideration	(110)	(2,556)	303	(2,005)
Nondeductible stock-based compensation	(2)	176	49	336
Unrecognized tax benefits	168	288	292	508
State and local income taxes, net of federal	25	(38)	27	(57)
Nondeductible interest expense	253	0	410	0
Other	(586)	713	(886)	(98)
Income tax provision (benefit) - at effective income tax rate	$ 1,781	$ (342)	$ 1,407	$ (2,669)

XML 76 R65.htm IDEA: XBRL DOCUMENT

Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Prepaid Expenses and Other Current Assets:
Valued-added tax recoverable	$ 671	$ 1,378
Prepaid and other expenses	2,594	2,145
Guarantee from Armistice	551	534
Income tax receivable	997	921
Research and development tax credit receivable	270	283
Short-term deposit	0	3,350
Other	82	225
Total	$ 5,165	$ 8,836

XML 77 R66.htm IDEA: XBRL DOCUMENT

Other Assets and Liabilities - Other Non-Current Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Other Non-Current Assets:
Deferred tax assets, net	$ 21,072	$ 23,029
Long-term deposits	1,477	1,477
Guarantee from Armistice	5,413	5,697
Right of use assets at contract manufacturing organizations	6,561	5,894
Other	50	49
Total	$ 34,573	$ 36,146

XML 78 R67.htm IDEA: XBRL DOCUMENT

Other Assets and Liabilities - Accrued Expenses (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Accrued Expenses
Accrued compensation	$ 1,946	$ 3,971
Accrued social charges	789	1,009
Accrued restructuring (see Note 15)	1,441	879
Customer allowances	6,279	6,541
Accrued contract research organization charges	1,815	1,000
Accrued contract manufacturing organization costs	1,591	2,028
Accrued contract sales organization and marketing costs	0	3,469
Other	1,876	2,798
Total	$ 15,737	$ 21,695

XML 79 R68.htm IDEA: XBRL DOCUMENT

Other Assets and Liabilities - Other Non-Current Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018
Other Non-Current Liabilities:
Provision for retirement indemnity	$ 0	$ 1,024
Customer allowances	867	1,352
Unrecognized tax benefits	5,315	5,315
Guarantee to Deerfield	5,432	5,717
Other	61	594
Total	$ 11,675	$ 14,002

XML 80 R69.htm IDEA: XBRL DOCUMENT

Divestiture of the Pediatric Assets - Narrative (Details) - USD ($) $ in Thousands		1 Months Ended
	Feb. 12, 2018	Jan. 31, 2021	Jun. 30, 2019	Dec. 31, 2018
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Guaranty liabilities			$ 5,432	$ 5,717
2016 MIPA \| Discontinued Operations, Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Debt instrument, periodic payment, interest	$ 263
Noncash or part noncash acquisition, debt assumed	2,625
Research and development reimbursement, in excess of	1,000
Guaranty liabilities	6,643		5,985
Guaranty assets	$ 6,620		$ 5,964
FSC \| 2016 MIPA \| Discontinued Operations, Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Percentage of royalty payable on net sales	15.00%
Royalty payable on net sales, maximum	$ 10,300
Scenario, Forecast \| 2016 MIPA \| Discontinued Operations, Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Repayments of assumed debt		$ 15,263

XML 81 R70.htm IDEA: XBRL DOCUMENT

Restructuring Costs - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Jun. 30, 2017
Restructuring Cost and Reserve [Line Items]
Restructuring costs	$ 1,506	$ 50	$ 2,734	$ 203
Fixed asset impairment						$ 66,087
2019 French Restructuring Obligation
Restructuring Cost and Reserve [Line Items]
Restructuring costs			1,939
Charges for employee severance, benefits and other costs			2,414
Fixed asset impairment			525
Benefit related to the reversal of retirement indemnity obligation	1,000		1,000
Restructuring reserve	1,102		1,102			0
2019 French Restructuring Obligation \| Scenario, Forecast
Restructuring Cost and Reserve [Line Items]
Severance costs					$ 3,500
2019 French Restructuring Obligation \| Accrued Liabilities
Restructuring Cost and Reserve [Line Items]
Restructuring reserve	1,078		1,078			24
2019 Corporate Restructuring Obligations
Restructuring Cost and Reserve [Line Items]
Restructuring costs	435		963
Charges for employee severance, benefits and other costs	541		2,359
Share-based compensation forfeitures related to the employees affected by the global reduction in workforce	976		1,396
Restructuring reserve	343		343			0
2019 Corporate Restructuring Obligations \| Scenario, Forecast
Restructuring Cost and Reserve [Line Items]
Severance costs					$ 3,000
Lyon France Workforce Reduction
Restructuring Cost and Reserve [Line Items]
Restructuring costs			168	203
Charges for employee severance, benefits and other costs			(168)	203
Restructuring reserve	$ 56	$ 633	$ 56	$ 633		$ 879	$ 1,000
Employee Severance \| Corporate Workforce Reduction
Restructuring Cost and Reserve [Line Items]
Expected number of positions eliminated (as a percent)	50.00%		50.00%
Employee Severance \| Lyon France Workforce Reduction
Restructuring Cost and Reserve [Line Items]
Expected number of positions eliminated (as a percent)								50.00%

XML 82 R71.htm IDEA: XBRL DOCUMENT

Restructuring Costs - Severance Obligation (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2019	Jun. 30, 2018
2019 French Restructuring Obligation
Restructuring Reserve [Roll Forward]
Restructuring reserve, beginning balance		$ 0
Charges for employee severance, benefits and other		2,414
Payments		(1,332)
Foreign currency impact		20
Restructuring reserve, ending balance	$ 1,102	1,102
2019 Corporate Restructuring Obligations
Restructuring Reserve [Roll Forward]
Restructuring reserve, beginning balance		0
Charges for employee severance, benefits and other	541	2,359
Payments		(2,016)
Restructuring reserve, ending balance	343	343
Lyon France Workforce Reduction
Restructuring Reserve [Roll Forward]
Restructuring reserve, beginning balance		879	$ 1,000
Charges for employee severance, benefits and other		(168)	203
Payments		(647)	(515)
Foreign currency impact		(8)	(55)
Restructuring reserve, ending balance	$ 56	$ 56	$ 633

XML 83 R72.htm IDEA: XBRL DOCUMENT

Net Loss Per Share - Reconciliation of Basic and Diluted Calculation (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2018	Mar. 31, 2018	Jun. 30, 2019	Jun. 30, 2018
Earnings Per Share [Abstract]
Net loss	$ (8,605)	$ (13,018)	$ (3,438)	$ (12,236)	$ (21,623)	$ (15,674)
Weighted average shares:
Basic shares (in shares)	37,356		36,772		37,355	37,666
Effect of dilutive securities—options and warrants outstanding (in shares)	0		0		0	0
Diluted shares (in shares)	37,356		36,772		37,355	37,666
Net income (loss) per share - basic (in dollars per share)	$ (0.23)		$ (0.09)		$ (0.58)	$ (0.42)
Net income (loss) per share - diluted (in dollars per share)	$ (0.23)		$ (0.09)		$ (0.58)	$ (0.42)

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1337-109256

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=109256448&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1252-109256

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=109260490&loc=SL5780133-109256

+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=109256448&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109260490&loc=d3e1337-109256

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=109260490&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263

+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

XML 84 R73.htm IDEA: XBRL DOCUMENT

Net Loss Per Share - Narrative (Details) - shares	3 Months Ended		6 Months Ended
Net Loss Per Share - Narrative (Details) - shares	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Earnings Per Share [Abstract]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	20,359	18,831	20,502	15,300

XML 85 R74.htm IDEA: XBRL DOCUMENT

Comprehensive Income (Loss) - Components (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Accumulated Other Comprehensive Loss:
Beginning balance	$ (9,582)	$ 86,639	$ 2,780	$ 85,580
Net other comprehensive (loss) income	(8,250)	(3,842)	(21,055)	(16,067)
Ending balance	(17,777)	78,546	(17,777)	78,546
Foreign currency translation adjustment:
Accumulated Other Comprehensive Loss:
Beginning balance	(23,782)	(22,953)	(23,621)	(23,202)
Net other comprehensive (loss) income	62	(482)	(99)	(233)
Ending balance	(23,720)	(23,435)	(23,720)	(23,435)
Unrealized gain (loss) on marketable securities, net
Accumulated Other Comprehensive Loss:
Beginning balance	579	(302)	205	(64)
Net other comprehensive (loss) income	293	78	667	(160)
Ending balance	872	(224)	872	(224)
Accumulated Other Comprehensive Loss:
Accumulated Other Comprehensive Loss:
Beginning balance	(23,203)	(23,670)	(23,416)	(23,266)
Ending balance	$ (22,848)	$ (23,659)	$ (22,848)	$ (23,659)

XML 86 R75.htm IDEA: XBRL DOCUMENT

Comprehensive Loss - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Stockholders' Equity Note [Abstract]
Other comprehensive income (loss), tax	$ (23)	$ (11)	$ (41)	$ (70)

XML 87 R76.htm IDEA: XBRL DOCUMENT

Revenue by Product - Summary of Revenue (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019 USD ($)	Jun. 30, 2018 USD ($)	Jun. 30, 2019 USD ($) segment	Jun. 30, 2018 USD ($)
Segment Reporting [Abstract]
Number of operating segments (in segments) \| segment			1
Segment Reporting Information [Line Items]
Total revenues	$ 17,554	$ 29,230	$ 33,991	$ 62,523
Bloxiverz
Segment Reporting Information [Line Items]
Total revenues	2,358	5,544	4,926	13,035
Vazculep
Segment Reporting Information [Line Items]
Total revenues	9,410	11,377	18,883	24,338
Akovaz
Segment Reporting Information [Line Items]
Total revenues	5,946	11,875	9,738	22,092
Other
Segment Reporting Information [Line Items]
Total revenues	(160)	320	444	2,812
Product sales
Segment Reporting Information [Line Items]
Total revenues	17,554	29,116	33,991	62,277
License revenue
Segment Reporting Information [Line Items]
Total revenues	$ 0	$ 114	$ 0	$ 246

XML 88 R77.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies - Narrative (Details) $ in Millions	Jan. 27, 2019 USD ($)
Specialty Pharma
Loss Contingencies [Line Items]
Loss contingency, damages sought, value	$ 1.7

XML 89 R78.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies - Purchase Commitments (Details) - Inventories $ in Thousands	Jun. 30, 2019 USD ($)
Long-term Purchase Commitment [Line Items]
2019	$ 7,194
2020	1,320
2021	1,320
2022	1,320
2023	220
Thereafter	0
Total	$ 11,374

XML 90 R79.htm IDEA: XBRL DOCUMENT

Subsequent Events - Narrative (Details) $ in Thousands	3 Months Ended
Subsequent Events - Narrative (Details) $ in Thousands	Sep. 30, 2019 USD ($)
Scenario, Forecast
Subsequent Event [Line Items]
Increase (decrease) in related party payable	$ (3,000)

EXCEL 91 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( .=H"4\?(\\#P !," + 7W)E;',O+G)E;'.MDD^+ MPD ,Q;]*F?L:5\'#8CUYZ6U9_ )Q)OU#.Y,A$[%^>X>];+=44/ 87O+>CT?V M/S2@=AQ2V\54C'X(J32M:OP"2+8ECVG%D4)6:A:/FD=I(*+ML2'8K-<[D*F' M.>RGGD7E2B.5^S3%":4A+,*P).B0\5?UX^8 TBTH_0(:+L A#&^NQT:E8(C M-R."?S]PN -02P,$% @ YV@)3R?HAPZ" L0 ! !D;V-0&UL38Y-"\(P$$3_2NG=;BGH06) L$?!D_>0;FP@R8;-"OGYIH(? MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/ M-(X'P"J8%EQV^3O8:W7..7AKQ%/25V^9"CGIYFHQ*/B76_..7+8\#?NW_+"" MWTG] E!+ P04 " #G: E/Z;)(S>\ K @ $0 &1O8U!R;W!S+V-O M&ULS9+/:L,P#(=?9?B>R&Y&64V:R\9.&PQ6V.C-V&IK&O_!UDCZ]DNR M-J5L#["CI9\_?0+5.DH=$KZE$#&1Q7S7N]9GJ>.:'8BB!,CZ@$[EFCVB,L.%^"0U)&D8(16,29R)K::*D3*@KIC#=ZQL>OU$XPHP%; M=.@I@R@%L&:<&$]]6\,5,,((D\L_!30S<:K^B9TZP,[)/MLYU75=V553;MA! MP.?KR_NT;F%])N4U#K^RE72*N&:7R1_5X]/FF34++E8%?RCX:B,JR9=2W&]' MUQN_J[ +QN[L/S:^"#8U_+J+YAM02P,$% @ YV@)3YE&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T M$W-I=MNTF83M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY M\^XN8NB&B)3R> +]O6N[!3+UES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4? M,_@5RU2-9:,!$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA M5,+$P&IG/U9KQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M M&N#C\7@XMLO2BW A(5M>5 TR 6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T M1G*=D 4. #?$T4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH]5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J M-2S%UGB5P/&MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2. MFJW"$2M"/F(9-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$. M$9)>-T(^8LZ+D!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]07 M2N0/)J<_Z3(T!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL! M_]':-\*K^(+ .7\N?<^E[[GT/:'2MSAD M6R4)RU3393>*$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W MF)&Y"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>( M\J(A[J&&F,_#0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R M4E5@,5O& RN0HGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K> M9;'!51W/55ORL+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4X MOT4SMA*7&+SCYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5 MYYN MTB42%(JP# 4A%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+ MA=OB5,V[&KXF8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'YA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> , M?-2K6J5D*Q$_2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H: M,]6+K#F-"F]!U4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ M 5!+ P04 " #G: E/,P"_#GH" ! "0 & 'AL+W=OU?782)Z SF-I. MN/Y];<-1:B]] =O,[.PR+';1<_$J*TI5\-:P5F[#2JGN.8KDN:(-D4^\HZU^ M?P:@X:3IB'.Q^_1 M/]KB=3$G(NF!LY_U157;>/^)C@5E83!6_X4^*--PDXG6.',F M[34XWZ7BS1A%I]*0M^%>M_;>#T_29*3!!#P2\$3 ^7\)R4A()@)*;?%#9K;4 M#T21LA"\#\3@5D?,1X&>$_TRSV;1OCO[3%JCC(OH8<*,B/V P#,$FA"1 MCCT)8$A@CSTZ_E?@X",26" !*T@L/9G14YB>@O34TM,9/7->@(]8P0(9*)!Y M]-P1\!%K6& %"JP\^L81\!$HAA5R4"'W^@1W.?*;&+OF0YBE6N!61WXGXY6K F"65.!^1WX[8^\; M S!+*G#/([^C\=KY=IUF&V:K MT_%@A^U^]A<^G"V^$G&K6QFQI7PSY$]2PU_T_%Q6W^N]]\WD M1Y$?Z_OIOFE.=U%4;_>^R.HOYRJK(FG!9/4?UJ?+9K@LJ\@CCV$9% M=CA.%_/NWM=J,2]?FOQP]%^K2?U2%%GUW]+GY?E^"M.W&]\.S_NFO1$MYJ?L MV?_IF[].7ZMP%5VS[ Z%/]:'\CBI_-/]] 'N-BIN SKB[X,_UX/ODU;*8UE^ M;R]^V]U/X[9'/O?;IDV1A8]7O_)YWF8*_?BW3SJ]MMD&#K^_9?^E$Q_$/&:U M7Y7Y/X==L[^?)M/)SC]E+WGSK3S_ZGM!9CKIU?_N7WT>\+8GH8UMF=?=W\GV MI6[*HL\2NE)D/RZ?AV/W>>[SOX7) =@'X#4@M/U>@.H#U,\ _6Z [@/T9ULP M?8 A+407[=U@KK,F6\RK\CRI+NOAE+7+#NY,F*YM>[.;G>Y_83SKD\ M>FWS],CR@N 4?$MLN8(7(DHM'_M!$J=6"(+Q]L&5IQ00/KP89+-NTENNJG$ ML5)=O!K&HQROQ7C=Q>MAO")C?4%LAQPO ^F,T60T.(4ILDGAE%)I2H9MPRF+ M!I6LRXBZ#!\7+<=;,=[R<3%D7"Z(&6JQ2!>) !D@T)I#-DD2,B@<@ACB$5%. M%.6X*$M$.:&5,)%$E4!!DM+)%BAGD4XVIQ 2/?(0)**NA.MR1%?"A]@9,L0K M#J%+-'D>UIP"AS%Y'C:<"BMX\#S::6&V/63LSY'1-;*HY3ANUOG$&GZ#*4J'BDDH*X$SX 5 )F$UD8!"C6?/6VR)@>>7=%V9D@=R9T M4U[VS(?J1(RK$S&N3L1&UIP1\ P!;K=K 5,.MX1,(LX9I%0WG21;[J#J;S-(&]KF'YZA)6\ M>RCA;9:.L.)UG/H9 0$@4[#^.,]&0%#3=1L-3F$+7SUW1^+U9%N^')MV, 9W MK\?N#]B>XI+[2[A;@7!_#7>;RZ'ZS_27,_X_LNKY<*PGCV73E$5WPOM4EHT/ M?0\U=#K9^VQWO%[=3E;OUPTY:G_W2"Z_GBQ^!]02P,$% @ MYV@)3T$DQS2L @ ( D !@ !X;"]W;W)K12)W8DV1-RQCK;JGP/C#9%JR8^1 MZ#@E>T-JZ@C$,8X:4K7A:F%L#WRU8&=95RU]X($X-PWAOTM:L^LR3,(WPV-U M/$EMB%:+CASI$Y7?NP>N5M'H95\UM!45:P-.#\OP/IEO"XTW@!\5O8K)>Z"5 M/#/VHA=?]LLPU@G1FNZD]D#4XT+7M*ZU(Y7&K\%G.(;4Q.G[F_=/1KO2\DP$ M7;/Z9[67IV68A\&>'LBYEH_L^ID.>E 8#.*_T@NM%5QGHF+L6"W,;[ ["\F: MP8M*I2&O_;-JS?,Z^'^C^0E@(("1H&)_1( # ;X3T@\)Z4!(_S<"&@C(BA#U MVDTQ-T22U8*S:\#[[= 1O>N2.5+MVFFCZ8[Y3]53*.MEA? BNF@_ Z3L(6 " M@?$M9.-"DA$1J?AC$L"71 D<.K@-L'81,+%R^*>3[8=.;M*$WEI!PX?36F5^ M?NKEIX:?3OAI8=6ZAV #:0UDEN,86=7PH& *@B:I(GM3>)"9FEN@38>4&'%VGHP $*_H,PK*',$ M8>O,E)D3!!16;]8N)K.[[$(PSBP]+F:63/*YT9-[]>2N'NO\E;D3!")[X[J8 M61JGEB(7A+"E>NMQ!(N_=*CP*BI<1=96*0O/803(ZN/:@X)Y:F\[#PHDL5V@ MK0>F.H7MSTPT^;PWE!_-K!7!CIU;J<_AQ#J.\WN@QX-E+Y/Y.O'8-VK\]]/Z MW7U_=_A&^+%J1?#,I!I*9G0<&)-491_?J8:' M3 ):&U/;A.W?US8.2PA*]R7V#.>0*V_'+E@1&E3G+!L!)"#)3&*0]]?8$:JVLM3Z]N)/.6MHE4-.X%DRQ@1 M?U= >9=Y@7=QO%2G4AD'SM.&G. 'J)_-3F@+#RJ'BD$M*UXC PJ6V]C@ M+>!7!9T

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
:3&.J'?VVC!2]5NVQ; 3@A.*#"; MG8527D&MB!8CWJ;1!K#DD];]0)2].640WL+!4=]52MMV]W(D(? 'G9QI^-6R MV\XXX=XJIV:+MJF!8M2I'*UM7&DP^'702XZ\_@YF3JJ_.8$#N$NR3/+A_G.7 M/DG1+JQBP+E*\/W'595KSJ1V6"5)G]'>%MYO;$AU.)#NWL!::#'Z5&++,5!: M!J71S4)<%>,)/%];O3J_G5U@2 W,XP4Y59(Y:IO)WP/MO[NO #A3.TF,]M8!ZI[GZ:]-X MG-'3ZBV&0@2G,![=<#W:D4)=@*UP$6"E.VTT1FB&>F+>)1MTK5 L\661E/>@ M4&[$12JMW$U8O!T8VS)@3SC.DA1FK4,JG/I?&\XIZ7MPF^E3G\.+G4I"/JEB MP-'K]'FX:4%>5_/:>?FSAVL6Z(:]$/$C,H*2><5531!B;6.SVNXIZ$NCE'7E M=$?,KP5Q,S]0,4CKD>#.T;2STU\_TC2+Z+4=O MKINS9S 5MDR6;B$4-P[8>2T$)$RH!88>=QA\X)S@U+0TDA9H2KVDS!:F^C(K M\38(N\8M4#%_32SF'!TC[:71+N- 4$37SN.MG0#2V=K=U7D7I;[;$F] ![ G M2\2URCPF1F&^#DR9>,5-LNY+38]ULQ"UC[TB)!E(@*2\L" M!:Y;Y*87RY>>&]I=FUT$"Z!UT9.E\K8E:*&9_U]R:Y7#R MG@H0ZMM<74!R!*Q,)KG&$KS>NK4])^(@WWL9J7$B@^!'JI_0&OKP55+P[UKM M/(W\!O8WX)?VA80[.Q=<58P(#H:Y3N?#07#J>"ZH[(76P71KP#!QU/J?.5\? MR(Q/V'-28_[R2IS&5;*1>HH4N+_-RY*=NI1TL:LH9<#V6[81UQSX_25.D_N< M*ZTY)@8ZC37H\>3KR80,.U(RB[^PLIO?1YOMFRMC F>A#D<[._M_&<>MRZC" MHGE.YSSI9('K?;:\GTCP?L)3YWI(&U5/+U%DS\0TP.IXY>QH?]*W,H.>!9M M$[0T>DD\[ZKU(!0O+78/U\P])X''@8*PQE,,2K^8I;AE"XFOU#'3QPL9R((# M&]4\=-F#9*()U%\72,("0)%U%0I4\2/_0HB2K @)5'\9=-GC046AFMWE;:M@H0OPSX&P<==(62Q=&HNY9FC!W!%2[^& MY4F3]QD;KU.>SQT:6&@HA4G@NM$,UWS5/8 U%9_Y)%ES6"5W94FW:V]^E!I( M;HF\7RL<^MISIV%'JH;#PW\$KT=#^Z54P/[^>BTS,*Y)RT+_]_-.O[Z4IJE5 MDZ+2H5)$#90@/!JG '>J-<(T]QMOY3$OOL#=KZ@:#W[QT^]_.YY,WF0),/1X M]S74*-022SBI[->Y9-=/0.DD6@(**4:&,4J8+(3B7XIQ$KAZ\@XY%9-+C'CC M 87$4LFE["[7$[_=T6^XQ2PVN8>E;LC@)*-$>1ZW3[1V/L#9+P&6HZ$LF.-7C+#C5P/CQK(W1F ]:)>!)B!TV0J=) M(HE)3[):UTTHR%AW4"X&-?A1AVW=O$A(11#"MHG%9,'>"V>21J6SYPO2H?!N MJTWBF]V@K4NK+4"_I@3=%YXJ*$W3T10;5;E5R&>@1SF64.K@HYS7U.(FA]MC M3+:46AP46VYJ)F',;"U*6T9-MMCJ$;::74?6DA37QIH%EH0H/:ZK"H0?%L;Y M$ATE]L7%)E_ON20K3(41'/EIS*I=U6&?XV;?>*]^I20;""%4J MS/%6(JTXFV+UI"P#)*V#%JEG0*6JAE2U:\]!M!0=/-86:E.NV5J#_)/Q$.@E=E)[%D M%H@G)7Y2M6S,Z/$X1L>R?.?R/@*N$8&1I]QAF0K&5FU(L7YFGT[DQ"1X3.V+"Q/AC M:\C^;\,&A]_/!D7]=R!?2?I^5CB=S-1,WL&K%O/)K\$J&VC;RCF[T-CE3U.G MA>.S8= OX;&M+!:CQ?8P2ZR(+U*STL+#G\_@,<4_O6O?+&9/&O.\1_GH!RF%C2=7__)203 MO$DKF8S#(>74O5#\P.2[O5NMRQ[XPC]*XJ@+%P..+W]..6WCL<#$Z^PY1%[EL!D\HF<]\692QGQKMJXNSDA7?1$D:@"JXE)Q&=7UY?G)U] MNC@B.PVNA>O)$[\&\AL#V_K M*, ;L51V/L4DN]Z,(MR[E,#>"3TS>SDUGLVIN\/D&9#2EVL--GY%Q8^/@(HT M2Z2ZEQO35KN4+JEAT\3:!I37?@7CW: L47\"JWB2B\4\L<> V1P.3>O)BLRV ME(D.)$ED%FS+$Z4KZ?8)E'L-0$[^&/.P2"5:_SS0^N?9CB1ZN#4:JD0_!](< M>EOPD1V/9*\>!.=)NF,B6DD3;L7[0]?COZ4]9W78EZ[GXBL6-><(:,V[.)+23-H_4O.YLQ+A%<1K7^RE-NP&Z@DZ[P#CR(GR50<7U8^.S+' M,NH.V:-5AQ7FOK1NZ,X,M!1-NVKBJHB-23S,SGB/[FPJL]@2M=$O6DL,]. MM*^G)O#-\:0M](@X4;XK(VI"X[=G_+82&DVJWUXVXX,N'0L4A'-*V*?2(U-* MDL=\GG.OGG3;T6UB);G!R#QC7'S+OCXS'_-<-_YO.YU%S M\S3 8/O#BZIGR! ?-EQ%A<(($SJF;=XQ,D\UP*T*8]>_RH$.6.V')F'O"R"\ MHJH9^]<1+M%+JA,E%L MA5RZ+7P'I-=$N:K"@M0;BTC9VE8+K4$#WW/3"OZ,!>F91+6=JB]HS\=!;TIC M]JC\&+P_"D+(Q!0$A/G$HH4K?O % MM>U[1HIL;S+DK8^'U 6$RO1W;5*;"=*4YNI[K\83K,/\:C2B?Z8C*1?ZZGAX MA(!1:Q&/57R.3X+Y'&OSS(>=YW)"*?5P)5SKR_OS]! @KQ_S.#R9GMB[G2W, MG3>__W1O):]VT]FS.O&M*<#J1^EPT# %SMF>J5@>_U#D11)5:\5(];NEAJ=M MW-L,U*':U:@'2B1P@U[%=V0ILV%B^\)^ZJ,UBMC:#FH%* MGE&BQ]PD(2^'PNGBO?5RG9WL"1L:2:&!F.&XQLJT6E9%,YEM/+CMY561#W%; M)(!!(.)N\_0)T]OY 9O+XZ6_&E XNT_B6Z<[R7F\XHSZ]]&7F)+<"( N/LKK M%Q\#[3HK[0?8,TI5I+WBPE'=S()QRQ5E_\6E">*,M*<LI M70\-0 GH,APXI3Y9;O!KFQ_4+/+.?;F22^,\S "D:):@"Z412#>PE7PC>H$ M-UPE@!8 ;LGYYWYT:Q:YV?-V69EIT$!6PR+'E"12_I^VK%9+>0*R.TA_>WR4 M=195V$S>3IP])$6>V=[ =5YKFI9&4KV%T^"D<8H4A&?K2FD7^JV,\-H943"K MG>_]D.9?@2H4?T?Z#:(M5:,-9],I]5-;C-'N-YJ$0V 6(2C$2@-DW"Q& %K#+&%C2;[R>G9QDZC MJ>U/,[7-:>1$7NF@KW#8\61(W6MIX%EP7&*,9$K"O?G0%&T2-@D?NGL M+?S$E.VW?IPT>L36E;PXX$#)QO.TZA6:0/L0J4Q)M?:2[!?0_T,3>1TZ!#HD M"P5HI)>R)4)I?(<,-A8;CQJSCTSC M 'AT1T6!2(3&Q X>8Q5E'-AA&G:;UA(M,>D2E.,79B&.Z#1L=4R%WIZXL3K) M5YR(]12D!LC" ).DM04*"@I^9VSTO-'Y$Q&-A?+2%7BKM^$J8CLTTD>T1M/9 MKR@L:?2TMGFH!76'MGL'61Q3S*9<4SL>![>N+4!K^!0'1KTD+FH)TL M=1;E MC!]AX_?1%@VJHQ&P8_/^"F4,-M,B/CKYTC?8]X.RU;A(BU,LS:TO,M=H# [\ MIX%,8V;Y44[$^F74Y>1$YR<9T%NN MSDFI?7!]6F\");FDD/+=U"3*C5LC%,"YP^:^J:N!<0PC!>*L?,W@PPW)&N0O MO3J+[XY_?HMJ*BI[\G#M,D*1B=GL93$BB%!M*JOF^M"HN .Q(2*Y,D4[9_0D MJ(U811V3#QMGB[(]24V.6;I^64C9D.01 CXFV!WVAQ@SS!#W&.:DI03>HSNU MIKVW[\'I*Q39)!G,2]A1U_*'/*6VX?67PV"95Y2ES(,K2>::=88YT37I.=$9 MN4Z'VBT, ,"E$X%9_B"X$=VF3-^+VX5_?F*W[4> M%G%+Z6HQ)<*>FLTDP%(VLJQZX22J$T2>FL=6F2*RF*@H630Q!VOR@XS1>D[:06"&RPPG)AW#-SX ME;/T*0.8!+Q<#<.F]]4.](A9ZSJ^9?M;XP9Q??3(!DM[<,)<(0*<$B,Y!E>1 MHE8O[MFU3R_T8HU&B8+5HE]VZSM](\LS;Y"ZV/'R\_]$EDND@P!Z&+D3KQNC M>'!(6V7VA/2"-^Y"R$O!+46'$F<7EK&N HG !F@:FMRWVSA*/7HQ\$NVS91I MMP(3+3/O\XU2ZY$-H3OZ$Y%L,E 8^J2\2GBDXSMTB*HCI[6P=5K>^\A=&4ES MF]S$.0'/3,A/' MO3S8Z,7N!71AQ5E>_<#2J&J*"NVVNY4QYSSG3%EJ=2?4? MF;-3G+I#X,[R2IS2C3/E=$/_MBT;*8Q7[/B- 6Y3@48S>P=V.AY(5([&9 ), M>HL6FARO.'5Y>D"YTJ/21FZ.)0;/M.QIM6?I6BWYVV6V69R00O_LCCOA#H^/ MWC/;).&!<0>1Y=5HVX>A98O\5JB5UB00?M5NE,+T(,8N&K$K7'_&H._VJ7DH><: U9' B$(-.@=>E*4Y M.&6[*V<.O D-2;E%C>\^-D8S=HY19:T$!;Q[TP)(_&:/B!%D97:,?[].&S72 M&.#56@BZNW3Q3>&M.<6W0C3G;Z*OE.[^-ZS^)%%CV=HMA,NVAP3KD:) *5$% MFJ.2)K=&\+1&#%;ME5^BJ/\8<;--NZJPUK?#>- P=T1=9HX._]I6%7"NWC;$ MDEY-Q^$(:RP/QT,LG0K_I0HHYN/8?IP$P$^I'F<UVU_/+67-9BL/F-JNVE'IG_%Z_/IP5+>.&"L2HYN[=0Q_ MP%)?,E&&!O.TU9KTONUU$;4[7S/)XJG?XLB-8[5Y/RWW,'P=U)I2U7VL'>?_ MKSAW\53H3COCUTQJ7ROH>5MN;2/7N>EO<[LU#T+.863R\=GIW_"9.3U,+U 8 M;;KXZP_LL0TWGW6^@0W7J**S?_*W8#VTQX@](M+D$ \AD=*F7+H18RGK1CH- MI&-0?DF76WRBWBA;E:3[O.32*$Y])60A!E MU V 2TJG*Z,9>R7UCRCSXIF)FLD6DIW7G\W5&MG*,IJ.P83+18H_XD7S_&]6^ NIFO\D*_ MW5D3"QF8EL"6$9E*(Y_4?+)2F9)K!L;#)%.C5(25T)$*_HZ>@)(C(,RC>,M,X7> MQ?D-AT&LHBH"?>[K4ZT,V*-IL\Q!.%A=**'N.HB.!*IKV+DTE!4N9% .=35< MB5.E6<[3BU+6"\R,K8GG1,4"!M>K[GU^?WZ$:'Q71)M!W3-U'T=K"2/FE9SO M@+?!%FQ%S/9$QBA(D.#2LWE,W!! G MCSV*]$!-'A\'$0'V *#*H$52ZG[Q%.BVJ4(J6@Q*53)0.8%Y^AD&MJ5/;KE) M,E;GZP2$R?SKTQ*I2&LPP!,L?P6?=YNM5-C&# !P,\ MG2Z0LE W$ A&@L>Y$E@RB4HJ2>,7OHI.J$83-CQR?7'SJ?_Q0PWV7,92[I8@ MZW"!%31QT_Z<IF M8?#YYHH*\P=1"K2X3R"WC*NH'ZT+]!O?8=S%78XD5"Q](- 2L=K>XY@2)T,* MT!WGRD454\XU D*\;@=OA;J4\I1 @$(6>?]$M)P#ZE?:BU@N7^^4CEV.*IUD:_NT[Q %<7;D=[E*'#N$+,AMQCBK9?YO??# M)A]V6V@E"J)%#Q'2QU1])_ON[D(L0\AQ)(@D=()3$-Y,_(F%=N%L=MHNZD L M)BI;&1Q2C%:^)>8+S3\FPFXQDA!R)N4NN*HVK.,!H:I673N48"% D+ND9!;H MO8:\<-5\"X,0TE6(TUKOS$C+M8I<)!V#MVFTJNF4)1?*B,FX\0-"'*I?(SQ6 M8)WW&-=?H7?))EB#6O,E1/M"^K3*<^+/S*>)_@BK5OYI0[7N,:A+,L%@UN%H MU)_,)OU1?WHRZX_&PR$O]C%>4JHR/.)SY%#2P4B9YQO%K)CIA MB\H60#DIG(2%,-@3Z=LQ!J04N>( V^987BF"VUTAEC%1-DGPO+'!Y3CMA30< M]A*,U=%S<>;5>2%C6TIYAV0NHD+]YD!D$H&8B&6;,EX-[O*'AM#%?LR5](= M#TM;*XG!Z0!IG^1S8A40KG16\3^P@3Q[VM@:9SQ(HR6+7WB&I;-^E?=5P .@ MSSZIQ;UE_F[Y$84;PRB]PKR602U.=T&W)!$/(=M_@5-I? :,(G,@$,G_X MQ0OX"+A4\:/)K$*TDB7YJ5C R-FXS-DZ6/&Q4-*' JJX.4[AC%'AA#.CB!@* M)>'W3T&U.)):[ R:E(",1)A*>F*%9#?GAZ=%MY-:KOVEN)J>%H%X-EYJ0;=&GR/O;8P>#E?XS:;71N M\PVG9W 0+5K=2MP;QY^MT:NA*4*%W8"E%]Y6FZY%12XG3@5O)?Y:V;@4&)B: MA:!10E0(.)0U2)<)(%BTQ%A#YU8I7B2NI H '*48VFP.Z2IBB5JVBI3O.K;, MFB*G75K09:O<HL5AYW::Y5L] ?2:1Z,KY[2D18?,; ,"0*S/A96:BIW0/9O3>VCSVENRA ML5G!.B^VK7*-$MA7[IJ@=6V,NIQ?=$P4.>[C(BC^W.-,TW6%XI2^X88[ M+Z,VUEGTM $:+@ UZ #CH/=,[QD??(^D8BI+SBZZBZ(/.+"*'3&=XQZGH2(.]@"Z3&;: MGL(T@19Z8SH@3QART+HSM$M=4XGXX2L-N_4,DQ>VOF)_2"1_T$!/$%Q;[ MB)K^7%/ICJQT!?E234(F,R0MN7=RN!Q(R/J%C^>GJ*=AF5N8JHF+4QY M%RL[IR#VK%)TE>%OUYRK@IART_^? 7$"W"A[CM!%N,ZI@+3Z(A%BO%0B4';R MO,HHZ5MF)JG)K(ID2%/VJ#UWK3#2\-HI$,Z>43@ BDN3%AG,F8O6 Z5SA& M[3SWG2X]Z<=8WFL9$= ,Z1):.X$=[K2FG ES:/62."_UFQXND'S7M<"J M+S=)DH*57]2VP14W\&YMLFR)/0*I>R 9?#*J3*]>\")6HY[SPI')' A-[L8V MR438M"7J,7$4U5KV"15H.L;Z^EN'$'4)? =G"8C)W20*J&UL3;A(WJ9&MB3E MOEF7*457VM02/E"B0+9P>^G69)&:'SC2M:R)8R^96.F$6L9?#X$M7V3$HXR, M6T^?;4/%*, M$(:MB-6!DX.%1AFBT3+G&[9+8@H #;../5+;DC3KF O&L6BI#YG\ M0NED21K]*N?,;8[C*W4K(6>4 66CF #*$ >ID\LK8@]C+/TI^5A.L"C+;D98 MP-2(8B;F2 M(K'=)D9N-TRA0PJT=SE*!]CZ,RX>,( 5I,'<5E!0@DMQ"9%U>^NR#8YXYT!G M[8>12615UP68@WDTNQ;3M*;$DVFLK.)MR0VA+[GSF(9]\S7WRB-UHNOA /0L MIM+]SWNGZW!E:3KD&[&JG'M'XK;1H3QB%SV/PRL!IGKA5< M?&CI47OR(_8I,V I*)3'CO+K='8IV[;KKHY6=,'W%+T:B,FA1BTTR*U00J+V7IQP=V$:[DD; M-R"<5)&Q96$^''':B,)PLA8%@A8#E$,;)TD6B1Z7W9@5P20"+E1:R3U<8V=RRCB4@=SV'5 M!"6S U.$YH;X-*4DZ>;=;95QFCHE2FSX@;7(Y3 #%*(&BG02?=,6=[V=RFF MZ&!;D\,4+FOU*V0DI5N2V6"R82?Y$@-MRSJKZ*BWHE8W"KDIL1B*>+UWW*=X M%2?;2EUE%C-.2XXRP[]1XA)PK4DYH W"$\53NZYH0H2=S=7RAB/*4XG9(LH@ MXEH;* VG2"@S.:IL"3:,1O;&54>[_S(+G1H1S&*:O%7$H/]2X0 *1%A&JR_P MA[9=U-Z#)5[4DI-[;5D*V0FROH@<:Q2X4+@QU+;_LM-7]!X4PKR@@P-1.VIT MI!9;&V"[*$\B08JNSOJ^(XG[K9OM^C1%4Q8F*QB8\BHJUKD(P);8A+WF]"_F M.Z(-I& JD>^JOA5E3>J4F\:PATH*/Q$#<*4I6$*2M70 DDV-(Q>^)+J V:78 M3EJ,][@;=H0R0M12A1S(5\#0VZX%)Z# F5$5#(I"S;5%N8@ZKRD4#+0_V!(G M)>RV<'J9V93T!/?ZB]NZ0F$M@;M%!1#G+D)9GP&IUMJXM-%5O%&C/*AR!0>8 M^L5TF-E%UIJ+,+XKW?JVCBT;P<;^?ZY?T:%KD1QD*>[;!DA[ A&&X31GI;D<.'09R7+/N N\S-).'H1[JK:R<*'>MGFK_-AQ:8CZ0G!QG_ M1$NB#O:P*/$SHE(EO%0-4?:HBN9JVB!'"O'[7]K 7V]AO^KE&C4KQS0'T5'8 M,R=4:AE7C_$S"JP4W\JP&#D1%098LWG;2DHRB[3"9AP5J-BQG1'["V 6O'W, M5!LW=)EB5VQ1SLCIJJ.U=4WMSCAY(&A*;EUU*+%=#6N$P5C#5!V4)&\R%-1O ME$#/@B1Y:QLW9,4Q?\V1+=YFNL;9D^I\=N].M*H07S2E%T<.S?N98H =\U0H M#*(-5C%,F 1-7^_'#(0'#$_'FCIY41K37QN!=# >418((9L$Q0=6+_^!CM(= M%35QW>YA('465E*K1Q*RXH?8.OL [LCLR.2:Z0N[A@$(L"?\VO*HY>Y)[?N* M,5NJHH0)?1^Y+J>>C#D/M^-!?9M+ZAA@J' =S3TZH6C>^-*(XDS M[ABYVBWS()7VY$#]"9"(2":E:=6$"L4Z09RW$EU]:V97@^#R5H=VA%J2Q!D# M'LA5_.Q M>9O^JQ;7K;!%)I=8AUXV!]$=$!/L_H4Z-&$DF K R?3.RU:&41+==*BU/7 MBGNJ+DFN7X8G'';%;=JE^HOS K;_I?+# 9K[F(\*4 M:\'4E@B[$F]- '!)9JV2""*\IWKYW!F#SY4YHQ0C]3= "E!6@8M(,5M)?F+9 M8JW52XT6X6H.5G61!!(72TP\!Q$9I/V>)-%*'=%JBM5IZI>KFH(2LF8M$;:! MB(6X75X1*K-71H%K /CAA!,UGD0;!_Y% E0D: 7^T+DWRO_T,*N-B+4(+8-# M8,B7RF5MI%QCZ&74E'"LZK]/M:X;;QKTO-7TA!P%[P6U[0UN?]MIQ?8K@8N& MWA(W^2\U(_6;=B3Q+W48DYZW)7V#IRATKT83 MU2\PPE=<3(5]W(A_2DG,%^C^$ $::Z5S4BZWQ36[E['9:&>-I:HYM7AWQ-54 MDW>DMU9IR_;9.O&D5WK%U%?4I"M>=[E6/!\5G(.(_<^_Z/IDI 03D8P"*0AH M$7G"@2WTK09(F.=X2ZZ;6]IU800AM9^2 IM &:2-"0@RV[QDD[\" #[DF9KV M D!-X)'T>CXUGC06VLJS4J9583HD"/G6O9C@QM 50;V!:E7[Z_3>\>A3\%ET M!_/>177IZ5,+&FJM#2GM[\I:Y<'&55>S!&V)@YMK+9>)<9F*_JJQ1>2%Y?T8 M'RP#7BBR8XCW3"4J<>O8/9<(-)NQ7+9EHS<9-6ZQO FG5'>D9-V5#\#MR"_ M\8P9NS5U"=6[=C(KG"X63N5"*=?E>Q#7.44]5Y;>N!)MM'[0YIQ8MBY9:9R> M;\ZH-*R,1/(L-U!@W,2<<2@-UHRUP;.2-@5HW[+K^5.XL+0ON_BQ 4%#)\'5:)\#7IF+;E8,KMH,K M 81GSO)IH=61;.P%G44'CW'=69Y$UFZ$M$J>FM+<&Z%MLDVM8SI+(-')3>XP M;[%KRN[<8H\0K.NGD<.-%L$4TR "CN$ME?C5V$%S 54M)4CQ^676Z+-U MK/"]46 +)VKNB0?(F:EU\ W5'VL16-Q^$*U-'D]H$N4JYV9W;@B=U@;ER_+) M/&(=)8?':]>-P\]S.CF;EM9* 1,#'43(*U0A12Y9%6W11RTYQ*>K)%4V/HO'Z48K" MIK7<4KRB4D*M\>8EG3")[E@UG>=A!\8GLU_0:X1WOL6<@I^ E6->*H$+1U5^ MPK4TZW3=8*W7';-%^VH8G-JT;[="H@Q)AH1KDPQ!257UD3_=M_1NH])BM'[2 M%-HB%17*2?6B#(D'VDW.2I_.R2V!'*.NFL[L&_<)''JQNG\*>N\0.\C'B!+9 MY,BW_279=E=)60ZNYYWNO/H?J$K2#7#"WTORQ,K7;94_Y;M&\XN@_?I@$-F! M_#N6?R>=W[]OZXH6](P\, ^.M"^?\SOVSQE.L)^.EMET/RW"T736^MM[P)$G M-2.CN%D&TV,8:=+HK#D;AXO%O/&UK>>QS/%M_7X2SN?3QM/S<#)9F+]^1#)- M78S XC_/"R0;VS"X. M^TF1Z8PNMN63[$DRR!]_]>H7NTE1\LSMWH?)T!39[$=5=55UU:^2.F6TTJ1) MG#FLH+T"?\N:N"A:Z[?+()"?6<.4B^2%EBHKXJRHAWYLXJ9(I(^VD_#@MOK, M;U&?!2LR10B=*MB08^#$8]+8"8V$2=4TUFLC^GIW>[)] *7^/_[T(-ZG/X5D MT)8*2 9UP87_Z5[=V?I'L6V(Y;>@7[/'[FQ"!7.Z<&GGO3>"2X)""G1%PL@#M(T*@MH%$MQD7 89?\R M3A%-&%J?8;U'E@+C; [L2-6[^!O,[ ILN$KCO$)6:-.*AI9S%4GDX3(-K,G_ MT:RG29PFJ3OM;5E1WUAJ!Z8=1'$-87&JYKU-J8(QT%":TKS#JK#P:Y.X M;)-H3*2<67[M=VB4X_2]0OW] )W%>(9MW80QP S[DF9K%28E9&2[.JDXIT7A M6.P0/NP8,+K.1S?I =VIP:F8/C(J+-:"(B1$S4=I-J9WA(8LTVN%^Q, R4] MC?X+TRS3XY(N@(B.81?BR[<(P*:./O1=7L(^31U%=5Y2^;XV:P>VE@GLK<5% M7+>-^2NO)G%ZD56@$]:EKXZX7 _45J7$2463.UW$+ZE-O4],YU+$8^K.IY[_ M%J)* YHF&\-*F;SZ([$@&,O)"_QX!!TO(YBALO;=$E-V$L: 1PUX0Y'^ MOI]?=[V_Z0047 7*S['Z2 %I5M/ND-5)=+GXHITKJ$,649DD>B&RN"(I!X.I MO?E^"PU2B@6.Z=S4]Q)39I(%A*4.NN,+.LSWFIBL^K')^A$ KIXD[$+#9]*9\DBPABOL\5F0Z;0*1^+3WKQ'.9D MM2$^#K5Q.C8CL&$N!;O!@"$:"%J0!JKP15B2F*LZCU/>0D#!D K+LZH"_JT= M77K7]S2N(^QM"0B'&>S 38YMI#&6:K9N%Z0C:(LCKC*UKXU3P9%JY,AJ_4C: M/XH:4&VX-'1:QX7L]?90^$L_C]/:B:&*(RR+6K2N%J%O!7[SGN)1[:+NYW_G M$<0H4Y +9*RV#HN:)@4R M(]2/$\434BRC24LNE=&D!1?*T-L4ELJP_M#F=G\H%Y1%.B@#46"!?BC0&0Q# M37[LT%:T''K80K^Q44,D'"%6WFD^G'?K<:H*H\KALM/'XI86IQ+2&@>68,49 M/.YK=,>EACN[U#![E.UUN="C4,6+0^^)9+T::%9^-O6PK;D!+D6>S-N"A%"+ MR>K\LRHNGX%JG8+:5"J[7+],M7Y1[ZCR@MKYNW(MVA_H>=MKXLZS$TU_>N"3R_6-S?HZ;Y9+"6@\I[B+&[7CQ@0^9[P\$#>(SCK0L>A MH+ MOUWK(7B._,"80MCN DRB,+95T.6&SS5QO@B)LC>3-DZW>M49FAH-+A0QA11$ M3;)2G[;[8]=/,I?$/R9@ @]Y[%E#AA4!$W(EJ=H_,60 M+ZBIG25FUF5U6 MJ"T;A_%T% D:$AE90"<&B[,"FUD0Q(P)Z \,-55X='2_XOWH'8P(*SQ==E3> M^H,-E>#-P#])C$<_X5Y#&,E>P96?=6XSXTUPUSX]K:XY7?E./K?AS_7+4&'8 M $.C&C&C3$A?K\3E4R+4E$\*K)RL$%@EL(FK-4H:LT:-6J-:K5'IK!'^M%9:!;W)OOG?4W)ED&KAO6F>Y'B]4TV%$X.(:$$IX4;VCOGG=6!#.*/,1B8R9"3ZD5CUZB_=;.^$Q6PCQW:,0:AL$RAFB\W],1[;:5HZ!ET* M&OIQ":]ZZ,J(?PKF: GP9@B9"DQ5@!62 MM95M@D!K354)*X6)5(X(T**(ZZ1VAI;#OW(FP&)191^H+736@M&#CK]9$V<5 M&EDB67=P!GP"W7YD!I1QV^31OYZ7&*E."+4-\Q%KC/\*3G)[]_^5C8JXK'!C MF&7 3\Q&L[RN>X=;S^.CI&B@?6I4\U$SE8W:NE*^?OURMIN'ZKAL6COMY:2 MXAA>PL[\F3&85LO/%C+RQ?QB?C;7&$SNO_R89[4Z1;+5@DA.% M3W9W#[?K;Q19>;JE=3%AIQ:;N///NI<$@4FN=21EIS"YP^,H"DW$A[/D!P;- M_^:6JE,IWS0PU6EKBDU6YT]NP+0 U# X/85B=9N'[A&/FW1=0M Y<=3]VGB! M))8M6UCA]N;$EM8L+1Q#+^<3DQO%ZTYK Q;JQ10B=YP]!XG M?OT PJDD6XSR_3:>, @EQ3,2/:95F*5:1.F\+G_0+4AT">6F*0RUD>6($)C@ MMJ\<9045A( QWW<6I"NEUPS/42\L$'[ Z3(R<:&.02Q>6+G9QUSW1>4H,E2% M+/3K'AD1.+N]E);5O==2:J'[GQU6*5_B3OX.Z;OB!W>DM!":\QQUB[=;]0A@4^!'IWA?LT5G 7Q%T=)4G5-#98 MR48.EK(DSLDY'U2A,)BJA/9@'",&D [*F3!$I9&/C!"_5PRI=#JB!Y\<:,35 MH0UA ;VZY]YN'P?KXIH$0''U@HHUL4TU[L-=PYZ?JU=W>(K]CP\.6_HDXC % M1+'B]5XGSO2D!)(-_]BKPS&'I\_=2QDP04O2('TRRQKEBG MI%ZI)#>&%]ANGXC;Q&&/ FF689!,B:HFT&!2HJ**)W1+=4)G^F1RYO4A0)2" MOEG!ZRFHFU6KHCSHTWC2EA;DZ^;*M/ALC=8K/(O$[JJ^=\:).$,_.#$JLG)O MGH_XFSG'TX'IG1H8%.L5)XU,&DK9*I,)S.(\R^4^+#X]XR)7MW$#FW)-IE(5HY,! MQ'"3DBSG;N&Z-U1+-R@R>A5=F M>3LOZ"(KY2)-^2?3@KM/W>,&1%G($N,0J\#O%_,:^I<,L^XDS!(^#^&#.IL')PD2;A$_82_.,,.\!LR M3GZ3V(]AS]:,T&0X1XO'F^Z:SF[AL_1R.D\BZD2*?R7SW!N+MBO4AC_+N>?6 M6#)HQ;G#FT<##V(_&Y[^ CZ)WT!B, QHL0>1$,AH[DS+7:MX=&DA1*2?5IFH MQ\A#6Y\6010TI8BJHI:++"ZS2EUF+=Z=1)>SFJ0>"K-4.7124+[P8IPP<[!6 MVRBE@ ?PG0_3 M7EH!XS?P7YM%9=+L1VN@5,QRU-(SF+VR]OKG45A6FGR# H;IAO7/R@8'7(-% M.FOH1%)G[R(JG%G5D%E ;NSD"&S10E MX@-6ZUE=*]#8&QVF5;(&,49?06S&_TY6HFG;UE&;I:9H51^?'I]?;L (?+1?P]C%K,FCJU_ M9%*Z*IF.5BI+#OJ*2+@LRK)2QS4"?U=XCM2$3B_ME;=)!R,K[D5W#I,8_'Z\ M[[J\4@FM.,Z%? @9DQSP"46<97F<@#RRU7(:ZA9)OZ[EW\GK$1? DF@\U-&E MPO$AV =#:F3:^\6]T^8=,UG+W91! Q3+RL4E4VKXGYAN@L30YZ#]EBCN917 M0"^CTWRZ7&ZP/.?%<,2#>D2SPJZ)52\XDA1)O"TJ"G9N@>350UB"#<_E":UD M&]5-2^?CK7X Y=[F24V$-:.D'L<%;#!-W6HP&1NXX@M&I1.B";5AF*D MTLY/ MB;ZD0G4*XT:;5GT[B,+I#'+0 YBM7MKM7D%S8N%(Y41W/"9O7YY2KDYR<3DC M1VY [\^CC8=K*.),^(^\U'+(!"/'[9+\>WKIS1;)[)*!;"V,3Q%U4#K%? ,F M\NK3O;A>EH2TBUR8)=,ZJ>: @GF2+.R6_D-69L=Z:$_T";N.IRT,O;'WZJ" M/1)I>, *S5 Y!N46%'"S0%6!>NZL)#D^M$JSAIXIC/#M5- MM'&0"CYU,J@3 C18JB'F-1! A5IC#=HO_57B_ZJJ$G<$X6+C+%*%(#=E./M1 M$QM/-I867.LR[@M&[["GD448=/8]^?G[J6G]_[^2Y9O0V_?>"H-URX1P1 XE MF:!DGK3JJFS4%5FWP284!4UL))1]L.E^0? [XUB=X;J_F)8R;J4(7K)WYZ#G=%]:'E(2P/[1G&L+XX:EVAZ!NQ_Z'@_EHUPSAS(0YR]N"Z/1> M:O*: T-@F>[3ZOZ>D3E8+B+7H:O=G "TRJT&]SFDD:\Q7(E)*S2KLUNB!'&\ M5%DT*ZC-&1W.P/NY)8Q=F4L=R!+]H2(O];5__V.UD\MI)O+A H7&7 MI!C,\H2'GB44(TI!7$.#5%D@]$F]]+.C+,?RZT=I2O\KTA='3G!H(GCOQ6IS"^3GU9B >,T-D>)<;/P*L]4@YW$"5*SS$ML8/: I>M!J M# ELFAR/_7/8$$\_KW]=_ 8MH.NYA,=K^ 76*VDSY2]E"LJ!3XH"G6Q- MJ@[:7$3]M(Y+0DR(4U",\CQNP>+#^>^F21ZHVW&T9O5%CW4E.ZN M40,4!?8;>?5D$$)-64ZK JI"O??J@8;K8/PJCMH>(+$"K\9H*LZB5BM!+K;M M$V%<;;9@D/ 3*_BWA&HWKDYK5[!M>-1_ M^K"91YF4G^W_^->GVWF49.$?WW0?X<:C*5O1!5XE6SW&9 M(HF-?"/9?_UVG?2L:]V:J3EMPAV]U6,!L!()L+A;>$LBL*<=QRL"AR^[[EH! M'/:A B@!0C'#:@A"PO\J3(,<8-[JS5+*,T6S\\NK%_ 4AK8*3AIKW\-G#)8 MY$TT/82 MQ=F6$\A>"P4FMLYHA_0>NUS8^T!VI&9>GROOYUK.#K#UJS LZ42PP('; MQV/P?R%A R)LA370Q"[:W>U+W:- [VMGG7;C:L7Y[MK;/#R>(UB "*#@/+Q['O.ZB&3>W[E;&@!^ @]QX2&*"V*1T4LE=6OWTP MR=C>W$ =$?P5.7&,_GGZ<4O[I;>!.(A]?KJ]"^ W\COC^0T3V,XQ_;197&L< M>0\6$\;W]^/WYR,#":_%X"):+A<+Y&'_I9NP-J,;>!^"SB,-A4C7_\$ U'F; M20BO;F>_7VNSD@4OSQSE)]FC(I!RK'PZ"@NW]S1JI#4-]!8(2=\(UHBQ!T:> M5LAM'DDZ0&V>5+-QVO9$8CMV ,-(F0L @NT_-^,08O[JZSX$8GN"&&;>Y&E( ML]#)7F] ODP8!^;R"3$ 1/9= 9]-?%JY!_=>L>=L1..07*-<_P;W9YX1.OP> MF&T!?T/#T!_VWF,U(%TAL# S_O%1FU:>MMW-TRU[JF;P"OF7/).MY/O#S8PA MAO7?0O=3X)ZGNJ)#*G#/4V($GJ9_.P_W^1W[]#P1/3!$08=Y'I']=0%6<9*& MW5&X>72P]].7,/UNN]RL'G:ZGOI(7B, 2/U'54[UCN?BZ$O_#-IR;5)+9'D- MDTTA[LHT56>,61U=+[X=\&6=*<8FJ=BB'IW.<]\051.\[G^$QX"E$KYA2AG6 M\;I?8C6W/AY4%\;@\WI-TX'9L^+8\(B,YJ-_MPY3GH=0=*8Z&-@25-K.%1[4 MTZG]SP\$MHO 9,=^4)PFZT%TO0/(/ @N%_ 0VW!CWLE7#U]NL..3X< F"\4Q M[*[ 9TXQL<&,,1H+F#7X!"?"\4U=>"ONN5C$EH5"NVLNEG19K7];'#Z M':GF;TGSQ)=F&H: E/\W0Z[\,_QBOY:S0 W@=1\^P#M%T,X^BB&3QU6Z,[2@ MX0+Z;S*Z@">C%%@*V(5<2^>[%?*+T(H7%V?>#"!DA:=TA-!ZQKOOX93X:D5H MJG?3L09<.L@#HLG-$R][ 1M-Q@QR%F M [UCF7GF(A$-NX.#:?K/FF;TCNZBHP#^T_=Q!*B#6U!R8%^BW4W4ZDJ='>]/ MV[N1-09H;Q!@(>B3\I A A)X%T+&\/2QR78]XAOV\ M?-__'CJ%G)(([;64S"N_)4R.3W[P%.-JWOK/5O/&OSF:4NU]#5/_ Y\C)(#0 M?00&"-U'G(# _>=E:ON*6F#"$%3 OXO8 O[=:S"!S9_W(%7,:.RAKX47+]B)?1+2 \,-?2D-SE@R3P//)B%GRGB6NT^M MX;7(L!OAW//^S09;\.>Q"5)U@8/VQQ&0"X-8#7Y?J^#LM,&9K((+F08#)*:+ M1SEU&):.TQ$D1M[<'V @K(0,A,L<3\_0/V"OF9[]WW]S+-E_Z"M^MG__R:$$ M\Y'Y-QG[GB#P$O?WG/FAE/M#G'Q#V?N^WAM.UA^VV52FOF=.')YXO^<\>8GS M!QST]9H8^GUL7PMGV@\]-9QN[^_Z?M;VER*Z$^V%I8F?*^^8N!G>N'J4,-YJ['[2Y^_N6@ZZ;_ M(YUR"1JH=Y@G\2VE(+>E('"ACS_5Z3=3GB9XY5.H:W.X+IB"DI,24$ MP@P]_IX]ZAXLT%.9YZ"?)80S\3QNL\\R OD/)M*ZWMT7 ;"@0)M1WI@"&1$P M)@]*7^^W\U)T5^4"U$C!T!)R/WD' _ DZ\&>N2.00*-#AHQ1RAZ=>92HAAP> MWL3O3 #XF0A+X!^^8E)T"#4-5NZFHYUCVY]]#1R/@/?=4J#;\9=/M^N/E!BG M.CW3Y1Q!92H/,O;J+M=<5&OZVB&E<-4=((?1A-T6 1[M^<(P\+'-&@1V"'N M?+MQ+430GX\KA Y]3XP$&6_"(=3^HL33KH;.9L* )1,[/GXX%0#+"/E27VI< M"P6,<+:X73[=CBW,GQ5X JP0^G=AVS(W])+%>YPV>HK;$-2$)YYMY F,^N%+ MC\RG $]PD3=>1@UM;B--C+3?0Y48>3*X+N$MF5OPS!%0&P*#D/Q-E<#*P+=Z MF3N%@6*!E>I; #S 23Q0OT\-T[$UOJ$PG5#^W9;1"+SETSN9"9Z21X6GY _, MMAQH8Q3H8#SG3<$&^.ZX6QEU%7*U?.UWV-FXT5L&]Q6 1AUGHDEPI77].@B:K ).F@M9@S"10BI.M'%5 M&32U I(W-HFS8!Z&RX 3*G :BY;?IU+$* (VQ5M MCO[_O,K_6/'EJS^7["Z50\%/J-%VJ!,0N3@%DD[5Y9>WQF]P<"M(R?6>GZ(()GNSW M5GBT'$>M1HH$3_8'R&G+KUS!Z2F7?@502P,$% @ YV@)3S(%_!#F!0 M$30 \ !X;"]W;W)K8F]O:RYX;6S%F]]3VS@0@/\539[:!RZ)XQ\M \Q0 M0GN9@<"0E-<;Q5:(!EO*23:4_O5=.81(.;-S+TN>2&S'_BQ;^ZU6XN19F\>% MUH_L5U4J>]I;U?7ZN-^W^4I4W/ZEUT+!GJ4V%:_AJWGHV[41O+ K(>JJ[$># M0=JON%2]LY/MN6Y-W_^B:Y'74BO8Z#;<2_%L=_O=5\;A@"%/K M[[*LA1GS6OPPNEE+]7#:&_;84AI;S]RUVR,KJ60E?XNB_697^OEO;>1OK6I> MSG*CR[+]E=O1_@BN8-^VW M3RSPXL.:+.PZLI[UT "=\DE8N9"GKE]->^[D4 M/;B+OG<;;3ML_VX:\=C\GV;4RZ7,Q5CG3254O6E'(TIW=657!8=R]PZ4FQN:\:6FP'R\RQA!UF4@P=.!WDS^GYS_%D M?CEF%S?3\>5TMODTN[F:C,_GEQYDA$!&!X3\)_(@1PCDZ)"0(P\R1B#C0T+& M'F2"0":'A$P\R!2!3 \)F7J0&0*9'1(R\R"_()!?:"%G355Q\\+TDLWD@Y+P M,^ZB9I[K!J*F!_D5@?Q*"SD5SR6$;VL;4;RAJ0<&EE3PV0_F RR:#ZC;& MW?,2Z*X%MXT1[@<^'>:8(;%DKKEY%)#LE(+-1-X8:#IA?3C,+4-BN4P4/-4: M\K@0"3/)D%@E/[0NGF59MEU@ MFE>G $[-Q:R/Y\2DPE0V*77,&+%K89YHPA ML32NM'HXF@M30?>$W1#O;KF!W/66O_"69(>)66-(K(T=YE@L@@Z*:6)([(F) MRG4EV)S_"AYHA$DA(I;"3;T2YO65;SO"E>3MZ"CLJ!%FA(C8"&,81EH8(D&\ M=8D $+-; 2*KCHB(];#-0Q8O+I$KX,'Z9)@2 M(F(E0)M5LG8';;KLA6[S3:'RO4Z+F2(B-H7+-L6_C:MQ7#KU!V"8&Z)##BF" M@D&$R2(BED5WKLD^S9UG[6>_KH'Y8T3LC\ZDLY,2,\B(V"!>]MG)AFEC1*P- M/ UE/B9:P2)6R"8/[6P]S!\C8G^@"6E8_L-D,B*629B0=K8B9I01L5'\S+03 M#C/)B-@D6(H*L#XFYI41L5-;^WI8V+JB8G5\Q[F MZQC"Q\34$Q.KIQOS;:N/B=DG)J]_>5GX&-!D&43+!/-.0NP=- T/PE"">2DV MLUS[F.B\//4(9XMYS>MM! ),.*5K6'\*+\'$DWS(=(H+X7"RHBG;BO+WIJTM M7X>8F'B20\ZSA-T<$T_R8?,L79A!-\?$DQ"+!\<,%HU@"DJ)%;17)/#?T+UI MK!134$I>3/.*!?\-G3XFIJ"46$%[F.%(\IN?L*>8@E)B!>UANN$%#-!*V1[) M_/">8A9*B2V$%F&._"IEBEDH);80BAED<2FZ/HS80CBF']Y3S$+I(2MO07A/ M,0NEQ!9"YX?#AXY9*"6V4%>!L+N"D&$6RH@MU(TY$T^0R*D\P,0LE!%;J*.4 MZ4=/'Q.S4$9LH4[,G3)]3,Q"&;&%L*HKC#Q\3,Q"V8>O%GBW-3$+91^^=&!7 M,X((Y6-B%LH.N8X@B)L9NDZ9V$(XIB_+#+-01KZN8&_!0Y@;^YB8A;+60OWV M8'MV4HBE5**8PB4L;,]YF=\:YOZTR]FB.'%+VI9-65[ MAMUI;G;WIYC^]\X M9W\ 4$L#!!0 ( .=H"4]TF.'C? ( $(O : >&PO7W)E;',O=V]R M:V)O;VLN>&UL+G)E;'/%VDUNVS 0AN&K&#I :,Z00Z>(L^HFV[87$&SZ![$E M0531Y/95O:D*)/JZ,#YM+!@6.._JL4#QZ5N^U,.Y;ZV/V@O06_AZ"]!;^'H+T%OX>@O0 M6_AZ"]!;^'H+T%OX>@O06_AZ*]!;^7HKT%OY>BO06Q?8*T&;)7R]%>BM?+T5 MZ*U\O17HK7R]%>BM?+T5Z*U\O17HK7R] ] [\/4.0._ USL O0-?[P#T#@OL M=:/-;K[> >@=^'H'H'?@ZQV WH&O=P!Z![[> >@=^'I'H'?DZQV!WI&O=P1Z M1[[>$>@=^7I'H'=EG)USL"O2-?[PCTCGR](] [\O6.0._(U]N WL;7 MVX#>QM?;@-[&U]N WL;7VX#>QM?;@-ZVP%D3=-B$K[B>^W@GHG?AZ)Z!WXNN=@-Z)KW<">B>^W@GHG?AZ)Z!W6N"L(#HLR-<[ M ;T37^\$]$Y\O3<3O7!E&ULS=K?;ILP% ;P5XFXG8+C_]O4]&;M M[59I>P$/3@(*8,MVN_3M9V@[:54F=6HB?37JQV.@M#J.PY2V M59=S^,Q8:CH:7:I]H*E4=CZ.+I?3N&?!-0>W)R8V&\,:/V6:\CK//:KKJQO: MN?LAK[X\79];;RL7PM W+O=^8@]3^ZKI^KEA'6E8UJ2N#^E#65"M;H^E2RK7 MME6IIHJ]8<+K&^?S^OER") <$B2' LFA07(8D!P6),='D!R?0'+P#4H0%%$Y"JD73_]*\E/[P\O\]GR+_#KWU!+ 0(4 Q0 ( .=H"4\? M(\\#P !," + " 0 !?D !D;V-0 M&UL4$L! A0#% @ YV@)3^FR2,WO *P( !$ M ( !F0$ &1O8U!R;W!S+V-O&UL4$L! A0#% @ YV@) M3YE&PO=V]R:W-H965T&UL4$L! A0#% @ YV@) M3R).L WX! R!@ !@ ( !J L 'AL+W=O&PO=V]R:W-H M965T&UL4$L! A0#% @ YV@)3S%#:CUW! NA4 !@ M ( !]14 'AL+W=O&PO=V]R:W-H965T&UL M4$L! A0#% @ YV@)3Q3:.WI1!0 81L !@ ( !/B0 M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ YV@)3UP/Z/JU 0 T@, !D M ( !AB\ 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ YV@)3X#["&&U 0 T , !D ( !1S4 M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ MYV@)3W_7$T"U 0 T@, !D ( !"CL 'AL+W=O&PO=V]R:W-H965T(^ !X;"]W M;W)K&UL4$L! A0#% @ YV@)3VSWY>RR 0 MT@, !D ( !S4 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ YV@)3R/XG%>S 0 T@, !D M ( !CD8 'AL+W=O&PO=V]R:W-H M965T&UL4$L! M A0#% @ YV@)3]6+Q'BS 0 T@, !D ( !44P 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ YV@) M3^H5;TFW 0 T@, !D ( !05( 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ YV@)3_RGRG'$ 0 -P0 M !D ( !&%@ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ YV@)3ULZ"M2W 0 T@, !D M ( !!EX 'AL+W=O3<,! W! &0 @ 'T7P >&PO=V]R:W-H965T MYA !X;"]W;W)K&UL4$L! A0# M% @ YV@)3YO0<$2W 0 T@, !D ( !!V0 'AL+W=O M&PO=V]R:W-H965T-G M !X;"]W;W)K&UL4$L! A0#% @ YV@)3]$* M*?ZW 0 T@, !D ( !T&D 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ YV@)3]K:E-N= 0 6 , !D M ( !C' 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ YV@)3]S &(4'! PA, !D ( ! M-'D 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ YV@)3[S8UN\) P [@P !D ( !'(, 'AL+W=OF( !X M;"]W;W)K&UL4$L! A0#% @ YV@)3ZNO]E,: M P J0T !D ( !;(L 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ YV@)3SB'-2+^ 0 NP4 !D M ( !3Y, 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ YV@)3Z@5H4EO @ Q0< !D ( !K)P M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ MYV@)3W4=+ZNV @ M0D !D ( !EZ0 'AL+W=O&UL4$L! A0#% @ YV@)3_WT5@XF @ MB08 !D ( !=ZX 'AL+W=OFP" P" &0 @ '4 ML >&PO=V]R:W-H965TS !X;"]W;W)K&UL4$L! A0#% @ YV@)3R)7(!^) @ D@D !D M ( !T[4 'AL+W=O&PO=V]R:W-H M965T&UL4$L! M A0#% @ YV@)3Z)MT5O? @ L !D ( !1, 'AL M+W=O,K T" M "4!0 &0 @ %:PP >&PO=V]R:W-H965T&UL4$L! A0#% @ YV@) M3X*#0RH* @ BP4 !D ( !5YEH# !R#@ &0 M @ &6RP >&PO=V]R:W-H965T&UL4$L! A0#% @ YV@)3RRE_.GZ 0 NP4 M !D ( !"-$ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ YV@)3S(%_!#F!0 $30 \ M ( !-F7!E&UL4$L%!@ !8 %@ *&A@ $YR 0 $! end XML 92 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 93 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 94 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.2 html 216 395 1 false 63 0 false 5 false false R1.htm 0001000 - Document - Document And Entity Information Sheet http://www.avadel.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 1001000 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF LOSS Sheet http://www.avadel.com/role/UnauditedCondensedConsolidatedStatementsOfLoss UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF LOSS Statements 2 false false R3.htm 1002000 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Sheet http://www.avadel.com/role/UnauditedCondensedConsolidatedStatementsOfComprehensiveLoss UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Statements 3 false false R4.htm 1002501 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) Sheet http://www.avadel.com/role/UnauditedCondensedConsolidatedStatementsOfComprehensiveIncomeLossParenthetical UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) Statements 4 false false R5.htm 1003000 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.avadel.com/role/UnauditedCondensedConsolidatedBalanceSheets UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS Statements 5 false false R6.htm 1003501 - Statement - UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.avadel.com/role/UnauditedCondensedConsolidatedBalanceSheetsParenthetical UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 6 false false R7.htm 1004000 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS??? (DEFICIT) EQUITY Statement Sheet http://www.avadel.com/role/UnauditedCondensedConsolidatedStatementsOfShareholdersDeficitEquityStatement UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS??? (DEFICIT) EQUITY Statement Statements 7 false false R8.htm 1005000 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.avadel.com/role/UnauditedCondensedConsolidatedStatementsOfCashFlows UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 8 false false R9.htm 2101100 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.avadel.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 2102100 - Disclosure - Newly Issued Accounting Pronouncements Sheet http://www.avadel.com/role/NewlyIssuedAccountingPronouncements Newly Issued Accounting Pronouncements Notes 10 false false R11.htm 2103100 - Disclosure - Subsidiary Bankruptcy and Deconsolidation Sheet http://www.avadel.com/role/SubsidiaryBankruptcyAndDeconsolidation Subsidiary Bankruptcy and Deconsolidation Notes 11 false false R12.htm 2104100 - Disclosure - Revenue Recognition Sheet http://www.avadel.com/role/RevenueRecognition Revenue Recognition Notes 12 false false R13.htm 2105100 - Disclosure - Fair Value Measurement Sheet http://www.avadel.com/role/FairValueMeasurement Fair Value Measurement Notes 13 false false R14.htm 2107100 - Disclosure - Marketable Securities Sheet http://www.avadel.com/role/MarketableSecurities Marketable Securities Notes 14 false false R15.htm 2108100 - Disclosure - Inventories Sheet http://www.avadel.com/role/Inventories Inventories Notes 15 false false R16.htm 2109100 - Disclosure - Goodwill and Intangible Assets Sheet http://www.avadel.com/role/GoodwillAndIntangibleAssets Goodwill and Intangible Assets Notes 16 false false R17.htm 2110100 - Disclosure - Leases Sheet http://www.avadel.com/role/Leases Leases Notes 17 false false R18.htm 2111100 - Disclosure - Long-Term Related Party Payable Sheet http://www.avadel.com/role/LongTermRelatedPartyPayable Long-Term Related Party Payable Notes 18 false false R19.htm 2112100 - Disclosure - Long-Term Debt Sheet http://www.avadel.com/role/LongTermDebt Long-Term Debt Notes 19 false false R20.htm 2113100 - Disclosure - Income Taxes Sheet http://www.avadel.com/role/IncomeTaxes Income Taxes Notes 20 false false R21.htm 2114100 - Disclosure - Other Assets and Liabilities Sheet http://www.avadel.com/role/OtherAssetsAndLiabilities Other Assets and Liabilities Notes 21 false false R22.htm 2115100 - Disclosure - Divestiture of the Pediatric Assets Sheet http://www.avadel.com/role/DivestitureOfPediatricAssets Divestiture of the Pediatric Assets Notes 22 false false R23.htm 2116100 - Disclosure - Restructuring Costs Sheet http://www.avadel.com/role/RestructuringCosts Restructuring Costs Notes 23 false false R24.htm 2117100 - Disclosure - Net Loss Per Share Sheet http://www.avadel.com/role/NetLossPerShare Net Loss Per Share Notes 24 false false R25.htm 2118100 - Disclosure - Comprehensive Loss Sheet http://www.avadel.com/role/ComprehensiveLoss Comprehensive Loss Notes 25 false false R26.htm 2119100 - Disclosure - Revenue by Product Sheet http://www.avadel.com/role/RevenueByProduct Revenue by Product Notes 26 false false R27.htm 2120100 - Disclosure - Commitments and Contingencies Sheet http://www.avadel.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 27 false false R28.htm 2122100 - Disclosure - Subsequent Events Sheet http://www.avadel.com/role/SubsequentEvents Subsequent Events Notes 28 false false R29.htm 2201201 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.avadel.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.avadel.com/role/SummaryOfSignificantAccountingPolicies 29 false false R30.htm 2305301 - Disclosure - Fair Value Measurement (Tables) Sheet http://www.avadel.com/role/FairValueMeasurementTables Fair Value Measurement (Tables) Tables http://www.avadel.com/role/FairValueMeasurement 30 false false R31.htm 2307301 - Disclosure - Marketable Securities (Tables) Sheet http://www.avadel.com/role/MarketableSecuritiesTables Marketable Securities (Tables) Tables http://www.avadel.com/role/MarketableSecurities 31 false false R32.htm 2308301 - Disclosure - Inventories (Tables) Sheet http://www.avadel.com/role/InventoriesTables Inventories (Tables) Tables http://www.avadel.com/role/Inventories 32 false false R33.htm 2309301 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://www.avadel.com/role/GoodwillAndIntangibleAssetsTables Goodwill and Intangible Assets (Tables) Tables http://www.avadel.com/role/GoodwillAndIntangibleAssets 33 false false R34.htm 2310301 - Disclosure - Leases (Tables) Sheet http://www.avadel.com/role/LeasesTables Leases (Tables) Tables http://www.avadel.com/role/Leases 34 false false R35.htm 2311301 - Disclosure - Long-Term Related Party Payable (Tables) Sheet http://www.avadel.com/role/LongTermRelatedPartyPayableTables Long-Term Related Party Payable (Tables) Tables http://www.avadel.com/role/LongTermRelatedPartyPayable 35 false false R36.htm 2312301 - Disclosure - Long-Term Debt (Tables) Sheet http://www.avadel.com/role/LongTermDebtTables Long-Term Debt (Tables) Tables http://www.avadel.com/role/LongTermDebt 36 false false R37.htm 2313301 - Disclosure - Income Taxes (Tables) Sheet http://www.avadel.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.avadel.com/role/IncomeTaxes 37 false false R38.htm 2314301 - Disclosure - Other Assets and Liabilities (Tables) Sheet http://www.avadel.com/role/OtherAssetsAndLiabilitiesTables Other Assets and Liabilities (Tables) Tables http://www.avadel.com/role/OtherAssetsAndLiabilities 38 false false R39.htm 2316301 - Disclosure - Restructuring Costs (Tables) Sheet http://www.avadel.com/role/RestructuringCostsTables Restructuring Costs (Tables) Tables http://www.avadel.com/role/RestructuringCosts 39 false false R40.htm 2317301 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.avadel.com/role/NetLossPerShareTables Net Loss Per Share (Tables) Tables http://www.avadel.com/role/NetLossPerShare 40 false false R41.htm 2318301 - Disclosure - Comprehensive Income (Loss) (Tables) Sheet http://www.avadel.com/role/ComprehensiveIncomeLossTables Comprehensive Income (Loss) (Tables) Tables 41 false false R42.htm 2319301 - Disclosure - Revenue by Product (Tables) Sheet http://www.avadel.com/role/RevenueByProductTables Revenue by Product (Tables) Tables http://www.avadel.com/role/RevenueByProduct 42 false false R43.htm 2320301 - Disclosure - Commitments and Contingencies - (Tables) Sheet http://www.avadel.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies - (Tables) Tables http://www.avadel.com/role/CommitmentsAndContingencies 43 false false R44.htm 2403401 - Disclosure - Subsidiary Bankruptcy and Deconsolidation (Details) Sheet http://www.avadel.com/role/SubsidiaryBankruptcyAndDeconsolidationDetails Subsidiary Bankruptcy and Deconsolidation (Details) Details http://www.avadel.com/role/SubsidiaryBankruptcyAndDeconsolidation 44 false false R45.htm 2404401 - Disclosure - Revenue Recognition - Narrative (Details) Sheet http://www.avadel.com/role/RevenueRecognitionNarrativeDetails Revenue Recognition - Narrative (Details) Details 45 false false R46.htm 2405402 - Disclosure - Fair Value Measurement Fair Value Measurement - Measured on Recurring Basis (Details) Sheet http://www.avadel.com/role/FairValueMeasurementFairValueMeasurementMeasuredOnRecurringBasisDetails Fair Value Measurement Fair Value Measurement - Measured on Recurring Basis (Details) Details 46 false false R47.htm 2407402 - Disclosure - Marketable Securities - Narrative (Details) Sheet http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails Marketable Securities - Narrative (Details) Details 47 false false R48.htm 2407403 - Disclosure - Marketable Securities - Summary of Marketable Securities (Details) Sheet http://www.avadel.com/role/MarketableSecuritiesSummaryOfMarketableSecuritiesDetails Marketable Securities - Summary of Marketable Securities (Details) Details 48 false false R49.htm 2407404 - Disclosure - Marketable Securities Marketable Securities - Schedule of Maturities (Details) Sheet http://www.avadel.com/role/MarketableSecuritiesMarketableSecuritiesScheduleOfMaturitiesDetails Marketable Securities Marketable Securities - Schedule of Maturities (Details) Details 49 false false R50.htm 2408402 - Disclosure - Inventories (Details) Sheet http://www.avadel.com/role/InventoriesDetails Inventories (Details) Details http://www.avadel.com/role/InventoriesTables 50 false false R51.htm 2409402 - Disclosure - Goodwill and Intangible Assets - Gross Value and Net Carrying Amount (Details) Sheet http://www.avadel.com/role/GoodwillAndIntangibleAssetsGrossValueAndNetCarryingAmountDetails Goodwill and Intangible Assets - Gross Value and Net Carrying Amount (Details) Details 51 false false R52.htm 2409403 - Disclosure - Goodwill and Intangible Assets - Narrative (Details) Sheet http://www.avadel.com/role/GoodwillAndIntangibleAssetsNarrativeDetails Goodwill and Intangible Assets - Narrative (Details) Details 52 false false R53.htm 2409404 - Disclosure - Goodwill and Intangible Assets - Estimated Future Amortization (Details) Sheet http://www.avadel.com/role/GoodwillAndIntangibleAssetsEstimatedFutureAmortizationDetails Goodwill and Intangible Assets - Estimated Future Amortization (Details) Details 53 false false R54.htm 2410402 - Disclosure - Leases - Narrative (Details) Sheet http://www.avadel.com/role/LeasesNarrativeDetails Leases - Narrative (Details) Details 54 false false R55.htm 2410403 - Disclosure - Leases - Components of lease costs (Details) Sheet http://www.avadel.com/role/LeasesComponentsOfLeaseCostsDetails Leases - Components of lease costs (Details) Details 55 false false R56.htm 2410404 - Disclosure - Leases - Maturities of operating lease liabilities (Details) Sheet http://www.avadel.com/role/LeasesMaturitiesOfOperatingLeaseLiabilitiesDetails Leases - Maturities of operating lease liabilities (Details) Details 56 false false R57.htm 2410405 - Disclosure - Leases - Schedule of Future Minimum Rental Payments for Operating Leases (Details) Sheet http://www.avadel.com/role/LeasesScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails Leases - Schedule of Future Minimum Rental Payments for Operating Leases (Details) Details 57 false false R58.htm 2411402 - Disclosure - Long-Term Related Party Payable - Narrative (Details) Sheet http://www.avadel.com/role/LongTermRelatedPartyPayableNarrativeDetails Long-Term Related Party Payable - Narrative (Details) Details 58 false false R59.htm 2411403 - Disclosure - Long-Term Related Party Payable - Activity (Details) Sheet http://www.avadel.com/role/LongTermRelatedPartyPayableActivityDetails Long-Term Related Party Payable - Activity (Details) Details 59 false false R60.htm 2411404 - Disclosure - Long-Term Related Party Payable Long-Term Related Party Payable - Payable Balance (Details) Sheet http://www.avadel.com/role/LongTermRelatedPartyPayableLongTermRelatedPartyPayablePayableBalanceDetails Long-Term Related Party Payable Long-Term Related Party Payable - Payable Balance (Details) Details 60 false false R61.htm 2412402 - Disclosure - Long-Term Debt Schedule of Debt (Details) Sheet http://www.avadel.com/role/LongTermDebtScheduleOfDebtDetails Long-Term Debt Schedule of Debt (Details) Details 61 false false R62.htm 2413402 - Disclosure - Income Taxes - Narrative (Details) Sheet http://www.avadel.com/role/IncomeTaxesNarrativeDetails Income Taxes - Narrative (Details) Details 62 false false R63.htm 2413403 - Disclosure - Income Taxes - Income (Loss) Before Income Taxes (Details) Sheet http://www.avadel.com/role/IncomeTaxesIncomeLossBeforeIncomeTaxesDetails Income Taxes - Income (Loss) Before Income Taxes (Details) Details 63 false false R64.htm 2413404 - Disclosure - Income Taxes - Reconciliation of Tax Rate (Details) Sheet http://www.avadel.com/role/IncomeTaxesReconciliationOfTaxRateDetails Income Taxes - Reconciliation of Tax Rate (Details) Details 64 false false R65.htm 2414402 - Disclosure - Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details) Sheet http://www.avadel.com/role/OtherAssetsAndLiabilitiesPrepaidExpensesAndOtherCurrentAssetsDetails Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details) Details 65 false false R66.htm 2414403 - Disclosure - Other Assets and Liabilities - Other Non-Current Assets (Details) Sheet http://www.avadel.com/role/OtherAssetsAndLiabilitiesOtherNonCurrentAssetsDetails Other Assets and Liabilities - Other Non-Current Assets (Details) Details 66 false false R67.htm 2414404 - Disclosure - Other Assets and Liabilities - Accrued Expenses (Details) Sheet http://www.avadel.com/role/OtherAssetsAndLiabilitiesAccruedExpensesDetails Other Assets and Liabilities - Accrued Expenses (Details) Details 67 false false R68.htm 2414405 - Disclosure - Other Assets and Liabilities - Other Non-Current Liabilities (Details) Sheet http://www.avadel.com/role/OtherAssetsAndLiabilitiesOtherNonCurrentLiabilitiesDetails Other Assets and Liabilities - Other Non-Current Liabilities (Details) Details 68 false false R69.htm 2415401 - Disclosure - Divestiture of the Pediatric Assets - Narrative (Details) Sheet http://www.avadel.com/role/DivestitureOfPediatricAssetsNarrativeDetails Divestiture of the Pediatric Assets - Narrative (Details) Details 69 false false R70.htm 2416402 - Disclosure - Restructuring Costs - Narrative (Details) Sheet http://www.avadel.com/role/RestructuringCostsNarrativeDetails Restructuring Costs - Narrative (Details) Details 70 false false R71.htm 2416403 - Disclosure - Restructuring Costs - Severance Obligation (Details) Sheet http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails Restructuring Costs - Severance Obligation (Details) Details 71 false false R72.htm 2417402 - Disclosure - Net Loss Per Share - Reconciliation of Basic and Diluted Calculation (Details) Sheet http://www.avadel.com/role/NetLossPerShareReconciliationOfBasicAndDilutedCalculationDetails Net Loss Per Share - Reconciliation of Basic and Diluted Calculation (Details) Details 72 false false R73.htm 2417403 - Disclosure - Net Loss Per Share - Narrative (Details) Sheet http://www.avadel.com/role/NetLossPerShareNarrativeDetails Net Loss Per Share - Narrative (Details) Details 73 false false R74.htm 2418402 - Disclosure - Comprehensive Income (Loss) - Components (Details) Sheet http://www.avadel.com/role/ComprehensiveIncomeLossComponentsDetails Comprehensive Income (Loss) - Components (Details) Details http://www.avadel.com/role/ComprehensiveIncomeLossTables 74 false false R75.htm 2418403 - Disclosure - Comprehensive Loss - Narrative (Details) Sheet http://www.avadel.com/role/ComprehensiveLossNarrativeDetails Comprehensive Loss - Narrative (Details) Details 75 false false R76.htm 2419402 - Disclosure - Revenue by Product - Summary of Revenue (Details) Sheet http://www.avadel.com/role/RevenueByProductSummaryOfRevenueDetails Revenue by Product - Summary of Revenue (Details) Details 76 false false R77.htm 2420402 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://www.avadel.com/role/CommitmentsAndContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 77 false false R78.htm 2420403 - Disclosure - Commitments and Contingencies - Purchase Commitments (Details) Sheet http://www.avadel.com/role/CommitmentsAndContingenciesPurchaseCommitmentsDetails Commitments and Contingencies - Purchase Commitments (Details) Details 78 false false R79.htm 2422401 - Disclosure - Subsequent Events - Narrative (Details) Sheet http://www.avadel.com/role/SubsequentEventsNarrativeDetails Subsequent Events - Narrative (Details) Details 79 false false All Reports Book All Reports avdl-20190630.xml avdl-20190630.xsd avdl-20190630_cal.xml avdl-20190630_def.xml avdl-20190630_lab.xml avdl-20190630_pre.xml http://fasb.org/srt/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/us-gaap/2018-01-31 http://xbrl.sec.gov/country/2017-01-31 true true ZIP 96 0001012477-19-000008-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001012477-19-000008-xbrl.zip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�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end